Motif 1059 (n=163)
Position-wise Probabilities
Download
uniprot | genes | site | source | protein | function |
---|---|---|---|---|---|
A5A3E0 | POTEF | T789 | ochoa | POTE ankyrin domain family member F (ANKRD26-like family C member 1B) (Chimeric POTE-actin protein) | None |
H0YHG0 | None | T378 | ochoa | DnaJ homolog subfamily C member 14 (Nuclear protein Hcc-1) (SAP domain-containing ribonucleoprotein) | Binds both single-stranded and double-stranded DNA with higher affinity for the single-stranded form. Specifically binds to scaffold/matrix attachment region DNA. Also binds single-stranded RNA. Enhances RNA unwinding activity of DDX39A. May participate in important transcriptional or translational control of cell growth, metabolism and carcinogenesis. Component of the TREX complex which is thought to couple mRNA transcription, processing and nuclear export, and specifically associates with spliced mRNA and not with unspliced pre-mRNA. The TREX complex is recruited to spliced mRNAs by a transcription-independent mechanism, binds to mRNA upstream of the exon-junction complex (EJC) and is recruited in a splicing- and cap-dependent manner to a region near the 5' end of the mRNA where it functions in mRNA export to the cytoplasm via the TAP/NXF1 pathway. Associates with DDX39B, which facilitates RNA binding of DDX39B and likely plays a role in mRNA export. {ECO:0000256|ARBA:ARBA00054093}.; FUNCTION: Regulates the export of target proteins, such as DRD1, from the endoplasmic reticulum to the cell surface. {ECO:0000256|ARBA:ARBA00055510}. |
H3BM21 | None | T210 | ochoa | Integrin beta | None |
L7N2F9 | None | T79 | ochoa | V-SNARE coiled-coil homology domain-containing protein | None |
O15400 | STX7 | T78 | ochoa | Syntaxin-7 | May be involved in protein trafficking from the plasma membrane to the early endosome (EE) as well as in homotypic fusion of endocytic organelles. Mediates the endocytic trafficking from early endosomes to late endosomes and lysosomes. |
O75116 | ROCK2 | T977 | ochoa | Rho-associated protein kinase 2 (EC 2.7.11.1) (Rho kinase 2) (Rho-associated, coiled-coil-containing protein kinase 2) (Rho-associated, coiled-coil-containing protein kinase II) (ROCK-II) (p164 ROCK-2) | Protein kinase which is a key regulator of actin cytoskeleton and cell polarity. Involved in regulation of smooth muscle contraction, actin cytoskeleton organization, stress fiber and focal adhesion formation, neurite retraction, cell adhesion and motility via phosphorylation of ADD1, BRCA2, CNN1, EZR, DPYSL2, EP300, MSN, MYL9/MLC2, NPM1, RDX, PPP1R12A and VIM. Phosphorylates SORL1 and IRF4. Acts as a negative regulator of VEGF-induced angiogenic endothelial cell activation. Positively regulates the activation of p42/MAPK1-p44/MAPK3 and of p90RSK/RPS6KA1 during myogenic differentiation. Plays an important role in the timely initiation of centrosome duplication. Inhibits keratinocyte terminal differentiation. May regulate closure of the eyelids and ventral body wall through organization of actomyosin bundles. Plays a critical role in the regulation of spine and synaptic properties in the hippocampus. Plays an important role in generating the circadian rhythm of the aortic myofilament Ca(2+) sensitivity and vascular contractility by modulating the myosin light chain phosphorylation. {ECO:0000269|PubMed:10579722, ECO:0000269|PubMed:15699075, ECO:0000269|PubMed:16574662, ECO:0000269|PubMed:17015463, ECO:0000269|PubMed:19131646, ECO:0000269|PubMed:19997641, ECO:0000269|PubMed:21084279, ECO:0000269|PubMed:21147781}. |
O94986 | CEP152 | T1241 | ochoa | Centrosomal protein of 152 kDa (Cep152) | Necessary for centrosome duplication; the function also seems to involve CEP63, CDK5RAP2 and WDR62 through a stepwise assembled complex at the centrosome that recruits CDK2 required for centriole duplication (PubMed:26297806). Acts as a molecular scaffold facilitating the interaction of PLK4 and CPAP, 2 molecules involved in centriole formation (PubMed:20852615, PubMed:21059844). Proposed to snatch PLK4 away from PLK4:CEP92 complexes in early G1 daughter centriole and to reposition PLK4 at the outer boundary of a newly forming CEP152 ring structure (PubMed:24997597). Also plays a key role in deuterosome-mediated centriole amplification in multiciliated that can generate more than 100 centrioles (By similarity). Overexpression of CEP152 can drive amplification of centrioles (PubMed:20852615). {ECO:0000250|UniProtKB:A2AUM9, ECO:0000250|UniProtKB:Q498G2, ECO:0000269|PubMed:20852615, ECO:0000269|PubMed:21059844, ECO:0000269|PubMed:21131973}. |
P02545 | LMNA | T157 | ochoa | Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)] | [Lamin-A/C]: Lamins are intermediate filament proteins that assemble into a filamentous meshwork, and which constitute the major components of the nuclear lamina, a fibrous layer on the nucleoplasmic side of the inner nuclear membrane (PubMed:10080180, PubMed:10580070, PubMed:10587585, PubMed:10814726, PubMed:11799477, PubMed:12075506, PubMed:12927431, PubMed:15317753, PubMed:18551513, PubMed:18611980, PubMed:2188730, PubMed:22431096, PubMed:2344612, PubMed:23666920, PubMed:24741066, PubMed:31434876, PubMed:31548606, PubMed:37788673, PubMed:37832547). Lamins provide a framework for the nuclear envelope, bridging the nuclear envelope and chromatin, thereby playing an important role in nuclear assembly, chromatin organization, nuclear membrane and telomere dynamics (PubMed:10080180, PubMed:10580070, PubMed:10587585, PubMed:10814726, PubMed:11799477, PubMed:12075506, PubMed:12927431, PubMed:15317753, PubMed:18551513, PubMed:18611980, PubMed:22431096, PubMed:23666920, PubMed:24741066, PubMed:31548606, PubMed:37788673, PubMed:37832547). Lamin A and C also regulate matrix stiffness by conferring nuclear mechanical properties (PubMed:23990565, PubMed:25127216). The structural integrity of the lamina is strictly controlled by the cell cycle, as seen by the disintegration and formation of the nuclear envelope in prophase and telophase, respectively (PubMed:2188730, PubMed:2344612). Lamin A and C are present in equal amounts in the lamina of mammals (PubMed:10080180, PubMed:10580070, PubMed:10587585, PubMed:10814726, PubMed:11799477, PubMed:12075506, PubMed:12927431, PubMed:15317753, PubMed:18551513, PubMed:18611980, PubMed:22431096, PubMed:23666920, PubMed:31548606). Also invoved in DNA repair: recruited by DNA repair proteins XRCC4 and IFFO1 to the DNA double-strand breaks (DSBs) to prevent chromosome translocation by immobilizing broken DNA ends (PubMed:31548606). Required for normal development of peripheral nervous system and skeletal muscle and for muscle satellite cell proliferation (PubMed:10080180, PubMed:10814726, PubMed:11799477, PubMed:18551513, PubMed:22431096). Required for osteoblastogenesis and bone formation (PubMed:12075506, PubMed:15317753, PubMed:18611980). Also prevents fat infiltration of muscle and bone marrow, helping to maintain the volume and strength of skeletal muscle and bone (PubMed:10587585). Required for cardiac homeostasis (PubMed:10580070, PubMed:12927431, PubMed:18611980, PubMed:23666920). {ECO:0000269|PubMed:10080180, ECO:0000269|PubMed:10580070, ECO:0000269|PubMed:10587585, ECO:0000269|PubMed:10814726, ECO:0000269|PubMed:11799477, ECO:0000269|PubMed:12075506, ECO:0000269|PubMed:12927431, ECO:0000269|PubMed:15317753, ECO:0000269|PubMed:18551513, ECO:0000269|PubMed:18611980, ECO:0000269|PubMed:2188730, ECO:0000269|PubMed:22431096, ECO:0000269|PubMed:2344612, ECO:0000269|PubMed:23666920, ECO:0000269|PubMed:23990565, ECO:0000269|PubMed:24741066, ECO:0000269|PubMed:25127216, ECO:0000269|PubMed:31434876, ECO:0000269|PubMed:31548606, ECO:0000269|PubMed:37788673, ECO:0000269|PubMed:37832547}.; FUNCTION: [Prelamin-A/C]: Prelamin-A/C can accelerate smooth muscle cell senescence (PubMed:20458013). It acts to disrupt mitosis and induce DNA damage in vascular smooth muscle cells (VSMCs), leading to mitotic failure, genomic instability, and premature senescence (PubMed:20458013). {ECO:0000269|PubMed:20458013}. |
P02730 | SLC4A1 | T49 | psp | Band 3 anion transport protein (Anion exchange protein 1) (AE 1) (Anion exchanger 1) (Solute carrier family 4 member 1) (CD antigen CD233) | Functions both as a transporter that mediates electroneutral anion exchange across the cell membrane and as a structural protein (PubMed:10926824, PubMed:14734552, PubMed:1538405, PubMed:16227998, PubMed:20151848, PubMed:24121512, PubMed:28387307, PubMed:35835865). Component of the ankyrin-1 complex of the erythrocyte membrane; required for normal flexibility and stability of the erythrocyte membrane and for normal erythrocyte shape via the interactions of its cytoplasmic domain with cytoskeletal proteins, glycolytic enzymes, and hemoglobin (PubMed:1538405, PubMed:20151848, PubMed:35835865). Functions as a transporter that mediates the 1:1 exchange of inorganic anions across the erythrocyte membrane. Mediates chloride-bicarbonate exchange in the kidney, and is required for normal acidification of the urine (PubMed:10926824, PubMed:14734552, PubMed:16227998, PubMed:24121512, PubMed:28387307). {ECO:0000269|PubMed:10926824, ECO:0000269|PubMed:14734552, ECO:0000269|PubMed:1538405, ECO:0000269|PubMed:16227998, ECO:0000269|PubMed:20151848, ECO:0000269|PubMed:24121512, ECO:0000269|PubMed:28387307, ECO:0000269|PubMed:35835865}.; FUNCTION: (Microbial infection) Acts as a receptor for P.falciparum (isolate 3D7) MSP9 and thus, facilitates merozoite invasion of erythrocytes (PubMed:14630931). Acts as a receptor for P.falciparum (isolate 3D7) MSP1 and thus, facilitates merozoite invasion of erythrocytes (PubMed:12692305). {ECO:0000269|PubMed:12692305, ECO:0000269|PubMed:14630931}. |
P05106 | ITGB3 | T221 | ochoa | Integrin beta-3 (Platelet membrane glycoprotein IIIa) (GPIIIa) (CD antigen CD61) | Integrin alpha-V/beta-3 (ITGAV:ITGB3) is a receptor for cytotactin, fibronectin, laminin, matrix metalloproteinase-2, osteopontin, osteomodulin, prothrombin, thrombospondin, vitronectin and von Willebrand factor. Integrin alpha-IIb/beta-3 (ITGA2B:ITGB3) is a receptor for fibronectin, fibrinogen, plasminogen, prothrombin, thrombospondin and vitronectin. Integrins alpha-IIb/beta-3 and alpha-V/beta-3 recognize the sequence R-G-D in a wide array of ligands. Integrin alpha-IIb/beta-3 recognizes the sequence H-H-L-G-G-G-A-K-Q-A-G-D-V in fibrinogen gamma chain (By similarity). Following activation integrin alpha-IIb/beta-3 brings about platelet/platelet interaction through binding of soluble fibrinogen (PubMed:9111081). This step leads to rapid platelet aggregation which physically plugs ruptured endothelial surface. Fibrinogen binding enhances SELP expression in activated platelets (By similarity). ITGAV:ITGB3 binds to fractalkine (CX3CL1) and acts as its coreceptor in CX3CR1-dependent fractalkine signaling (PubMed:23125415, PubMed:24789099). ITGAV:ITGB3 binds to NRG1 (via EGF domain) and this binding is essential for NRG1-ERBB signaling (PubMed:20682778). ITGAV:ITGB3 binds to FGF1 and this binding is essential for FGF1 signaling (PubMed:18441324). ITGAV:ITGB3 binds to FGF2 and this binding is essential for FGF2 signaling (PubMed:28302677). ITGAV:ITGB3 binds to IGF1 and this binding is essential for IGF1 signaling (PubMed:19578119). ITGAV:ITGB3 binds to IGF2 and this binding is essential for IGF2 signaling (PubMed:28873464). ITGAV:ITGB3 binds to IL1B and this binding is essential for IL1B signaling (PubMed:29030430). ITGAV:ITGB3 binds to PLA2G2A via a site (site 2) which is distinct from the classical ligand-binding site (site 1) and this induces integrin conformational changes and enhanced ligand binding to site 1 (PubMed:18635536, PubMed:25398877). ITGAV:ITGB3 acts as a receptor for fibrillin-1 (FBN1) and mediates R-G-D-dependent cell adhesion to FBN1 (PubMed:12807887). In brain, plays a role in synaptic transmission and plasticity. Involved in the regulation of the serotonin neurotransmission, is required to localize to specific compartments within the synapse the serotonin receptor SLC6A4 and for an appropriate reuptake of serotonin. Controls excitatory synaptic strength by regulating GRIA2-containing AMPAR endocytosis, which affects AMPAR abundance and composition (By similarity). ITGAV:ITGB3 act as a receptor for CD40LG (PubMed:31331973). ITGAV:ITGB3 acts as a receptor for IBSP and promotes cell adhesion and migration to IBSP (PubMed:10640428). {ECO:0000250|UniProtKB:O54890, ECO:0000269|PubMed:10640428, ECO:0000269|PubMed:12807887, ECO:0000269|PubMed:18441324, ECO:0000269|PubMed:18635536, ECO:0000269|PubMed:19578119, ECO:0000269|PubMed:20682778, ECO:0000269|PubMed:23125415, ECO:0000269|PubMed:24789099, ECO:0000269|PubMed:25398877, ECO:0000269|PubMed:28302677, ECO:0000269|PubMed:28873464, ECO:0000269|PubMed:29030430, ECO:0000269|PubMed:31331973, ECO:0000269|PubMed:9111081, ECO:0000269|PubMed:9195946, ECO:0000303|PubMed:16322781, ECO:0000303|PubMed:17635696}.; FUNCTION: (Microbial infection) Integrin ITGAV:ITGB3 acts as a receptor for Herpes virus 8/HHV-8. {ECO:0000269|PubMed:18045938}.; FUNCTION: (Microbial infection) Integrin ITGAV:ITGB3 acts as a receptor for Coxsackievirus A9. {ECO:0000269|PubMed:7519807}.; FUNCTION: (Microbial infection) Acts as a receptor for Hantaan virus. {ECO:0000269|PubMed:9618541}.; FUNCTION: (Microbial infection) Integrin ITGAV:ITGB3 acts as a receptor for Cytomegalovirus/HHV-5. {ECO:0000269|PubMed:15834425}.; FUNCTION: (Microbial infection) Integrin ITGA5:ITGB3 acts as a receptor for Human metapneumovirus. {ECO:0000269|PubMed:24478423}.; FUNCTION: (Microbial infection) Integrin ITGAV:ITGB3 acts aP05556s a receptor for Human parechovirus 1. {ECO:0000269|PubMed:11160695}.; FUNCTION: (Microbial infection) Integrin ITGAV:ITGB3 acts as a receptor for West nile virus. {ECO:0000269|PubMed:23658209}.; FUNCTION: (Microbial infection) In case of HIV-1 infection, the interaction with extracellular viral Tat protein seems to enhance angiogenesis in Kaposi's sarcoma lesions. {ECO:0000269|PubMed:10397733}. |
P05198 | EIF2S1 | T281 | ochoa | Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha) (eIF-2A) (eIF-2alpha) (eIF2-alpha) | Member of the eIF2 complex that functions in the early steps of protein synthesis by forming a ternary complex with GTP and initiator tRNA (PubMed:16289705, PubMed:38340717). This complex binds to a 40S ribosomal subunit, followed by mRNA binding to form a 43S pre-initiation complex (43S PIC) (PubMed:16289705). Junction of the 60S ribosomal subunit to form the 80S initiation complex is preceded by hydrolysis of the GTP bound to eIF2 and release of an eIF2-GDP binary complex (PubMed:16289705). In order for eIF2 to recycle and catalyze another round of initiation, the GDP bound to eIF2 must exchange with GTP by way of a reaction catalyzed by eIF2B (PubMed:16289705). EIF2S1/eIF2-alpha is a key component of the integrated stress response (ISR), required for adaptation to various stress: phosphorylation by metabolic-stress sensing protein kinases (EIF2AK1/HRI, EIF2AK2/PKR, EIF2AK3/PERK and EIF2AK4/GCN2) in response to stress converts EIF2S1/eIF2-alpha in a global protein synthesis inhibitor, leading to an attenuation of cap-dependent translation, while concomitantly initiating the preferential translation of ISR-specific mRNAs, such as the transcriptional activators ATF4 and QRICH1, and hence allowing ATF4- and QRICH1-mediated reprogramming (PubMed:19131336, PubMed:33384352, PubMed:38340717). EIF2S1/eIF2-alpha also acts as an activator of mitophagy in response to mitochondrial damage: phosphorylation by EIF2AK1/HRI promotes relocalization to the mitochondrial surface, thereby triggering PRKN-independent mitophagy (PubMed:38340717). {ECO:0000269|PubMed:16289705, ECO:0000269|PubMed:19131336, ECO:0000269|PubMed:33384352, ECO:0000269|PubMed:38340717}. |
P07195 | LDHB | T302 | ochoa | L-lactate dehydrogenase B chain (LDH-B) (EC 1.1.1.27) (LDH heart subunit) (LDH-H) (Renal carcinoma antigen NY-REN-46) | Interconverts simultaneously and stereospecifically pyruvate and lactate with concomitant interconversion of NADH and NAD(+). {ECO:0000269|PubMed:27618187}. |
P07900 | HSP90AA1 | T195 | ochoa | Heat shock protein HSP 90-alpha (EC 3.6.4.10) (Heat shock 86 kDa) (HSP 86) (HSP86) (Heat shock protein family C member 1) (Lipopolysaccharide-associated protein 2) (LAP-2) (LPS-associated protein 2) (Renal carcinoma antigen NY-REN-38) | Molecular chaperone that promotes the maturation, structural maintenance and proper regulation of specific target proteins involved for instance in cell cycle control and signal transduction. Undergoes a functional cycle that is linked to its ATPase activity which is essential for its chaperone activity. This cycle probably induces conformational changes in the client proteins, thereby causing their activation. Interacts dynamically with various co-chaperones that modulate its substrate recognition, ATPase cycle and chaperone function (PubMed:11274138, PubMed:12526792, PubMed:15577939, PubMed:15937123, PubMed:27353360, PubMed:29127155). Engages with a range of client protein classes via its interaction with various co-chaperone proteins or complexes, that act as adapters, simultaneously able to interact with the specific client and the central chaperone itself (PubMed:29127155). Recruitment of ATP and co-chaperone followed by client protein forms a functional chaperone. After the completion of the chaperoning process, properly folded client protein and co-chaperone leave HSP90 in an ADP-bound partially open conformation and finally, ADP is released from HSP90 which acquires an open conformation for the next cycle (PubMed:26991466, PubMed:27295069). Plays a critical role in mitochondrial import, delivers preproteins to the mitochondrial import receptor TOMM70 (PubMed:12526792). Apart from its chaperone activity, it also plays a role in the regulation of the transcription machinery. HSP90 and its co-chaperones modulate transcription at least at three different levels (PubMed:25973397). In the first place, they alter the steady-state levels of certain transcription factors in response to various physiological cues (PubMed:25973397). Second, they modulate the activity of certain epigenetic modifiers, such as histone deacetylases or DNA methyl transferases, and thereby respond to the change in the environment (PubMed:25973397). Third, they participate in the eviction of histones from the promoter region of certain genes and thereby turn on gene expression (PubMed:25973397). Binds bacterial lipopolysaccharide (LPS) and mediates LPS-induced inflammatory response, including TNF secretion by monocytes (PubMed:11276205). Antagonizes STUB1-mediated inhibition of TGF-beta signaling via inhibition of STUB1-mediated SMAD3 ubiquitination and degradation (PubMed:24613385). Mediates the association of TOMM70 with IRF3 or TBK1 in mitochondrial outer membrane which promotes host antiviral response (PubMed:20628368, PubMed:25609812). {ECO:0000269|PubMed:11274138, ECO:0000269|PubMed:11276205, ECO:0000269|PubMed:12526792, ECO:0000269|PubMed:15577939, ECO:0000269|PubMed:15937123, ECO:0000269|PubMed:20628368, ECO:0000269|PubMed:24613385, ECO:0000269|PubMed:25609812, ECO:0000269|PubMed:27353360, ECO:0000269|PubMed:29127155, ECO:0000303|PubMed:25973397, ECO:0000303|PubMed:26991466, ECO:0000303|PubMed:27295069}.; FUNCTION: (Microbial infection) Seems to interfere with N.meningitidis NadA-mediated invasion of human cells. Decreasing HSP90 levels increases adhesion and entry of E.coli expressing NadA into human Chang cells; increasing its levels leads to decreased adhesion and invasion. {ECO:0000305|PubMed:22066472}. |
P08238 | HSP90AB1 | T190 | ochoa | Heat shock protein HSP 90-beta (HSP 90) (Heat shock 84 kDa) (HSP 84) (HSP84) (Heat shock protein family C member 3) | Molecular chaperone that promotes the maturation, structural maintenance and proper regulation of specific target proteins involved for instance in cell cycle control and signal transduction. Undergoes a functional cycle linked to its ATPase activity. This cycle probably induces conformational changes in the client proteins, thereby causing their activation. Interacts dynamically with various co-chaperones that modulate its substrate recognition, ATPase cycle and chaperone function (PubMed:16478993, PubMed:19696785). Engages with a range of client protein classes via its interaction with various co-chaperone proteins or complexes, that act as adapters, simultaneously able to interact with the specific client and the central chaperone itself. Recruitment of ATP and co-chaperone followed by client protein forms a functional chaperone. After the completion of the chaperoning process, properly folded client protein and co-chaperone leave HSP90 in an ADP-bound partially open conformation and finally, ADP is released from HSP90 which acquires an open conformation for the next cycle (PubMed:26991466, PubMed:27295069). Apart from its chaperone activity, it also plays a role in the regulation of the transcription machinery. HSP90 and its co-chaperones modulate transcription at least at three different levels. They first alter the steady-state levels of certain transcription factors in response to various physiological cues. Second, they modulate the activity of certain epigenetic modifiers, such as histone deacetylases or DNA methyl transferases, and thereby respond to the change in the environment. Third, they participate in the eviction of histones from the promoter region of certain genes and thereby turn on gene expression (PubMed:25973397). Antagonizes STUB1-mediated inhibition of TGF-beta signaling via inhibition of STUB1-mediated SMAD3 ubiquitination and degradation (PubMed:24613385). Promotes cell differentiation by chaperoning BIRC2 and thereby protecting from auto-ubiquitination and degradation by the proteasomal machinery (PubMed:18239673). Main chaperone involved in the phosphorylation/activation of the STAT1 by chaperoning both JAK2 and PRKCE under heat shock and in turn, activates its own transcription (PubMed:20353823). Involved in the translocation into ERGIC (endoplasmic reticulum-Golgi intermediate compartment) of leaderless cargos (lacking the secretion signal sequence) such as the interleukin 1/IL-1; the translocation process is mediated by the cargo receptor TMED10 (PubMed:32272059). {ECO:0000269|PubMed:16478993, ECO:0000269|PubMed:18239673, ECO:0000269|PubMed:19696785, ECO:0000269|PubMed:20353823, ECO:0000269|PubMed:24613385, ECO:0000269|PubMed:32272059, ECO:0000303|PubMed:25973397, ECO:0000303|PubMed:26991466, ECO:0000303|PubMed:27295069}.; FUNCTION: (Microbial infection) Binding to N.meningitidis NadA stimulates monocytes (PubMed:21949862). Seems to interfere with N.meningitidis NadA-mediated invasion of human cells (Probable). {ECO:0000269|PubMed:21949862, ECO:0000305|PubMed:22066472}. |
P0CG38 | POTEI | T789 | ochoa | POTE ankyrin domain family member I | None |
P0CG39 | POTEJ | T752 | ochoa | POTE ankyrin domain family member J | None |
P11055 | MYH3 | T1480 | ochoa | Myosin-3 (Muscle embryonic myosin heavy chain) (Myosin heavy chain 3) (Myosin heavy chain, fast skeletal muscle, embryonic) (SMHCE) | Muscle contraction. |
P11717 | IGF2R | T2362 | ochoa | Cation-independent mannose-6-phosphate receptor (CI Man-6-P receptor) (CI-MPR) (M6PR) (300 kDa mannose 6-phosphate receptor) (MPR 300) (Insulin-like growth factor 2 receptor) (Insulin-like growth factor II receptor) (IGF-II receptor) (M6P/IGF2 receptor) (M6P/IGF2R) (CD antigen CD222) | Mediates the transport of phosphorylated lysosomal enzymes from the Golgi complex and the cell surface to lysosomes (PubMed:18817523, PubMed:2963003). Lysosomal enzymes bearing phosphomannosyl residues bind specifically to mannose-6-phosphate receptors in the Golgi apparatus and the resulting receptor-ligand complex is transported to an acidic prelysosomal compartment where the low pH mediates the dissociation of the complex (PubMed:18817523, PubMed:2963003). The receptor is then recycled back to the Golgi for another round of trafficking through its binding to the retromer (PubMed:18817523). This receptor also binds IGF2 (PubMed:18046459). Acts as a positive regulator of T-cell coactivation by binding DPP4 (PubMed:10900005). {ECO:0000269|PubMed:10900005, ECO:0000269|PubMed:18046459, ECO:0000269|PubMed:18817523, ECO:0000269|PubMed:2963003}. |
P12882 | MYH1 | T1023 | ochoa | Myosin-1 (Myosin heavy chain 1) (Myosin heavy chain 2x) (MyHC-2x) (Myosin heavy chain IIx/d) (MyHC-IIx/d) (Myosin heavy chain, skeletal muscle, adult 1) | Required for normal hearing. It plays a role in cochlear amplification of auditory stimuli, likely through the positive regulation of prestin (SLC26A5) activity and outer hair cell (OHC) electromotility. {ECO:0000250|UniProtKB:Q5SX40}. |
P12882 | MYH1 | T1286 | ochoa | Myosin-1 (Myosin heavy chain 1) (Myosin heavy chain 2x) (MyHC-2x) (Myosin heavy chain IIx/d) (MyHC-IIx/d) (Myosin heavy chain, skeletal muscle, adult 1) | Required for normal hearing. It plays a role in cochlear amplification of auditory stimuli, likely through the positive regulation of prestin (SLC26A5) activity and outer hair cell (OHC) electromotility. {ECO:0000250|UniProtKB:Q5SX40}. |
P12882 | MYH1 | T1300 | ochoa | Myosin-1 (Myosin heavy chain 1) (Myosin heavy chain 2x) (MyHC-2x) (Myosin heavy chain IIx/d) (MyHC-IIx/d) (Myosin heavy chain, skeletal muscle, adult 1) | Required for normal hearing. It plays a role in cochlear amplification of auditory stimuli, likely through the positive regulation of prestin (SLC26A5) activity and outer hair cell (OHC) electromotility. {ECO:0000250|UniProtKB:Q5SX40}. |
P12882 | MYH1 | T1483 | ochoa | Myosin-1 (Myosin heavy chain 1) (Myosin heavy chain 2x) (MyHC-2x) (Myosin heavy chain IIx/d) (MyHC-IIx/d) (Myosin heavy chain, skeletal muscle, adult 1) | Required for normal hearing. It plays a role in cochlear amplification of auditory stimuli, likely through the positive regulation of prestin (SLC26A5) activity and outer hair cell (OHC) electromotility. {ECO:0000250|UniProtKB:Q5SX40}. |
P12882 | MYH1 | T1501 | ochoa | Myosin-1 (Myosin heavy chain 1) (Myosin heavy chain 2x) (MyHC-2x) (Myosin heavy chain IIx/d) (MyHC-IIx/d) (Myosin heavy chain, skeletal muscle, adult 1) | Required for normal hearing. It plays a role in cochlear amplification of auditory stimuli, likely through the positive regulation of prestin (SLC26A5) activity and outer hair cell (OHC) electromotility. {ECO:0000250|UniProtKB:Q5SX40}. |
P12883 | MYH7 | T1019 | ochoa | Myosin-7 (Myosin heavy chain 7) (Myosin heavy chain slow isoform) (MyHC-slow) (Myosin heavy chain, cardiac muscle beta isoform) (MyHC-beta) | Myosins are actin-based motor molecules with ATPase activity essential for muscle contraction. Forms regular bipolar thick filaments that, together with actin thin filaments, constitute the fundamental contractile unit of skeletal and cardiac muscle. {ECO:0000305|PubMed:26150528, ECO:0000305|PubMed:26246073}. |
P12883 | MYH7 | T1127 | ochoa | Myosin-7 (Myosin heavy chain 7) (Myosin heavy chain slow isoform) (MyHC-slow) (Myosin heavy chain, cardiac muscle beta isoform) (MyHC-beta) | Myosins are actin-based motor molecules with ATPase activity essential for muscle contraction. Forms regular bipolar thick filaments that, together with actin thin filaments, constitute the fundamental contractile unit of skeletal and cardiac muscle. {ECO:0000305|PubMed:26150528, ECO:0000305|PubMed:26246073}. |
P12883 | MYH7 | T1282 | ochoa | Myosin-7 (Myosin heavy chain 7) (Myosin heavy chain slow isoform) (MyHC-slow) (Myosin heavy chain, cardiac muscle beta isoform) (MyHC-beta) | Myosins are actin-based motor molecules with ATPase activity essential for muscle contraction. Forms regular bipolar thick filaments that, together with actin thin filaments, constitute the fundamental contractile unit of skeletal and cardiac muscle. {ECO:0000305|PubMed:26150528, ECO:0000305|PubMed:26246073}. |
P12883 | MYH7 | T1479 | ochoa | Myosin-7 (Myosin heavy chain 7) (Myosin heavy chain slow isoform) (MyHC-slow) (Myosin heavy chain, cardiac muscle beta isoform) (MyHC-beta) | Myosins are actin-based motor molecules with ATPase activity essential for muscle contraction. Forms regular bipolar thick filaments that, together with actin thin filaments, constitute the fundamental contractile unit of skeletal and cardiac muscle. {ECO:0000305|PubMed:26150528, ECO:0000305|PubMed:26246073}. |
P12883 | MYH7 | T1497 | ochoa | Myosin-7 (Myosin heavy chain 7) (Myosin heavy chain slow isoform) (MyHC-slow) (Myosin heavy chain, cardiac muscle beta isoform) (MyHC-beta) | Myosins are actin-based motor molecules with ATPase activity essential for muscle contraction. Forms regular bipolar thick filaments that, together with actin thin filaments, constitute the fundamental contractile unit of skeletal and cardiac muscle. {ECO:0000305|PubMed:26150528, ECO:0000305|PubMed:26246073}. |
P13533 | MYH6 | T1129 | ochoa | Myosin-6 (Myosin heavy chain 6) (Myosin heavy chain, cardiac muscle alpha isoform) (MyHC-alpha) | Muscle contraction. |
P13533 | MYH6 | T1481 | ochoa | Myosin-6 (Myosin heavy chain 6) (Myosin heavy chain, cardiac muscle alpha isoform) (MyHC-alpha) | Muscle contraction. |
P13533 | MYH6 | T1499 | ochoa | Myosin-6 (Myosin heavy chain 6) (Myosin heavy chain, cardiac muscle alpha isoform) (MyHC-alpha) | Muscle contraction. |
P13535 | MYH8 | T1482 | ochoa | Myosin-8 (Myosin heavy chain 8) (Myosin heavy chain, skeletal muscle, perinatal) (MyHC-perinatal) | Muscle contraction. |
P13569 | CFTR | T682 | psp | Cystic fibrosis transmembrane conductance regulator (CFTR) (ATP-binding cassette sub-family C member 7) (Channel conductance-controlling ATPase) (EC 5.6.1.6) (cAMP-dependent chloride channel) | Epithelial ion channel that plays an important role in the regulation of epithelial ion and water transport and fluid homeostasis (PubMed:26823428). Mediates the transport of chloride ions across the cell membrane (PubMed:10792060, PubMed:11524016, PubMed:11707463, PubMed:12519745, PubMed:12529365, PubMed:12588899, PubMed:12727866, PubMed:15010471, PubMed:17036051, PubMed:1712898, PubMed:17182731, PubMed:19398555, PubMed:19621064, PubMed:22178883, PubMed:25330774, PubMed:26846474, PubMed:28087700, PubMed:8910473, PubMed:9804160). Possesses an intrinsic ATPase activity and utilizes ATP to gate its channel; the passive flow of anions through the channel is gated by cycles of ATP binding and hydrolysis by the ATP-binding domains (PubMed:11524016, PubMed:15284228, PubMed:26627831, PubMed:8910473). The ion channel is also permeable to HCO(3)(-); selectivity depends on the extracellular chloride concentration (PubMed:15010471, PubMed:19019741). In vitro, mediates ATP-dependent glutathione flux (PubMed:12727866). Exerts its function also by modulating the activity of other ion channels and transporters (PubMed:12403779, PubMed:22121115, PubMed:22178883, PubMed:27941075). Plays an important role in airway fluid homeostasis (PubMed:16645176, PubMed:19621064, PubMed:26823428). Contributes to the regulation of the pH and the ion content of the airway surface fluid layer and thereby plays an important role in defense against pathogens (PubMed:14668433, PubMed:16645176, PubMed:26823428). Modulates the activity of the epithelial sodium channel (ENaC) complex, in part by regulating the cell surface expression of the ENaC complex (PubMed:17182731, PubMed:17434346, PubMed:27941075). Inhibits the activity of the ENaC channel containing subunits SCNN1A, SCNN1B and SCNN1G (PubMed:17182731). Inhibits the activity of the ENaC channel containing subunits SCNN1D, SCNN1B and SCNN1G, but not of the ENaC channel containing subunits SCNN1A, SCNN1B and SCNN1G (PubMed:17182731, PubMed:27941075). May regulate bicarbonate secretion and salvage in epithelial cells by regulating the transporter SLC4A7 (PubMed:12403779). Can inhibit the chloride channel activity of ANO1 (PubMed:22178883). Plays a role in the chloride and bicarbonate homeostasis during sperm epididymal maturation and capacitation (PubMed:19923167, PubMed:27714810, PubMed:29393851). {ECO:0000269|PubMed:10792060, ECO:0000269|PubMed:11524016, ECO:0000269|PubMed:11707463, ECO:0000269|PubMed:12403779, ECO:0000269|PubMed:12519745, ECO:0000269|PubMed:12529365, ECO:0000269|PubMed:12588899, ECO:0000269|PubMed:12727866, ECO:0000269|PubMed:14668433, ECO:0000269|PubMed:15010471, ECO:0000269|PubMed:15284228, ECO:0000269|PubMed:16645176, ECO:0000269|PubMed:17036051, ECO:0000269|PubMed:1712898, ECO:0000269|PubMed:17182731, ECO:0000269|PubMed:19019741, ECO:0000269|PubMed:19398555, ECO:0000269|PubMed:19621064, ECO:0000269|PubMed:22178883, ECO:0000269|PubMed:25330774, ECO:0000269|PubMed:26627831, ECO:0000269|PubMed:26823428, ECO:0000269|PubMed:26846474, ECO:0000269|PubMed:27714810, ECO:0000269|PubMed:27941075, ECO:0000269|PubMed:28087700, ECO:0000269|PubMed:29393851, ECO:0000269|PubMed:8910473, ECO:0000269|PubMed:9804160, ECO:0000305|PubMed:19923167}. |
P15311 | EZR | T533 | ochoa | Ezrin (Cytovillin) (Villin-2) (p81) | Probably involved in connections of major cytoskeletal structures to the plasma membrane. In epithelial cells, required for the formation of microvilli and membrane ruffles on the apical pole. Along with PLEKHG6, required for normal macropinocytosis. {ECO:0000269|PubMed:17881735, ECO:0000269|PubMed:18270268, ECO:0000269|PubMed:19111582}. |
P16157 | ANK1 | T1631 | ochoa | Ankyrin-1 (ANK-1) (Ankyrin-R) (Erythrocyte ankyrin) | Component of the ankyrin-1 complex, a multiprotein complex involved in the stability and shape of the erythrocyte membrane (PubMed:35835865). Attaches integral membrane proteins to cytoskeletal elements; binds to the erythrocyte membrane protein band 4.2, to Na-K ATPase, to the lymphocyte membrane protein GP85, and to the cytoskeletal proteins fodrin, tubulin, vimentin and desmin. Erythrocyte ankyrins also link spectrin (beta chain) to the cytoplasmic domain of the erythrocytes anion exchange protein; they retain most or all of these binding functions. {ECO:0000269|PubMed:12456646, ECO:0000269|PubMed:35835865}.; FUNCTION: [Isoform Mu17]: Together with obscurin in skeletal muscle may provide a molecular link between the sarcoplasmic reticulum and myofibrils. {ECO:0000269|PubMed:12527750}. |
P18031 | PTPN1 | T338 | ochoa | Tyrosine-protein phosphatase non-receptor type 1 (EC 3.1.3.48) (Protein-tyrosine phosphatase 1B) (PTP-1B) | Tyrosine-protein phosphatase which acts as a regulator of endoplasmic reticulum unfolded protein response. Mediates dephosphorylation of EIF2AK3/PERK; inactivating the protein kinase activity of EIF2AK3/PERK. May play an important role in CKII- and p60c-src-induced signal transduction cascades. May regulate the EFNA5-EPHA3 signaling pathway which modulates cell reorganization and cell-cell repulsion. May also regulate the hepatocyte growth factor receptor signaling pathway through dephosphorylation of MET. {ECO:0000269|PubMed:18819921, ECO:0000269|PubMed:21135139, ECO:0000269|PubMed:22169477}. |
P20700 | LMNB1 | T55 | ochoa | Lamin-B1 | Lamins are intermediate filament proteins that assemble into a filamentous meshwork, and which constitute the major components of the nuclear lamina, a fibrous layer on the nucleoplasmic side of the inner nuclear membrane (PubMed:28716252, PubMed:32910914). Lamins provide a framework for the nuclear envelope, bridging the nuclear envelope and chromatin, thereby playing an important role in nuclear assembly, chromatin organization, nuclear membrane and telomere dynamics (PubMed:28716252, PubMed:32910914). The structural integrity of the lamina is strictly controlled by the cell cycle, as seen by the disintegration and formation of the nuclear envelope in prophase and telophase, respectively (PubMed:28716252, PubMed:32910914). {ECO:0000269|PubMed:28716252, ECO:0000269|PubMed:32910914}. |
P30260 | CDC27 | T200 | ochoa | Cell division cycle protein 27 homolog (Anaphase-promoting complex subunit 3) (APC3) (CDC27 homolog) (CDC27Hs) (H-NUC) | Component of the anaphase promoting complex/cyclosome (APC/C), a cell cycle-regulated E3 ubiquitin ligase that controls progression through mitosis and the G1 phase of the cell cycle (PubMed:18485873). The APC/C complex acts by mediating ubiquitination and subsequent degradation of target proteins: it mainly mediates the formation of 'Lys-11'-linked polyubiquitin chains and, to a lower extent, the formation of 'Lys-48'- and 'Lys-63'-linked polyubiquitin chains (PubMed:18485873). The APC/C complex catalyzes assembly of branched 'Lys-11'-/'Lys-48'-linked branched ubiquitin chains on target proteins (PubMed:29033132). {ECO:0000269|PubMed:18485873, ECO:0000269|PubMed:29033132}. |
P31327 | CPS1 | T1022 | ochoa | Carbamoyl-phosphate synthase [ammonia], mitochondrial (EC 6.3.4.16) (Carbamoyl-phosphate synthetase I) (CPSase I) | Involved in the urea cycle of ureotelic animals where the enzyme plays an important role in removing excess ammonia from the cell. |
P35580 | MYH10 | T1203 | ochoa | Myosin-10 (Cellular myosin heavy chain, type B) (Myosin heavy chain 10) (Myosin heavy chain, non-muscle IIb) (Non-muscle myosin heavy chain B) (NMMHC-B) (Non-muscle myosin heavy chain IIb) (NMMHC II-b) (NMMHC-IIB) | Cellular myosin that appears to play a role in cytokinesis, cell shape, and specialized functions such as secretion and capping. Involved with LARP6 in the stabilization of type I collagen mRNAs for CO1A1 and CO1A2. During cell spreading, plays an important role in cytoskeleton reorganization, focal contacts formation (in the central part but not the margins of spreading cells), and lamellipodial extension; this function is mechanically antagonized by MYH9. {ECO:0000269|PubMed:20052411, ECO:0000269|PubMed:20603131}.; FUNCTION: (Microbial infection) Acts as a receptor for herpes simplex virus 1/HHV-1 envelope glycoprotein B. {ECO:0000305|PubMed:25428876, ECO:0000305|PubMed:39048823}. |
P35606 | COPB2 | T869 | ochoa | Coatomer subunit beta' (Beta'-coat protein) (Beta'-COP) (p102) | The coatomer is a cytosolic protein complex that binds to dilysine motifs and reversibly associates with Golgi non-clathrin-coated vesicles, which further mediate biosynthetic protein transport from the ER, via the Golgi up to the trans Golgi network. Coatomer complex is required for budding from Golgi membranes, and is essential for the retrograde Golgi-to-ER transport of dilysine-tagged proteins. In mammals, the coatomer can only be recruited by membranes associated to ADP-ribosylation factors (ARFs), which are small GTP-binding proteins; the complex also influences the Golgi structural integrity, as well as the processing, activity, and endocytic recycling of LDL receptors. {ECO:0000269|PubMed:34450031}.; FUNCTION: This coatomer complex protein, essential for Golgi budding and vesicular trafficking, is a selective binding protein (RACK) for protein kinase C, epsilon type. It binds to Golgi membranes in a GTP-dependent manner (By similarity). {ECO:0000250}. |
P35612 | ADD2 | T55 | psp | Beta-adducin (Erythrocyte adducin subunit beta) | Membrane-cytoskeleton-associated protein that promotes the assembly of the spectrin-actin network. Binds to the erythrocyte membrane receptor SLC2A1/GLUT1 and may therefore provide a link between the spectrin cytoskeleton to the plasma membrane. Binds to calmodulin. Calmodulin binds preferentially to the beta subunit. {ECO:0000269|PubMed:18347014}. |
P40222 | TXLNA | T184 | ochoa | Alpha-taxilin | May be involved in intracellular vesicle traffic and potentially in calcium-dependent exocytosis in neuroendocrine cells. |
P41208 | CETN2 | T118 | psp | Centrin-2 (Caltractin isoform 1) | Plays a fundamental role in microtubule organizing center structure and function. Required for centriole duplication and correct spindle formation. Has a role in regulating cytokinesis and genome stability via cooperation with CALM1 and CCP110.; FUNCTION: Involved in global genome nucleotide excision repair (GG-NER) by acting as component of the XPC complex. Cooperatively with RAD23B appears to stabilize XPC. In vitro, stimulates DNA binding of the XPC:RAD23B dimer.; FUNCTION: The XPC complex is proposed to represent the first factor bound at the sites of DNA damage and together with other core recognition factors, XPA, RPA and the TFIIH complex, is part of the pre-incision (or initial recognition) complex. The XPC complex recognizes a wide spectrum of damaged DNA characterized by distortions of the DNA helix such as single-stranded loops, mismatched bubbles or single-stranded overhangs. The orientation of XPC complex binding appears to be crucial for inducing a productive NER. XPC complex is proposed to recognize and to interact with unpaired bases on the undamaged DNA strand which is followed by recruitment of the TFIIH complex and subsequent scanning for lesions in the opposite strand in a 5'-to-3' direction by the NER machinery. Cyclobutane pyrimidine dimers (CPDs) which are formed upon UV-induced DNA damage esacpe detection by the XPC complex due to a low degree of structural perurbation. Instead they are detected by the UV-DDB complex which in turn recruits and cooperates with the XPC complex in the respective DNA repair.; FUNCTION: As a component of the TREX-2 complex, involved in the export of mRNAs to the cytoplasm through the nuclear pores. {ECO:0000269|PubMed:22307388, ECO:0000305|PubMed:23591820}. |
P48681 | NES | T567 | ochoa | Nestin | Required for brain and eye development. Promotes the disassembly of phosphorylated vimentin intermediate filaments (IF) during mitosis and may play a role in the trafficking and distribution of IF proteins and other cellular factors to daughter cells during progenitor cell division. Required for survival, renewal and mitogen-stimulated proliferation of neural progenitor cells (By similarity). {ECO:0000250}. |
P55010 | EIF5 | T227 | ochoa | Eukaryotic translation initiation factor 5 (eIF-5) | Component of the 43S pre-initiation complex (43S PIC), which binds to the mRNA cap-proximal region, scans mRNA 5'-untranslated region, and locates the initiation codon (PubMed:11166181, PubMed:22813744, PubMed:24319994). In this complex, acts as a GTPase-activating protein, by promoting GTP hydrolysis by eIF2G (EIF2S3) (PubMed:11166181). During scanning, interacts with both EIF1 (via its C-terminal domain (CTD)) and EIF1A (via its NTD) (PubMed:22813744). This interaction with EIF1A contributes to the maintenance of EIF1 within the open 43S PIC (PubMed:24319994). When start codon is recognized, EIF5, via its NTD, induces eIF2G (EIF2S3) to hydrolyze the GTP (PubMed:11166181). Start codon recognition also induces a conformational change of the PIC to a closed state (PubMed:22813744). This change increases the affinity of EIF5-CTD for EIF2-beta (EIF2S2), which allows the release, by an indirect mechanism, of EIF1 from the PIC (PubMed:22813744). Finally, EIF5 stabilizes the PIC in its closed conformation (PubMed:22813744). {ECO:0000269|PubMed:11166181, ECO:0000269|PubMed:22813744, ECO:0000269|PubMed:24319994}. |
P60709 | ACTB | T89 | ochoa | Actin, cytoplasmic 1 (EC 3.6.4.-) (Beta-actin) [Cleaved into: Actin, cytoplasmic 1, N-terminally processed] | Actin is a highly conserved protein that polymerizes to produce filaments that form cross-linked networks in the cytoplasm of cells (PubMed:25255767, PubMed:29581253). Actin exists in both monomeric (G-actin) and polymeric (F-actin) forms, both forms playing key functions, such as cell motility and contraction (PubMed:29581253). In addition to their role in the cytoplasmic cytoskeleton, G- and F-actin also localize in the nucleus, and regulate gene transcription and motility and repair of damaged DNA (PubMed:29925947). Plays a role in the assembly of the gamma-tubulin ring complex (gTuRC), which regulates the minus-end nucleation of alpha-beta tubulin heterodimers that grow into microtubule protafilaments (PubMed:39321809, PubMed:38609661). Part of the ACTR1A/ACTB filament around which the dynactin complex is built (By similarity). The dynactin multiprotein complex activates the molecular motor dynein for ultra-processive transport along microtubules (By similarity). {ECO:0000250|UniProtKB:Q6QAQ1, ECO:0000269|PubMed:25255767, ECO:0000269|PubMed:29581253, ECO:0000269|PubMed:29925947, ECO:0000269|PubMed:38609661, ECO:0000269|PubMed:39321809}. |
P62258 | YWHAE | T229 | ochoa | 14-3-3 protein epsilon (14-3-3E) | Adapter protein implicated in the regulation of a large spectrum of both general and specialized signaling pathways (PubMed:21189250). Binds to a large number of partners, usually by recognition of a phosphoserine or phosphothreonine motif (PubMed:35343654). Binding generally results in the modulation of the activity of the binding partner (By similarity). Positively regulates phosphorylated protein HSF1 nuclear export to the cytoplasm (PubMed:12917326). Plays a positive role in the antiviral signaling pathway upstream of TBK1 via interaction with RIGI (PubMed:37555661). Mechanistically, directs RIGI redistribution from the cytosol to mitochondrial associated membranes where it mediates MAVS-dependent innate immune signaling during viral infection (PubMed:22607805). Plays a role in proliferation inhibition and cell cycle arrest by exporting HNRNPC from the nucleus to the cytoplasm to be degraded by ubiquitination (PubMed:37599448). {ECO:0000250|UniProtKB:P62261, ECO:0000269|PubMed:12917326, ECO:0000269|PubMed:21189250, ECO:0000269|PubMed:22607805, ECO:0000269|PubMed:35343654, ECO:0000269|PubMed:37555661, ECO:0000269|PubMed:37599448}. |
P62736 | ACTA2 | S91 | ochoa | Actin, aortic smooth muscle (EC 3.6.4.-) (Alpha-actin-2) (Cell growth-inhibiting gene 46 protein) [Cleaved into: Actin, aortic smooth muscle, intermediate form] | Actins are highly conserved proteins that are involved in various types of cell motility and are ubiquitously expressed in all eukaryotic cells. |
P63027 | VAMP2 | T79 | ochoa | Vesicle-associated membrane protein 2 (VAMP-2) (Synaptobrevin-2) | Involved in the targeting and/or fusion of transport vesicles to their target membrane (By similarity). Major SNARE protein of synaptic vesicles which mediates fusion of synaptic vesicles to release neurotransmitters. Essential for fast vesicular exocytosis and activity-dependent neurotransmitter release as well as fast endocytosis that mediates rapid reuse of synaptic vesicles (By similarity) (PubMed:30929742). Modulates the gating characteristics of the delayed rectifier voltage-dependent potassium channel KCNB1. {ECO:0000250|UniProtKB:P63044, ECO:0000250|UniProtKB:P63045, ECO:0000269|PubMed:30929742}. |
P63261 | ACTG1 | T89 | ochoa | Actin, cytoplasmic 2 (EC 3.6.4.-) (Gamma-actin) [Cleaved into: Actin, cytoplasmic 2, N-terminally processed] | Actins are highly conserved proteins that are involved in various types of cell motility and are ubiquitously expressed in all eukaryotic cells. May play a role in the repair of noise-induced stereocilia gaps thereby maintains hearing sensitivity following loud noise damage (By similarity). {ECO:0000250|UniProtKB:P63260, ECO:0000305|PubMed:29581253}. |
P63267 | ACTG2 | S90 | ochoa | Actin, gamma-enteric smooth muscle (EC 3.6.4.-) (Alpha-actin-3) (Gamma-2-actin) (Smooth muscle gamma-actin) [Cleaved into: Actin, gamma-enteric smooth muscle, intermediate form] | Actins are highly conserved proteins that are involved in various types of cell motility and are ubiquitously expressed in all eukaryotic cells. |
P68032 | ACTC1 | T91 | ochoa | Actin, alpha cardiac muscle 1 (EC 3.6.4.-) (Alpha-cardiac actin) [Cleaved into: Actin, alpha cardiac muscle 1, intermediate form] | Actins are highly conserved proteins that are involved in various types of cell motility and are ubiquitously expressed in all eukaryotic cells. |
P68133 | ACTA1 | T91 | ochoa | Actin, alpha skeletal muscle (EC 3.6.4.-) (Alpha-actin-1) [Cleaved into: Actin, alpha skeletal muscle, intermediate form] | Actins are highly conserved proteins that are involved in various types of cell motility and are ubiquitously expressed in all eukaryotic cells. |
P78363 | ABCA4 | T901 | psp | Retinal-specific phospholipid-transporting ATPase ABCA4 (EC 7.6.2.1) (ATP-binding cassette sub-family A member 4) (RIM ABC transporter) (RIM proteinv) (RmP) (Retinal-specific ATP-binding cassette transporter) (Stargardt disease protein) | Flippase that catalyzes in an ATP-dependent manner the transport of retinal-phosphatidylethanolamine conjugates like 11-cis and all-trans isomers of N-retinylidene-phosphatidylethanolamine (N-Ret-PE) from the lumen to the cytoplasmic leaflet of photoreceptor outer segment disk membranes, where 11-cis-retinylidene-phosphatidylethanolamine is then isomerized to its all-trans isomer and reduced by RDH8 to produce all-trans-retinol. This transport activity ensures that all-trans-retinal generated from photoexcitation and 11-cis-retinal not needed for the regeneration of rhodopsin and cone opsins are effectively cleared from the photoreceptors, therefore preventing their accumulation and the formation of toxic bisretinoid (PubMed:10075733, PubMed:20404325, PubMed:22735453, PubMed:23144455, PubMed:24097981, PubMed:29847635, PubMed:33375396). Displays ATPase activity in vitro in absence of retinal substrate (PubMed:33605212, PubMed:39128720, PubMed:29847635, PubMed:33375396). May display GTPase activity that is strongly influenced by the lipid environment and the presence of retinoid compounds (PubMed:22735453). Binds the unprotonated form of N-retinylidene-phosphatidylethanolamine with high affinity in the absence of ATP, and ATP binding and hydrolysis induce a protein conformational change that causes N-retinylidene-phosphatidylethanolamine release (By similarity). {ECO:0000250|UniProtKB:F1MWM0, ECO:0000269|PubMed:10075733, ECO:0000269|PubMed:20404325, ECO:0000269|PubMed:22735453, ECO:0000269|PubMed:23144455, ECO:0000269|PubMed:24097981, ECO:0000269|PubMed:29847635, ECO:0000269|PubMed:33375396, ECO:0000269|PubMed:33605212, ECO:0000269|PubMed:39128720}. |
P80303 | NUCB2 | T335 | ochoa | Nucleobindin-2 (DNA-binding protein NEFA) (Epididymis secretory protein Li 109) (Gastric cancer antigen Zg4) (Prepronesfatin) [Cleaved into: Nesfatin-1] | Calcium-binding protein which may have a role in calcium homeostasis (By similarity). Acts as a non-receptor guanine nucleotide exchange factor which binds to and activates guanine nucleotide-binding protein (G-protein) alpha subunit GNAI3 (By similarity). {ECO:0000250|UniProtKB:P81117, ECO:0000250|UniProtKB:Q9JI85}.; FUNCTION: [Nesfatin-1]: Anorexigenic peptide, seems to play an important role in hypothalamic pathways regulating food intake and energy homeostasis, acting in a leptin-independent manner. May also exert hypertensive roles and modulate blood pressure through directly acting on peripheral arterial resistance. In intestinal epithelial cells, plays a role in the inhibition of hepatic glucose production via MC4R receptor leading to increased cyclic adenosine monophosphate (cAMP) levels and glucagon-like peptide 1 (GLP-1) secretion (PubMed:39562740). {ECO:0000250|UniProtKB:Q9JI85, ECO:0000269|PubMed:39562740}. |
P82979 | SARNP | T65 | ochoa | SAP domain-containing ribonucleoprotein (Cytokine-induced protein of 29 kDa) (Nuclear protein Hcc-1) (Proliferation-associated cytokine-inducible protein CIP29) | Binds both single-stranded and double-stranded DNA with higher affinity for the single-stranded form. Specifically binds to scaffold/matrix attachment region DNA. Also binds single-stranded RNA. Enhances RNA unwinding activity of DDX39A. May participate in important transcriptional or translational control of cell growth, metabolism and carcinogenesis. Component of the TREX complex which is thought to couple mRNA transcription, processing and nuclear export, and specifically associates with spliced mRNA and not with unspliced pre-mRNA (PubMed:15338056, PubMed:17196963, PubMed:20844015). The TREX complex is recruited to spliced mRNAs by a transcription-independent mechanism, binds to mRNA upstream of the exon-junction complex (EJC) and is recruited in a splicing- and cap-dependent manner to a region near the 5' end of the mRNA where it functions in mRNA export to the cytoplasm via the TAP/NXF1 pathway (PubMed:15338056, PubMed:17196963, PubMed:20844015). Associates with DDX39B, which facilitates RNA binding of DDX39B and likely plays a role in mRNA export (PubMed:37578863). {ECO:0000269|PubMed:15338056, ECO:0000269|PubMed:17196963, ECO:0000269|PubMed:20844015, ECO:0000269|PubMed:37578863}. |
Q00341 | HDLBP | T626 | ochoa | Vigilin (High density lipoprotein-binding protein) (HDL-binding protein) | Appears to play a role in cell sterol metabolism. It may function to protect cells from over-accumulation of cholesterol. |
Q01484 | ANK2 | T3797 | ochoa | Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin) (Non-erythroid ankyrin) | Plays an essential role in the localization and membrane stabilization of ion transporters and ion channels in several cell types, including cardiomyocytes, as well as in striated muscle cells. In skeletal muscle, required for proper localization of DMD and DCTN4 and for the formation and/or stability of a special subset of microtubules associated with costameres and neuromuscular junctions. In cardiomyocytes, required for coordinate assembly of Na/Ca exchanger, SLC8A1/NCX1, Na/K ATPases ATP1A1 and ATP1A2 and inositol 1,4,5-trisphosphate (InsP3) receptors at sarcoplasmic reticulum/sarcolemma sites. Required for expression and targeting of SPTBN1 in neonatal cardiomyocytes and for the regulation of neonatal cardiomyocyte contraction rate (PubMed:12571597). In the inner segment of rod photoreceptors, required for the coordinated expression of the Na/K ATPase, Na/Ca exchanger and beta-2-spectrin (SPTBN1) (By similarity). Plays a role in endocytosis and intracellular protein transport. Associates with phosphatidylinositol 3-phosphate (PI3P)-positive organelles and binds dynactin to promote long-range motility of cells. Recruits RABGAP1L to (PI3P)-positive early endosomes, where RABGAP1L inactivates RAB22A, and promotes polarized trafficking to the leading edge of the migrating cells. Part of the ANK2/RABGAP1L complex which is required for the polarized recycling of fibronectin receptor ITGA5 ITGB1 to the plasma membrane that enables continuous directional cell migration (By similarity). {ECO:0000250|UniProtKB:Q8C8R3, ECO:0000269|PubMed:12571597}. |
Q03701 | CEBPZ | T33 | ochoa | CCAAT/enhancer-binding protein zeta (CCAAT-box-binding transcription factor) (CBF) (CCAAT-binding factor) | Stimulates transcription from the HSP70 promoter. |
Q08379 | GOLGA2 | T437 | ochoa | Golgin subfamily A member 2 (130 kDa cis-Golgi matrix protein) (GM130) (GM130 autoantigen) (Golgin-95) | Peripheral membrane component of the cis-Golgi stack that acts as a membrane skeleton that maintains the structure of the Golgi apparatus, and as a vesicle thether that facilitates vesicle fusion to the Golgi membrane (Probable) (PubMed:16489344). Required for normal protein transport from the endoplasmic reticulum to the Golgi apparatus and the cell membrane (By similarity). Together with p115/USO1 and STX5, involved in vesicle tethering and fusion at the cis-Golgi membrane to maintain the stacked and inter-connected structure of the Golgi apparatus. Plays a central role in mitotic Golgi disassembly: phosphorylation at Ser-37 by CDK1 at the onset of mitosis inhibits the interaction with p115/USO1, preventing tethering of COPI vesicles and thereby inhibiting transport through the Golgi apparatus during mitosis (By similarity). Also plays a key role in spindle pole assembly and centrosome organization (PubMed:26165940). Promotes the mitotic spindle pole assembly by activating the spindle assembly factor TPX2 to nucleate microtubules around the Golgi and capture them to couple mitotic membranes to the spindle: upon phosphorylation at the onset of mitosis, GOLGA2 interacts with importin-alpha via the nuclear localization signal region, leading to recruit importin-alpha to the Golgi membranes and liberate the spindle assembly factor TPX2 from importin-alpha. TPX2 then activates AURKA kinase and stimulates local microtubule nucleation. Upon filament assembly, nascent microtubules are further captured by GOLGA2, thus linking Golgi membranes to the spindle (PubMed:19242490, PubMed:26165940). Regulates the meiotic spindle pole assembly, probably via the same mechanism (By similarity). Also regulates the centrosome organization (PubMed:18045989, PubMed:19109421). Also required for the Golgi ribbon formation and glycosylation of membrane and secretory proteins (PubMed:16489344, PubMed:17314401). {ECO:0000250|UniProtKB:Q62839, ECO:0000250|UniProtKB:Q921M4, ECO:0000269|PubMed:16489344, ECO:0000269|PubMed:17314401, ECO:0000269|PubMed:18045989, ECO:0000269|PubMed:19109421, ECO:0000269|PubMed:19242490, ECO:0000269|PubMed:26165940, ECO:0000305|PubMed:26363069}. |
Q08477 | CYP4F3 | T233 | ochoa | Cytochrome P450 4F3 (EC 1.14.14.1) (20-hydroxyeicosatetraenoic acid synthase) (20-HETE synthase) (CYPIVF3) (Cytochrome P450-LTB-omega) (Docosahexaenoic acid omega-hydroxylase CYP4F3) (EC 1.14.14.79) (Leukotriene-B(4) 20-monooxygenase 2) (Leukotriene-B(4) omega-hydroxylase 2) (EC 1.14.14.94) | A cytochrome P450 monooxygenase involved in the metabolism of various endogenous substrates, including fatty acids and their oxygenated derivatives (oxylipins) (PubMed:11461919, PubMed:15145985, PubMed:16547005, PubMed:16820285, PubMed:18065749, PubMed:18182499, PubMed:18577768, PubMed:8486631, PubMed:9675028). Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate, and reducing the second into a water molecule, with two electrons provided by NADPH via cytochrome P450 reductase (CPR; NADPH-ferrihemoprotein reductase) (PubMed:9675028). May play a role in inactivation of pro-inflammatory and anti-inflammatory oxylipins during the resolution of inflammation (PubMed:11461919, PubMed:15145985, PubMed:15364545, PubMed:16547005, PubMed:16820285, PubMed:18065749, PubMed:18182499, PubMed:18577768, PubMed:8486631, PubMed:9675028). {ECO:0000269|PubMed:11461919, ECO:0000269|PubMed:15145985, ECO:0000269|PubMed:15364545, ECO:0000269|PubMed:16547005, ECO:0000269|PubMed:16820285, ECO:0000269|PubMed:18065749, ECO:0000269|PubMed:18182499, ECO:0000269|PubMed:18577768, ECO:0000269|PubMed:8486631, ECO:0000269|PubMed:9675028}.; FUNCTION: [Isoform CYP4F3A]: Catalyzes predominantly the oxidation of the terminal carbon (omega-oxidation) of oxylipins in myeloid cells, displaying higher affinity for arachidonate metabolite leukotriene B4 (LTB4) (PubMed:11461919, PubMed:15364545, PubMed:8486631, PubMed:9675028). Inactivates LTB4 via three successive oxidative transformations to 20-hydroxy-LTB4, then to 20-oxo-LTB4 and to 20-carboxy-LTB4 (PubMed:9675028). Has omega-hydroxylase activity toward long-chain fatty acid epoxides with preference for 8,9-epoxy-(5Z,11Z,14Z)-eicosatrienoate (EET) and 9,10-epoxyoctadecanoate (PubMed:15145985). Omega-hydroxylates monohydroxy polyunsaturated fatty acids (PUFAs), including hydroxyeicosatetraenoates (HETEs) and hydroxyeicosapentaenoates (HEPEs), to dihydroxy compounds (PubMed:15364545, PubMed:9675028). Contributes to the degradation of saturated very long-chain fatty acids (VLCFAs) such as docosanoic acid, by catalyzing successive omega-oxidations to the corresponding dicarboxylic acid, thereby initiating chain shortening (PubMed:18182499). Has low hydroxylase activity toward PUFAs (PubMed:11461919, PubMed:18577768). {ECO:0000269|PubMed:11461919, ECO:0000269|PubMed:15145985, ECO:0000269|PubMed:15364545, ECO:0000269|PubMed:18182499, ECO:0000269|PubMed:18577768, ECO:0000269|PubMed:8486631, ECO:0000269|PubMed:9675028}.; FUNCTION: [Isoform CYP4F3B]: Catalyzes predominantly the oxidation of the terminal carbon (omega-oxidation) of polyunsaturated fatty acids (PUFAs) (PubMed:11461919, PubMed:16820285, PubMed:18577768). Participates in the conversion of arachidonic acid to 20-hydroxyeicosatetraenoic acid (20-HETE), a signaling molecule acting both as vasoconstrictive and natriuretic with overall effect on arterial blood pressure (PubMed:11461919, PubMed:16820285, PubMed:18577768). Has high omega-hydroxylase activity toward other PUFAs, including eicosatrienoic acid (ETA), eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) (PubMed:16820285, PubMed:18577768). Can also catalyze the oxidation of the penultimate carbon (omega-1 oxidation) of PUFAs with lower efficiency (PubMed:18577768). Contributes to the degradation of saturated very long-chain fatty acids (VLCFAs) such as docosanoic acid and hexacosanoic acid, by catalyzing successive omega-oxidations to the corresponding dicarboxylic acids, thereby initiating chain shortening (PubMed:16547005, PubMed:18182499). Omega-hydroxylates long-chain 3-hydroxy fatty acids, likely initiating the oxidative conversion to the corresponding 3-hydroxydicarboxylic fatty acids (PubMed:18065749). Has omega-hydroxylase activity toward long-chain fatty acid epoxides with preference for 8,9-epoxy-(5Z,11Z,14Z)-eicosatrienoate (EET) and 9,10-epoxyoctadecanoate (PubMed:15145985). {ECO:0000269|PubMed:11461919, ECO:0000269|PubMed:15145985, ECO:0000269|PubMed:16547005, ECO:0000269|PubMed:16820285, ECO:0000269|PubMed:18065749, ECO:0000269|PubMed:18182499, ECO:0000269|PubMed:18577768}. |
Q13464 | ROCK1 | T455 | psp | Rho-associated protein kinase 1 (EC 2.7.11.1) (Renal carcinoma antigen NY-REN-35) (Rho-associated, coiled-coil-containing protein kinase 1) (Rho-associated, coiled-coil-containing protein kinase I) (ROCK-I) (p160 ROCK-1) (p160ROCK) | Protein kinase which is a key regulator of the actin cytoskeleton and cell polarity (PubMed:10436159, PubMed:10652353, PubMed:11018042, PubMed:11283607, PubMed:17158456, PubMed:18573880, PubMed:19131646, PubMed:8617235, PubMed:9722579). Involved in regulation of smooth muscle contraction, actin cytoskeleton organization, stress fiber and focal adhesion formation, neurite retraction, cell adhesion and motility via phosphorylation of DAPK3, GFAP, LIMK1, LIMK2, MYL9/MLC2, TPPP, PFN1 and PPP1R12A (PubMed:10436159, PubMed:10652353, PubMed:11018042, PubMed:11283607, PubMed:17158456, PubMed:18573880, PubMed:19131646, PubMed:23093407, PubMed:23355470, PubMed:8617235, PubMed:9722579). Phosphorylates FHOD1 and acts synergistically with it to promote SRC-dependent non-apoptotic plasma membrane blebbing (PubMed:18694941). Phosphorylates JIP3 and regulates the recruitment of JNK to JIP3 upon UVB-induced stress (PubMed:19036714). Acts as a suppressor of inflammatory cell migration by regulating PTEN phosphorylation and stability (By similarity). Acts as a negative regulator of VEGF-induced angiogenic endothelial cell activation (PubMed:19181962). Required for centrosome positioning and centrosome-dependent exit from mitosis (By similarity). Plays a role in terminal erythroid differentiation (PubMed:21072057). Inhibits podocyte motility via regulation of actin cytoskeletal dynamics and phosphorylation of CFL1 (By similarity). Promotes keratinocyte terminal differentiation (PubMed:19997641). Involved in osteoblast compaction through the fibronectin fibrillogenesis cell-mediated matrix assembly process, essential for osteoblast mineralization (By similarity). May regulate closure of the eyelids and ventral body wall by inducing the assembly of actomyosin bundles (By similarity). {ECO:0000250|UniProtKB:P70335, ECO:0000250|UniProtKB:Q8MIT6, ECO:0000269|PubMed:10436159, ECO:0000269|PubMed:10652353, ECO:0000269|PubMed:11018042, ECO:0000269|PubMed:11283607, ECO:0000269|PubMed:17158456, ECO:0000269|PubMed:18573880, ECO:0000269|PubMed:18694941, ECO:0000269|PubMed:19036714, ECO:0000269|PubMed:19131646, ECO:0000269|PubMed:19181962, ECO:0000269|PubMed:19997641, ECO:0000269|PubMed:21072057, ECO:0000269|PubMed:23093407, ECO:0000269|PubMed:23355470, ECO:0000269|PubMed:8617235, ECO:0000269|PubMed:9722579}. |
Q13823 | GNL2 | T510 | ochoa | Nucleolar GTP-binding protein 2 (Autoantigen NGP-1) | GTPase that associates with pre-60S ribosomal subunits in the nucleolus and is required for their nuclear export and maturation (PubMed:32669547). May promote cell proliferation possibly by increasing p53/TP53 protein levels, and consequently those of its downstream product CDKN1A/p21, and decreasing RPL23A protein levels (PubMed:26203195). {ECO:0000269|PubMed:26203195, ECO:0000269|PubMed:32669547}. |
Q14141 | SEPTIN6 | T323 | ochoa | Septin-6 | Filament-forming cytoskeletal GTPase. Required for normal organization of the actin cytoskeleton. Involved in cytokinesis. May play a role in HCV RNA replication. Forms a filamentous structure with SEPTIN12, SEPTIN6, SEPTIN2 and probably SEPTIN4 at the sperm annulus which is required for the structural integrity and motility of the sperm tail during postmeiotic differentiation (PubMed:25588830). {ECO:0000269|PubMed:17229681, ECO:0000269|PubMed:17803907, ECO:0000305|PubMed:25588830}. |
Q14151 | SAFB2 | T193 | ochoa | Scaffold attachment factor B2 (SAF-B2) | Binds to scaffold/matrix attachment region (S/MAR) DNA. Can function as an estrogen receptor corepressor and can also inhibit cell proliferation. |
Q14320 | FAM50A | T164 | ochoa | Protein FAM50A (Protein HXC-26) (Protein XAP-5) | Probably involved in the regulation of pre-mRNA splicing. {ECO:0000269|PubMed:32703943}. |
Q14978 | NOLC1 | T607 | ochoa | Nucleolar and coiled-body phosphoprotein 1 (140 kDa nucleolar phosphoprotein) (Nopp140) (Hepatitis C virus NS5A-transactivated protein 13) (HCV NS5A-transactivated protein 13) (Nucleolar 130 kDa protein) (Nucleolar phosphoprotein p130) | Nucleolar protein that acts as a regulator of RNA polymerase I by connecting RNA polymerase I with enzymes responsible for ribosomal processing and modification (PubMed:10567578, PubMed:26399832). Required for neural crest specification: following monoubiquitination by the BCR(KBTBD8) complex, associates with TCOF1 and acts as a platform to connect RNA polymerase I with enzymes responsible for ribosomal processing and modification, leading to remodel the translational program of differentiating cells in favor of neural crest specification (PubMed:26399832). Involved in nucleologenesis, possibly by playing a role in the maintenance of the fundamental structure of the fibrillar center and dense fibrillar component in the nucleolus (PubMed:9016786). It has intrinsic GTPase and ATPase activities (PubMed:9016786). {ECO:0000269|PubMed:10567578, ECO:0000269|PubMed:26399832, ECO:0000269|PubMed:9016786}. |
Q15424 | SAFB | T194 | ochoa | Scaffold attachment factor B1 (SAF-B) (SAF-B1) (HSP27 estrogen response element-TATA box-binding protein) (HSP27 ERE-TATA-binding protein) | Binds to scaffold/matrix attachment region (S/MAR) DNA and forms a molecular assembly point to allow the formation of a 'transcriptosomal' complex (consisting of SR proteins and RNA polymerase II) coupling transcription and RNA processing (PubMed:9671816). Functions as an estrogen receptor corepressor and can also bind to the HSP27 promoter and decrease its transcription (PubMed:12660241). Thereby acts as a negative regulator of cell proliferation (PubMed:12660241). When associated with RBMX, binds to and stimulates transcription from the SREBF1 promoter (By similarity). {ECO:0000250|UniProtKB:D3YXK2, ECO:0000269|PubMed:12660241, ECO:0000269|PubMed:9671816}. |
Q15836 | VAMP3 | T62 | ochoa | Vesicle-associated membrane protein 3 (VAMP-3) (Cellubrevin) (CEB) (Synaptobrevin-3) | SNARE involved in vesicular transport from the late endosomes to the trans-Golgi network. {ECO:0000269|PubMed:18195106}. |
Q16513 | PKN2 | T951 | ochoa | Serine/threonine-protein kinase N2 (EC 2.7.11.13) (PKN gamma) (Protein kinase C-like 2) (Protein-kinase C-related kinase 2) | PKC-related serine/threonine-protein kinase and Rho/Rac effector protein that participates in specific signal transduction responses in the cell. Plays a role in the regulation of cell cycle progression, actin cytoskeleton assembly, cell migration, cell adhesion, tumor cell invasion and transcription activation signaling processes. Phosphorylates CTTN in hyaluronan-induced astrocytes and hence decreases CTTN ability to associate with filamentous actin. Phosphorylates HDAC5, therefore lead to impair HDAC5 import. Direct RhoA target required for the regulation of the maturation of primordial junctions into apical junction formation in bronchial epithelial cells. Required for G2/M phases of the cell cycle progression and abscission during cytokinesis in a ECT2-dependent manner. Stimulates FYN kinase activity that is required for establishment of skin cell-cell adhesion during keratinocytes differentiation. Regulates epithelial bladder cells speed and direction of movement during cell migration and tumor cell invasion. Inhibits Akt pro-survival-induced kinase activity. Mediates Rho protein-induced transcriptional activation via the c-fos serum response factor (SRF). Involved in the negative regulation of ciliogenesis (PubMed:27104747). {ECO:0000269|PubMed:10226025, ECO:0000269|PubMed:10926925, ECO:0000269|PubMed:11777936, ECO:0000269|PubMed:11781095, ECO:0000269|PubMed:15123640, ECO:0000269|PubMed:15364941, ECO:0000269|PubMed:17332740, ECO:0000269|PubMed:20188095, ECO:0000269|PubMed:20974804, ECO:0000269|PubMed:21754995, ECO:0000269|PubMed:27104747, ECO:0000269|PubMed:9121475}.; FUNCTION: (Microbial infection) Phosphorylates HCV NS5B leading to stimulation of HCV RNA replication. {ECO:0000269|PubMed:15364941}. |
Q16625 | OCLN | T438 | psp | Occludin | May play a role in the formation and regulation of the tight junction (TJ) paracellular permeability barrier. It is able to induce adhesion when expressed in cells lacking tight junctions. {ECO:0000269|PubMed:19114660}.; FUNCTION: (Microbial infection) Acts as a coreceptor for hepatitis C virus (HCV) in hepatocytes. {ECO:0000269|PubMed:19182773, ECO:0000269|PubMed:20375010}. |
Q58FF7 | HSP90AB3P | T169 | ochoa | Putative heat shock protein HSP 90-beta-3 (Heat shock protein 90-beta c) (Heat shock protein 90Bc) | Putative molecular chaperone that may promote the maturation, structural maintenance and proper regulation of specific target proteins. {ECO:0000250}. |
Q5M775 | SPECC1 | T424 | ochoa | Cytospin-B (Nuclear structure protein 5) (NSP5) (Sperm antigen HCMOGT-1) (Sperm antigen with calponin homology and coiled-coil domains 1) | None |
Q5THJ4 | VPS13D | T911 | ochoa | Intermembrane lipid transfer protein VPS13D (Vacuolar protein sorting-associated protein 13D) | Mediates the transfer of lipids between membranes at organelle contact sites (By similarity). Functions in promoting mitochondrial clearance by mitochondrial autophagy (mitophagy), also possibly by positively regulating mitochondrial fission (PubMed:29307555, PubMed:29604224). Mitophagy plays an important role in regulating cell health and mitochondrial size and homeostasis. {ECO:0000250|UniProtKB:Q07878, ECO:0000269|PubMed:29307555, ECO:0000269|PubMed:29604224}. |
Q5VST9 | OBSCN | T5798 | psp | Obscurin (EC 2.7.11.1) (Obscurin-RhoGEF) (Obscurin-myosin light chain kinase) (Obscurin-MLCK) | Structural component of striated muscles which plays a role in myofibrillogenesis. Probably involved in the assembly of myosin into sarcomeric A bands in striated muscle (PubMed:11448995, PubMed:16205939). Has serine/threonine protein kinase activity and phosphorylates N-cadherin CDH2 and sodium/potassium-transporting ATPase subunit ATP1B1 (By similarity). Binds (via the PH domain) strongly to phosphatidylinositol 3,4-bisphosphate (PtdIns(3,4)P2) and phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P2), and to a lesser extent to phosphatidylinositol 3-phosphate (PtdIns(3)P), phosphatidylinositol 4-phosphate (PtdIns(4)P), phosphatidylinositol 5-phosphate (PtdIns(5)P) and phosphatidylinositol 3,4,5-trisphosphate (PtdIns(3,4,5)P3) (PubMed:28826662). {ECO:0000250|UniProtKB:A2AAJ9, ECO:0000269|PubMed:11448995, ECO:0000269|PubMed:16205939, ECO:0000269|PubMed:28826662}. |
Q6NUP7 | PPP4R4 | T156 | ochoa | Serine/threonine-protein phosphatase 4 regulatory subunit 4 | Putative regulatory subunit of serine/threonine-protein phosphatase 4. |
Q6S8J3 | POTEE | T789 | ochoa | POTE ankyrin domain family member E (ANKRD26-like family C member 1A) (Prostate, ovary, testis-expressed protein on chromosome 2) (POTE-2) | None |
Q7L7X3 | TAOK1 | T480 | ochoa | Serine/threonine-protein kinase TAO1 (EC 2.7.11.1) (Kinase from chicken homolog B) (hKFC-B) (MARK Kinase) (MARKK) (Prostate-derived sterile 20-like kinase 2) (PSK-2) (PSK2) (Prostate-derived STE20-like kinase 2) (Thousand and one amino acid protein kinase 1) (TAOK1) (hTAOK1) | Serine/threonine-protein kinase involved in various processes such as p38/MAPK14 stress-activated MAPK cascade, DNA damage response and regulation of cytoskeleton stability. Phosphorylates MAP2K3, MAP2K6 and MARK2. Acts as an activator of the p38/MAPK14 stress-activated MAPK cascade by mediating phosphorylation and subsequent activation of the upstream MAP2K3 and MAP2K6 kinases. Involved in G-protein coupled receptor signaling to p38/MAPK14. In response to DNA damage, involved in the G2/M transition DNA damage checkpoint by activating the p38/MAPK14 stress-activated MAPK cascade, probably by mediating phosphorylation of MAP2K3 and MAP2K6. Acts as a regulator of cytoskeleton stability by phosphorylating 'Thr-208' of MARK2, leading to activate MARK2 kinase activity and subsequent phosphorylation and detachment of MAPT/TAU from microtubules. Also acts as a regulator of apoptosis: regulates apoptotic morphological changes, including cell contraction, membrane blebbing and apoptotic bodies formation via activation of the MAPK8/JNK cascade. Plays an essential role in the regulation of neuronal development in the central nervous system (PubMed:33565190). Also plays a role in the regulation of neuronal migration to the cortical plate (By similarity). {ECO:0000250|UniProtKB:Q5F2E8, ECO:0000269|PubMed:12665513, ECO:0000269|PubMed:13679851, ECO:0000269|PubMed:16407310, ECO:0000269|PubMed:17396146, ECO:0000269|PubMed:17900936, ECO:0000269|PubMed:33565190}. |
Q86Y82 | STX12 | T93 | ochoa | Syntaxin-12 | SNARE promoting fusion of transport vesicles with target membranes. Together with SNARE STX6, promotes movement of vesicles from endosomes to the cell membrane, and may therefore function in the endocytic recycling pathway. Through complex formation with GRIP1, GRIA2 and NSG1 controls the intracellular fate of AMPAR and the endosomal sorting of the GRIA2 subunit toward recycling and membrane targeting. {ECO:0000250|UniProtKB:G3V7P1}. |
Q8IUG5 | MYO18B | T1548 | ochoa | Unconventional myosin-XVIIIb | May be involved in intracellular trafficking of the muscle cell when in the cytoplasm, whereas entering the nucleus, may be involved in the regulation of muscle specific genes. May play a role in the control of tumor development and progression; restored MYO18B expression in lung cancer cells suppresses anchorage-independent growth. |
Q8IX12 | CCAR1 | T667 | psp | Cell division cycle and apoptosis regulator protein 1 (Cell cycle and apoptosis regulatory protein 1) (CARP-1) (Death inducer with SAP domain) | Associates with components of the Mediator and p160 coactivator complexes that play a role as intermediaries transducing regulatory signals from upstream transcriptional activator proteins to basal transcription machinery at the core promoter. Recruited to endogenous nuclear receptor target genes in response to the appropriate hormone. Also functions as a p53 coactivator. May thus play an important role in transcriptional regulation (By similarity). May be involved in apoptosis signaling in the presence of the reinoid CD437. Apoptosis induction involves sequestration of 14-3-3 protein(s) and mediated altered expression of multiple cell cycle regulatory genes including MYC, CCNB1 and CDKN1A. Plays a role in cell cycle progression and/or cell proliferation (PubMed:12816952). In association with CALCOCO1 enhances GATA1- and MED1-mediated transcriptional activation from the gamma-globin promoter during erythroid differentiation of K562 erythroleukemia cells (PubMed:24245781). Can act as a both a coactivator and corepressor of AR-mediated transcription. Contributes to chromatin looping and AR transcription complex assembly by stabilizing AR-GATA2 association on chromatin and facilitating MED1 and RNA polymerase II recruitment to AR-binding sites. May play an important role in the growth and tumorigenesis of prostate cancer cells (PubMed:23887938). {ECO:0000250|UniProtKB:Q8CH18, ECO:0000269|PubMed:12816952, ECO:0000269|PubMed:23887938, ECO:0000269|PubMed:24245781}. |
Q8NDB2 | BANK1 | T668 | ochoa | B-cell scaffold protein with ankyrin repeats | Involved in B-cell receptor (BCR)-induced Ca(2+) mobilization from intracellular stores. Promotes Lyn-mediated phosphorylation of IP3 receptors 1 and 2. {ECO:0000269|PubMed:11782428}. |
Q8NEZ4 | KMT2C | T74 | ochoa | Histone-lysine N-methyltransferase 2C (Lysine N-methyltransferase 2C) (EC 2.1.1.364) (Homologous to ALR protein) (Myeloid/lymphoid or mixed-lineage leukemia protein 3) | Histone methyltransferase that catalyzes methyl group transfer from S-adenosyl-L-methionine to the epsilon-amino group of 'Lys-4' of histone H3 (H3K4) (PubMed:25561738). Part of chromatin remodeling machinery predominantly forms H3K4me1 methylation marks at active chromatin sites where transcription and DNA repair take place (PubMed:22266653, PubMed:24081332, PubMed:25561738). Likely plays a redundant role with KMT2D in enriching H3K4me1 mark on primed and active enhancer elements (PubMed:24081332). {ECO:0000269|PubMed:22266653, ECO:0000269|PubMed:24081332, ECO:0000269|PubMed:25561738}. |
Q8NG31 | KNL1 | T1019 | ochoa | Outer kinetochore KNL1 complex subunit KNL1 (ALL1-fused gene from chromosome 15q14 protein) (AF15q14) (Bub-linking kinetochore protein) (Blinkin) (Cancer susceptibility candidate gene 5 protein) (Cancer/testis antigen 29) (CT29) (Kinetochore scaffold 1) (Kinetochore-null protein 1) (Protein CASC5) (Protein D40/AF15q14) | Acts as a component of the outer kinetochore KNL1 complex that serves as a docking point for spindle assembly checkpoint components and mediates microtubule-kinetochore interactions (PubMed:15502821, PubMed:17981135, PubMed:18045986, PubMed:19893618, PubMed:21199919, PubMed:22000412, PubMed:22331848, PubMed:27881301, PubMed:30100357). Kinetochores, consisting of a centromere-associated inner segment and a microtubule-contacting outer segment, play a crucial role in chromosome segregation by mediating the physical connection between centromeric DNA and spindle microtubules (PubMed:18045986, PubMed:19893618, PubMed:27881301). The outer kinetochore is made up of the ten-subunit KMN network, comprising the MIS12, NDC80 and KNL1 complexes, and auxiliary microtubule-associated components; together they connect the outer kinetochore with the inner kinetochore, bind microtubules, and mediate interactions with mitotic checkpoint proteins that delay anaphase until chromosomes are bioriented on the spindle (PubMed:17981135, PubMed:19893618, PubMed:22000412, PubMed:38459127, PubMed:38459128). Required for kinetochore binding by a distinct subset of kMAPs (kinetochore-bound microtubule-associated proteins) and motors (PubMed:19893618). Acts in coordination with CENPK to recruit the NDC80 complex to the outer kinetochore (PubMed:18045986, PubMed:27881301). Can bind either to microtubules or to the protein phosphatase 1 (PP1) catalytic subunits PPP1CA and PPP1CC (via overlapping binding sites), it has higher affinity for PP1 (PubMed:30100357). Recruits MAD2L1 to the kinetochore and also directly links BUB1 and BUB1B to the kinetochore (PubMed:17981135, PubMed:19893618, PubMed:22000412, PubMed:22331848, PubMed:25308863). In addition to orienting mitotic chromosomes, it is also essential for alignment of homologous chromosomes during meiotic metaphase I (By similarity). In meiosis I, required to activate the spindle assembly checkpoint at unattached kinetochores to correct erroneous kinetochore-microtubule attachments (By similarity). {ECO:0000250|UniProtKB:Q66JQ7, ECO:0000269|PubMed:15502821, ECO:0000269|PubMed:17981135, ECO:0000269|PubMed:18045986, ECO:0000269|PubMed:19893618, ECO:0000269|PubMed:21199919, ECO:0000269|PubMed:22000412, ECO:0000269|PubMed:22331848, ECO:0000269|PubMed:25308863, ECO:0000269|PubMed:27881301, ECO:0000269|PubMed:30100357, ECO:0000269|PubMed:38459127, ECO:0000269|PubMed:38459128}. |
Q8TEQ6 | GEMIN5 | T1330 | ochoa | Gem-associated protein 5 (Gemin5) | The SMN complex catalyzes the assembly of small nuclear ribonucleoproteins (snRNPs), the building blocks of the spliceosome, and thereby plays an important role in the splicing of cellular pre-mRNAs (PubMed:16857593, PubMed:18984161, PubMed:20513430, PubMed:33963192). Most spliceosomal snRNPs contain a common set of Sm proteins SNRPB, SNRPD1, SNRPD2, SNRPD3, SNRPE, SNRPF and SNRPG that assemble in a heptameric protein ring on the Sm site of the small nuclear RNA to form the core snRNP (Sm core). In the cytosol, the Sm proteins SNRPD1, SNRPD2, SNRPE, SNRPF and SNRPG are trapped in an inactive 6S pICln-Sm complex by the chaperone CLNS1A that controls the assembly of the core snRNP (PubMed:18984161). To assemble core snRNPs, the SMN complex accepts the trapped 5Sm proteins from CLNS1A forming an intermediate (PubMed:18984161). Binding of snRNA inside 5Sm ultimately triggers eviction of the SMN complex, thereby allowing binding of SNRPD3 and SNRPB to complete assembly of the core snRNP. Within the SMN complex, GEMIN5 recognizes and delivers the small nuclear RNAs (snRNAs) to the SMN complex (PubMed:11714716, PubMed:16314521, PubMed:16857593, PubMed:19377484, PubMed:19750007, PubMed:20513430, PubMed:27834343, PubMed:27881600, PubMed:27881601). Binds to the 7-methylguanosine cap of RNA molecules (PubMed:19750007, PubMed:27834343, PubMed:27881600, PubMed:27881601, Ref.27). Binds to the 3'-UTR of SMN1 mRNA and regulates its translation; does not affect mRNA stability (PubMed:25911097). May play a role in the regulation of protein synthesis via its interaction with ribosomes (PubMed:27507887). {ECO:0000269|PubMed:11714716, ECO:0000269|PubMed:16314521, ECO:0000269|PubMed:16857593, ECO:0000269|PubMed:18984161, ECO:0000269|PubMed:19377484, ECO:0000269|PubMed:19750007, ECO:0000269|PubMed:20513430, ECO:0000269|PubMed:25911097, ECO:0000269|PubMed:27507887, ECO:0000269|PubMed:27834343, ECO:0000269|PubMed:27881600, ECO:0000269|PubMed:27881601, ECO:0000269|PubMed:33963192, ECO:0000269|Ref.27}. |
Q8WWQ0 | PHIP | T1775 | ochoa | PH-interacting protein (PHIP) (DDB1- and CUL4-associated factor 14) (IRS-1 PH domain-binding protein) (WD repeat-containing protein 11) | Probable regulator of the insulin and insulin-like growth factor signaling pathways. Stimulates cell proliferation through regulation of cyclin transcription and has an anti-apoptotic activity through AKT1 phosphorylation and activation. Plays a role in the regulation of cell morphology and cytoskeletal organization. {ECO:0000269|PubMed:12242307, ECO:0000269|PubMed:21834987}. |
Q92932 | PTPRN2 | T441 | ochoa | Receptor-type tyrosine-protein phosphatase N2 (R-PTP-N2) (EC 3.1.3.-) (EC 3.1.3.48) (Islet cell autoantigen-related protein) (IAR) (ICAAR) (Phogrin) [Cleaved into: IA-2beta60] | Plays a role in vesicle-mediated secretory processes. Required for normal accumulation of secretory vesicles in hippocampus, pituitary and pancreatic islets. Required for the accumulation of normal levels of insulin-containing vesicles and preventing their degradation. Plays a role in insulin secretion in response to glucose stimuli. Required for normal accumulation of the neurotransmitters norepinephrine, dopamine and serotonin in the brain. In females, but not in males, required for normal accumulation and secretion of pituitary hormones, such as luteinizing hormone (LH) and follicle-stimulating hormone (FSH) (By similarity). Required to maintain normal levels of renin expression and renin release (By similarity). May regulate catalytic active protein-tyrosine phosphatases such as PTPRA through dimerization (By similarity). Has phosphatidylinositol phosphatase activity; the PIPase activity is involved in its ability to regulate insulin secretion. Can dephosphorylate phosphatidylinositol 4,5-biphosphate (PI(4,5)P2), phosphatidylinositol 5-phosphate and phosphatidylinositol 3-phosphate (By similarity). Regulates PI(4,5)P2 level in the plasma membrane and localization of cofilin at the plasma membrane and thus is indirectly involved in regulation of actin dynamics related to cell migration and metastasis; upon hydrolysis of PI(4,5)P2 cofilin is released from the plasma membrane and acts in the cytoplasm in severing F-actin filaments (PubMed:26620550). {ECO:0000250|UniProtKB:P80560, ECO:0000250|UniProtKB:Q63475, ECO:0000269|PubMed:26620550}. |
Q96PY5 | FMNL2 | T450 | ochoa | Formin-like protein 2 (Formin homology 2 domain-containing protein 2) | Plays a role in the regulation of cell morphology and cytoskeletal organization. Required in the cortical actin filament dynamics. {ECO:0000269|PubMed:21834987}. |
Q99708 | RBBP8 | T126 | psp | DNA endonuclease RBBP8 (EC 3.1.-.-) (CtBP-interacting protein) (CtIP) (Retinoblastoma-binding protein 8) (RBBP-8) (Retinoblastoma-interacting protein and myosin-like) (RIM) (Sporulation in the absence of SPO11 protein 2 homolog) (SAE2) | Endonuclease that cooperates with the MRE11-RAD50-NBN (MRN) complex in DNA-end resection, the first step of double-strand break (DSB) repair through the homologous recombination (HR) pathway (PubMed:17965729, PubMed:19202191, PubMed:19759395, PubMed:20064462, PubMed:23273981, PubMed:26721387, PubMed:27814491, PubMed:27889449, PubMed:30787182). HR is restricted to S and G2 phases of the cell cycle and preferentially repairs DSBs resulting from replication fork collapse (PubMed:17965729, PubMed:19202191, PubMed:23273981, PubMed:27814491, PubMed:27889449, PubMed:30787182). Key determinant of DSB repair pathway choice, as it commits cells to HR by preventing classical non-homologous end-joining (NHEJ) (PubMed:19202191). Specifically promotes the endonuclease activity of the MRN complex to clear DNA ends containing protein adducts: recruited to DSBs by NBN following phosphorylation by CDK1, and promotes the endonuclease activity of MRE11 to clear protein-DNA adducts and generate clean double-strand break ends (PubMed:27814491, PubMed:27889449, PubMed:30787182, PubMed:33836577). Functions downstream of the MRN complex and ATM, promotes ATR activation and its recruitment to DSBs in the S/G2 phase facilitating the generation of ssDNA (PubMed:16581787, PubMed:17965729, PubMed:19759395, PubMed:20064462). Component of the BRCA1-RBBP8 complex that regulates CHEK1 activation and controls cell cycle G2/M checkpoints on DNA damage (PubMed:15485915, PubMed:16818604). During immunoglobulin heavy chain class-switch recombination, promotes microhomology-mediated alternative end joining (A-NHEJ) and plays an essential role in chromosomal translocations (By similarity). Binds preferentially to DNA Y-junctions and to DNA substrates with blocked ends and promotes intermolecular DNA bridging (PubMed:30601117). {ECO:0000250|UniProtKB:Q80YR6, ECO:0000269|PubMed:15485915, ECO:0000269|PubMed:16581787, ECO:0000269|PubMed:16818604, ECO:0000269|PubMed:17965729, ECO:0000269|PubMed:19202191, ECO:0000269|PubMed:19759395, ECO:0000269|PubMed:20064462, ECO:0000269|PubMed:23273981, ECO:0000269|PubMed:26721387, ECO:0000269|PubMed:27814491, ECO:0000269|PubMed:27889449, ECO:0000269|PubMed:30601117, ECO:0000269|PubMed:30787182, ECO:0000269|PubMed:33836577}. |
Q9BV73 | CEP250 | T2233 | ochoa | Centrosome-associated protein CEP250 (250 kDa centrosomal protein) (Cep250) (Centrosomal Nek2-associated protein 1) (C-Nap1) (Centrosomal protein 2) | Plays an important role in centrosome cohesion during interphase (PubMed:30404835, PubMed:36282799). Recruits CCDC102B to the proximal ends of centrioles (PubMed:30404835). Maintains centrosome cohesion by forming intercentriolar linkages (PubMed:36282799). Accumulates at the proximal end of each centriole, forming supramolecular assemblies with viscous material properties that promote organelle cohesion (PubMed:36282799). May be involved in ciliogenesis (PubMed:28005958). {ECO:0000269|PubMed:28005958, ECO:0000269|PubMed:30404835, ECO:0000269|PubMed:36282799}. |
Q9BYM8 | RBCK1 | T329 | ochoa | RanBP-type and C3HC4-type zinc finger-containing protein 1 (EC 2.3.2.31) (HBV-associated factor 4) (Heme-oxidized IRP2 ubiquitin ligase 1) (HOIL-1) (Hepatitis B virus X-associated protein 4) (RING finger protein 54) (RING-type E3 ubiquitin transferase HOIL-1) (Ubiquitin-conjugating enzyme 7-interacting protein 3) | E3 ubiquitin-protein ligase, which accepts ubiquitin from specific E2 ubiquitin-conjugating enzymes, such as UBE2L3/UBCM4, and then transfers it to substrates (PubMed:12629548, PubMed:17449468, PubMed:18711448). Functions as an E3 ligase for oxidized IREB2 and both heme and oxygen are necessary for IREB2 ubiquitination (PubMed:12629548). Promotes ubiquitination of TAB2 and IRF3 and their degradation by the proteasome (PubMed:17449468, PubMed:18711448). Component of the LUBAC complex which conjugates linear ('Met-1'-linked) polyubiquitin chains to substrates and plays a key role in NF-kappa-B activation and regulation of inflammation (PubMed:17006537, PubMed:19136968, PubMed:21455173, PubMed:21455180, PubMed:21455181). LUBAC conjugates linear polyubiquitin to IKBKG and RIPK1 and is involved in activation of the canonical NF-kappa-B and the JNK signaling pathways (PubMed:17006537, PubMed:19136968, PubMed:21455173, PubMed:21455180, PubMed:21455181). Linear ubiquitination mediated by the LUBAC complex interferes with TNF-induced cell death and thereby prevents inflammation (PubMed:17006537, PubMed:21455173, PubMed:21455180, PubMed:21455181). LUBAC is recruited to the TNF-R1 signaling complex (TNF-RSC) following polyubiquitination of TNF-RSC components by BIRC2 and/or BIRC3 and to conjugate linear polyubiquitin to IKBKG and possibly other components contributing to the stability of the complex (PubMed:17006537, PubMed:19136968, PubMed:21455173, PubMed:21455180, PubMed:21455181). The LUBAC complex is also involved in innate immunity by conjugating linear polyubiquitin chains at the surface of bacteria invading the cytosol to form the ubiquitin coat surrounding bacteria (PubMed:28481331). LUBAC is not able to initiate formation of the bacterial ubiquitin coat, and can only promote formation of linear polyubiquitins on pre-existing ubiquitin (PubMed:28481331). The bacterial ubiquitin coat acts as an 'eat-me' signal for xenophagy and promotes NF-kappa-B activation (PubMed:28481331). Together with OTULIN, the LUBAC complex regulates the canonical Wnt signaling during angiogenesis (PubMed:23708998). Binds polyubiquitin of different linkage types (PubMed:20005846, PubMed:21455181). {ECO:0000269|PubMed:12629548, ECO:0000269|PubMed:17006537, ECO:0000269|PubMed:17449468, ECO:0000269|PubMed:18711448, ECO:0000269|PubMed:19136968, ECO:0000269|PubMed:20005846, ECO:0000269|PubMed:21455173, ECO:0000269|PubMed:21455180, ECO:0000269|PubMed:21455181, ECO:0000269|PubMed:23708998, ECO:0000269|PubMed:28481331}. |
Q9BYW2 | SETD2 | T1897 | ochoa | Histone-lysine N-methyltransferase SETD2 (EC 2.1.1.359) (HIF-1) (Huntingtin yeast partner B) (Huntingtin-interacting protein 1) (HIP-1) (Huntingtin-interacting protein B) (Lysine N-methyltransferase 3A) (Protein-lysine N-methyltransferase SETD2) (EC 2.1.1.-) (SET domain-containing protein 2) (hSET2) (p231HBP) | Histone methyltransferase that specifically trimethylates 'Lys-36' of histone H3 (H3K36me3) using dimethylated 'Lys-36' (H3K36me2) as substrate (PubMed:16118227, PubMed:19141475, PubMed:21526191, PubMed:21792193, PubMed:23043551, PubMed:27474439). It is capable of trimethylating unmethylated H3K36 (H3K36me0) in vitro (PubMed:19332550). Represents the main enzyme generating H3K36me3, a specific tag for epigenetic transcriptional activation (By similarity). Plays a role in chromatin structure modulation during elongation by coordinating recruitment of the FACT complex and by interacting with hyperphosphorylated POLR2A (PubMed:23325844). Acts as a key regulator of DNA mismatch repair in G1 and early S phase by generating H3K36me3, a mark required to recruit MSH6 subunit of the MutS alpha complex: early recruitment of the MutS alpha complex to chromatin to be replicated allows a quick identification of mismatch DNA to initiate the mismatch repair reaction (PubMed:23622243). Required for DNA double-strand break repair in response to DNA damage: acts by mediating formation of H3K36me3, promoting recruitment of RAD51 and DNA repair via homologous recombination (HR) (PubMed:24843002). Acts as a tumor suppressor (PubMed:24509477). H3K36me3 also plays an essential role in the maintenance of a heterochromatic state, by recruiting DNA methyltransferase DNMT3A (PubMed:27317772). H3K36me3 is also enhanced in intron-containing genes, suggesting that SETD2 recruitment is enhanced by splicing and that splicing is coupled to recruitment of elongating RNA polymerase (PubMed:21792193). Required during angiogenesis (By similarity). Required for endoderm development by promoting embryonic stem cell differentiation toward endoderm: acts by mediating formation of H3K36me3 in distal promoter regions of FGFR3, leading to regulate transcription initiation of FGFR3 (By similarity). In addition to histones, also mediates methylation of other proteins, such as tubulins and STAT1 (PubMed:27518565, PubMed:28753426). Trimethylates 'Lys-40' of alpha-tubulins such as TUBA1B (alpha-TubK40me3); alpha-TubK40me3 is required for normal mitosis and cytokinesis and may be a specific tag in cytoskeletal remodeling (PubMed:27518565). Involved in interferon-alpha-induced antiviral defense by mediating both monomethylation of STAT1 at 'Lys-525' and catalyzing H3K36me3 on promoters of some interferon-stimulated genes (ISGs) to activate gene transcription (PubMed:28753426). {ECO:0000250|UniProtKB:E9Q5F9, ECO:0000269|PubMed:16118227, ECO:0000269|PubMed:19141475, ECO:0000269|PubMed:21526191, ECO:0000269|PubMed:21792193, ECO:0000269|PubMed:23043551, ECO:0000269|PubMed:23325844, ECO:0000269|PubMed:23622243, ECO:0000269|PubMed:24509477, ECO:0000269|PubMed:24843002, ECO:0000269|PubMed:27317772, ECO:0000269|PubMed:27474439, ECO:0000269|PubMed:27518565, ECO:0000269|PubMed:28753426}.; FUNCTION: (Microbial infection) Recruited to the promoters of adenovirus 12 E1A gene in case of infection, possibly leading to regulate its expression. {ECO:0000269|PubMed:11461154}. |
Q9BYX7 | POTEKP | T89 | ochoa | Putative beta-actin-like protein 3 (Kappa-actin) (POTE ankyrin domain family member K) | None |
Q9BZC7 | ABCA2 | T2412 | ochoa | ATP-binding cassette sub-family A member 2 (EC 7.6.2.-) (ATP-binding cassette transporter 2) (ATP-binding cassette 2) | Probable lipid transporter that modulates cholesterol sequestration in the late endosome/lysosome by regulating the intracellular sphingolipid metabolism, in turn participates in cholesterol homeostasis (Probable) (PubMed:15238223, PubMed:21810484, PubMed:24201375). May alter the transbilayer distribution of ceramide in the intraluminal membrane lipid bilayer, favoring its retention in the outer leaflet that results in increased acid ceramidase activity in the late endosome/lysosome, facilitating ceramide deacylation to sphingosine leading to the sequestration of free cholesterol in lysosomes (PubMed:24201375). In addition regulates amyloid-beta production either by activating a signaling pathway that regulates amyloid precursor protein transcription through the modulation of sphingolipid metabolism or through its role in gamma-secretase processing of APP (PubMed:22086926, PubMed:26510981). May play a role in myelin formation (By similarity). {ECO:0000250|UniProtKB:P41234, ECO:0000269|PubMed:15238223, ECO:0000269|PubMed:21810484, ECO:0000269|PubMed:22086926, ECO:0000269|PubMed:24201375, ECO:0000269|PubMed:26510981, ECO:0000305|PubMed:15999530}. |
Q9GZX5 | ZNF350 | T283 | ochoa | Zinc finger protein 350 (KRAB zinc finger protein ZFQR) (Zinc finger and BRCA1-interacting protein with a KRAB domain 1) (Zinc finger protein ZBRK1) | Transcriptional repressor. Binds to a specific sequence, 5'-GGGxxxCAGxxxTTT-3', within GADD45 intron 3. {ECO:0000269|PubMed:11090615}. |
Q9H0A0 | NAT10 | T672 | ochoa | RNA cytidine acetyltransferase (EC 2.3.1.-) (18S rRNA cytosine acetyltransferase) (N-acetyltransferase 10) (N-acetyltransferase-like protein) (hALP) | RNA cytidine acetyltransferase that catalyzes the formation of N(4)-acetylcytidine (ac4C) modification on mRNAs, 18S rRNA and tRNAs (PubMed:25411247, PubMed:25653167, PubMed:30449621, PubMed:35679869). Catalyzes ac4C modification of a broad range of mRNAs, enhancing mRNA stability and translation (PubMed:30449621, PubMed:35679869). mRNA ac4C modification is frequently present within wobble cytidine sites and promotes translation efficiency (PubMed:30449621). Mediates the formation of ac4C at position 1842 in 18S rRNA (PubMed:25411247). May also catalyze the formation of ac4C at position 1337 in 18S rRNA (By similarity). Required for early nucleolar cleavages of precursor rRNA at sites A0, A1 and A2 during 18S rRNA synthesis (PubMed:25411247, PubMed:25653167). Catalyzes the formation of ac4C in serine and leucine tRNAs (By similarity). Requires the tRNA-binding adapter protein THUMPD1 for full tRNA acetyltransferase activity but not for 18S rRNA acetylation (PubMed:25653167). In addition to RNA acetyltransferase activity, also able to acetylate lysine residues of proteins, such as histones, microtubules, p53/TP53 and MDM2, in vitro (PubMed:14592445, PubMed:17631499, PubMed:19303003, PubMed:26882543, PubMed:27993683, PubMed:30165671). The relevance of the protein lysine acetyltransferase activity is however unsure in vivo (PubMed:30449621). Activates telomerase activity by stimulating the transcription of TERT, and may also regulate telomerase function by affecting the balance of telomerase subunit assembly, disassembly, and localization (PubMed:14592445, PubMed:18082603). Involved in the regulation of centrosome duplication by acetylating CENATAC during mitosis, promoting SASS6 proteasome degradation (PubMed:31722219). Part of the small subunit (SSU) processome, first precursor of the small eukaryotic ribosomal subunit. During the assembly of the SSU processome in the nucleolus, many ribosome biogenesis factors, an RNA chaperone and ribosomal proteins associate with the nascent pre-rRNA and work in concert to generate RNA folding, modifications, rearrangements and cleavage as well as targeted degradation of pre-ribosomal RNA by the RNA exosome (PubMed:34516797). {ECO:0000250|UniProtKB:P53914, ECO:0000269|PubMed:14592445, ECO:0000269|PubMed:17631499, ECO:0000269|PubMed:18082603, ECO:0000269|PubMed:19303003, ECO:0000269|PubMed:25411247, ECO:0000269|PubMed:25653167, ECO:0000269|PubMed:26882543, ECO:0000269|PubMed:27993683, ECO:0000269|PubMed:30165671, ECO:0000269|PubMed:30449621, ECO:0000269|PubMed:31722219, ECO:0000269|PubMed:34516797, ECO:0000269|PubMed:35679869}. |
Q9H0X9 | OSBPL5 | T332 | ochoa | Oxysterol-binding protein-related protein 5 (ORP-5) (OSBP-related protein 5) (Oxysterol-binding protein homolog 1) | Lipid transporter involved in lipid countertransport between the endoplasmic reticulum and the plasma membrane: specifically exchanges phosphatidylserine with phosphatidylinositol 4-phosphate (PI4P), delivering phosphatidylserine to the plasma membrane in exchange for PI4P, which is degraded by the SAC1/SACM1L phosphatase in the endoplasmic reticulum. Binds phosphatidylserine and PI4P in a mutually exclusive manner (PubMed:23934110, PubMed:26206935). May cooperate with NPC1 to mediate the exit of cholesterol from endosomes/lysosomes (PubMed:21220512). Binds 25-hydroxycholesterol and cholesterol (PubMed:17428193). {ECO:0000269|PubMed:17428193, ECO:0000269|PubMed:21220512, ECO:0000269|PubMed:23934110, ECO:0000269|PubMed:26206935}. |
Q9H2M9 | RAB3GAP2 | T566 | ochoa | Rab3 GTPase-activating protein non-catalytic subunit (RGAP-iso) (Rab3 GTPase-activating protein 150 kDa subunit) (Rab3-GAP p150) (Rab3-GAP150) (Rab3-GAP regulatory subunit) | Regulatory subunit of the Rab3 GTPase-activating (Rab3GAP) complex composed of RAB3GAP1 and RAB3GAP2, which has GTPase-activating protein (GAP) activity towards various Rab3 subfamily members (RAB3A, RAB3B, RAB3C and RAB3D), RAB5A and RAB43, and guanine nucleotide exchange factor (GEF) activity towards RAB18 (PubMed:24891604, PubMed:9733780). As part of the Rab3GAP complex, acts as a GAP for Rab3 proteins by converting active RAB3-GTP to the inactive form RAB3-GDP (By similarity). Rab3 proteins are involved in regulated exocytosis of neurotransmitters and hormones (By similarity). The Rab3GAP complex acts as a GEF for RAB18 by promoting the conversion of inactive RAB18-GDP to the active form RAB18-GTP (PubMed:24891604). Recruits and stabilizes RAB18 at the cis-Golgi membrane in human fibroblasts where RAB18 is most likely activated (PubMed:26063829). Also involved in RAB18 recruitment at the endoplasmic reticulum (ER) membrane where it maintains proper ER structure (PubMed:24891604). Required for normal eye and brain development (By similarity). May participate in neurodevelopmental processes such as proliferation, migration and differentiation before synapse formation, and non-synaptic vesicular release of neurotransmitters (By similarity). {ECO:0000250|UniProtKB:Q15042, ECO:0000269|PubMed:24891604, ECO:0000269|PubMed:26063829, ECO:0000269|PubMed:9733780}. |
Q9H2X9 | SLC12A5 | T929 | psp | Solute carrier family 12 member 5 (Electroneutral potassium-chloride cotransporter 2) (K-Cl cotransporter 2) (hKCC2) (Neuronal K-Cl cotransporter) | Mediates electroneutral potassium-chloride cotransport in mature neurons and is required for neuronal Cl(-) homeostasis (PubMed:12106695). As major extruder of intracellular chloride, it establishes the low neuronal Cl(-) levels required for chloride influx after binding of GABA-A and glycine to their receptors, with subsequent hyperpolarization and neuronal inhibition (By similarity). Involved in the regulation of dendritic spine formation and maturation (PubMed:24668262). {ECO:0000250|UniProtKB:Q63633, ECO:0000269|PubMed:12106695, ECO:0000269|PubMed:24668262}. |
Q9H2Y7 | ZNF106 | T397 | ochoa | Zinc finger protein 106 (Zfp-106) (Zinc finger protein 474) | RNA-binding protein. Specifically binds to 5'-GGGGCC-3' sequence repeats in RNA. Essential for maintenance of peripheral motor neuron and skeletal muscle function. Required for normal expression and/or alternative splicing of a number of genes in spinal cord and skeletal muscle, including the neurite outgrowth inhibitor RTN4. Also contributes to normal mitochondrial respiratory function in motor neurons, via an unknown mechanism. {ECO:0000250|UniProtKB:O88466}. |
Q9H4A6 | GOLPH3 | T143 | psp | Golgi phosphoprotein 3 (Coat protein GPP34) (Mitochondrial DNA absence factor) (MIDAS) | Phosphatidylinositol-4-phosphate-binding protein that links Golgi membranes to the cytoskeleton and may participate in the tensile force required for vesicle budding from the Golgi. Thereby, may play a role in Golgi membrane trafficking and could indirectly give its flattened shape to the Golgi apparatus. May also bind to the coatomer to regulate Golgi membrane trafficking. May play a role in anterograde transport from the Golgi to the plasma membrane and regulate secretion. Has also been involved in the control of the localization of Golgi enzymes through interaction with their cytoplasmic part. May play an indirect role in cell migration. Has also been involved in the modulation of mTOR signaling. May also be involved in the regulation of mitochondrial lipids biosynthesis. {ECO:0000269|PubMed:16263763, ECO:0000269|PubMed:19553991, ECO:0000269|PubMed:19837035, ECO:0000269|PubMed:22745132, ECO:0000269|PubMed:23027862, ECO:0000269|PubMed:23345592, ECO:0000269|PubMed:23500462}. |
Q9H4G0 | EPB41L1 | T54 | ochoa | Band 4.1-like protein 1 (Erythrocyte membrane protein band 4.1-like 1) (Neuronal protein 4.1) (4.1N) | May function to confer stability and plasticity to neuronal membrane via multiple interactions, including the spectrin-actin-based cytoskeleton, integral membrane channels and membrane-associated guanylate kinases. |
Q9H501 | ESF1 | T630 | ochoa | ESF1 homolog (ABT1-associated protein) | May constitute a novel regulatory system for basal transcription. Negatively regulates ABT1 (By similarity). {ECO:0000250}. |
Q9H9H4 | VPS37B | T68 | ochoa | Vacuolar protein sorting-associated protein 37B (hVps37B) (ESCRT-I complex subunit VPS37B) | Component of the ESCRT-I complex, a regulator of vesicular trafficking process. Required for the sorting of endocytic ubiquitinated cargos into multivesicular bodies. May be involved in cell growth and differentiation. {ECO:0000269|PubMed:15218037}. |
Q9NP79 | VTA1 | T150 | ochoa | Vacuolar protein sorting-associated protein VTA1 homolog (Dopamine-responsive gene 1 protein) (DRG-1) (LYST-interacting protein 5) (LIP5) (SKD1-binding protein 1) (SBP1) | Involved in the endosomal multivesicular bodies (MVB) pathway. MVBs contain intraluminal vesicles (ILVs) that are generated by invagination and scission from the limiting membrane of the endosome and mostly are delivered to lysosomes enabling degradation of membrane proteins, such as stimulated growth factor receptors, lysosomal enzymes and lipids. Thought to be a cofactor of VPS4A/B, which catalyzes disassembles membrane-associated ESCRT-III assemblies. Involved in the sorting and down-regulation of EGFR (By similarity). Involved in HIV-1 budding. {ECO:0000250, ECO:0000269|PubMed:15644320}. |
Q9NS00 | C1GALT1 | T77 | ochoa | Glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1 (EC 2.4.1.122) (B3Gal-T8) (Core 1 O-glycan T-synthase) (Core 1 UDP-galactose:N-acetylgalactosamine-alpha-R beta 1,3-galactosyltransferase 1) (Beta-1,3-galactosyltransferase) (Core 1 beta1,3-galactosyltransferase 1) (C1GalT1) (Core 1 beta3-Gal-T1) | Glycosyltransferase that generates the core 1 O-glycan Gal-beta1-3GalNAc-alpha1-Ser/Thr (T antigen), which is a precursor for many extended O-glycans in glycoproteins (PubMed:11677243). Plays a central role in many processes, such as angiogenesis, thrombopoiesis and kidney homeostasis development (By similarity). {ECO:0000250|UniProtKB:Q7K237, ECO:0000250|UniProtKB:Q9JJ06, ECO:0000269|PubMed:11677243}. |
Q9NVA2 | SEPTIN11 | T322 | ochoa | Septin-11 | Filament-forming cytoskeletal GTPase. May play a role in cytokinesis (Potential). May play a role in the cytoarchitecture of neurons, including dendritic arborization and dendritic spines, and in GABAergic synaptic connectivity (By similarity). During Listeria monocytogenes infection, not required for the bacterial entry process, but restricts its efficacy. {ECO:0000250, ECO:0000269|PubMed:15196925, ECO:0000269|PubMed:19234302, ECO:0000305}. |
Q9NZU5 | LMCD1 | T227 | ochoa | LIM and cysteine-rich domains protein 1 (Dyxin) | Transcriptional cofactor that restricts GATA6 function by inhibiting DNA-binding, resulting in repression of GATA6 transcriptional activation of downstream target genes. Represses GATA6-mediated trans activation of lung- and cardiac tissue-specific promoters. Inhibits DNA-binding by GATA4 and GATA1 to the cTNC promoter (By similarity). Plays a critical role in the development of cardiac hypertrophy via activation of calcineurin/nuclear factor of activated T-cells signaling pathway. {ECO:0000250, ECO:0000269|PubMed:20026769}. |
Q9P0V9 | SEPTIN10 | T347 | ochoa | Septin-10 | Filament-forming cytoskeletal GTPase. May play a role in cytokinesis (Potential). {ECO:0000305}. |
Q9UHP3 | USP25 | T680 | psp | Ubiquitin carboxyl-terminal hydrolase 25 (EC 3.4.19.12) (Deubiquitinating enzyme 25) (USP on chromosome 21) (Ubiquitin thioesterase 25) (Ubiquitin-specific-processing protease 25) | Deubiquitinating enzyme that hydrolyzes ubiquitin moieties conjugated to substrates and thus, functions in various biological processes including inflammation and immune response (PubMed:29518389, PubMed:37683630). Modulates the Wnt/beta-catenin pathway by deubiquitinating and stabilizing tankyrases TNKS1 and TNKS2 (PubMed:28619731, PubMed:30926243, PubMed:38875478). Regulates KEAP1-NRF2 axis in the defense against oxidative assaults by deubiquitinating KEAP1 and protecting it from degradation leading to degradation of the NRF2 transcription factor that is responsible for mounting an anti-oxidation gene expression program (PubMed:37339955). Positively regulates RNA virus-induced innate signaling by interacting with and deubiquitinating ERLIN1 and ERLIN2 (PubMed:37683630). In turn, restricts virus production by regulating cholesterol biosynthetic flux (PubMed:37683630). Acts as a negative regulator of interleukin-17-mediated signaling and inflammation through the removal of 'Lys-63'-linked ubiquitination of TRAF5 and TRAF6 (PubMed:23042150). Prevents the ubiquitination and degradation of TRAF3 to reduce the phosphorylation levels of JNK and P38, the secretion of IL-1B and to induce endotoxin tolerance (PubMed:30579117). {ECO:0000269|PubMed:23042150, ECO:0000269|PubMed:28619731, ECO:0000269|PubMed:29518389, ECO:0000269|PubMed:30579117, ECO:0000269|PubMed:30926243, ECO:0000269|PubMed:37339955, ECO:0000269|PubMed:37683630, ECO:0000269|PubMed:38875478}.; FUNCTION: The muscle-specific isoform (USP25m) may have a role in the regulation of muscular differentiation and function. |
Q9UHW9 | SLC12A6 | T991 | ochoa|psp | Solute carrier family 12 member 6 (Electroneutral potassium-chloride cotransporter 3) (K-Cl cotransporter 3) | [Isoform 1]: Mediates electroneutral potassium-chloride cotransport when activated by cell swelling (PubMed:10600773, PubMed:11551954, PubMed:16048901, PubMed:18566107, PubMed:19665974, PubMed:21628467, PubMed:27485015). May contribute to cell volume homeostasis in single cells (PubMed:16048901, PubMed:27485015). {ECO:0000269|PubMed:10600773, ECO:0000269|PubMed:11551954, ECO:0000269|PubMed:16048901, ECO:0000269|PubMed:18566107, ECO:0000269|PubMed:19665974, ECO:0000269|PubMed:21628467, ECO:0000269|PubMed:27485015, ECO:0000305|PubMed:16048901}.; FUNCTION: [Isoform 2]: Mediates electroneutral potassium-chloride cotransport when activated by cell swelling (PubMed:16048901, PubMed:33199848, PubMed:34031912). May contribute to cell volume homeostasis in single cells (Probable). {ECO:0000269|PubMed:16048901, ECO:0000269|PubMed:33199848, ECO:0000269|PubMed:34031912, ECO:0000305|PubMed:16048901}.; FUNCTION: [Isoform 3]: Mediates electroneutral potassium-chloride cotransport when activated by cell swelling (PubMed:16048901). May contribute to cell volume homeostasis in single cells (Probable). {ECO:0000269|PubMed:16048901, ECO:0000305|PubMed:16048901}.; FUNCTION: [Isoform 4]: Mediates electroneutral potassium-chloride cotransport when activated by cell swelling (PubMed:16048901). May contribute to cell volume homeostasis in single cells (Probable). {ECO:0000269|PubMed:16048901, ECO:0000305|PubMed:16048901}.; FUNCTION: [Isoform 5]: Mediates electroneutral potassium-chloride cotransport when activated by cell swelling (PubMed:16048901). May contribute to cell volume homeostasis in single cells (Probable). {ECO:0000269|PubMed:16048901, ECO:0000305|PubMed:16048901}.; FUNCTION: [Isoform 6]: Mediates electroneutral potassium-chloride cotransport when activated by cell swelling (PubMed:16048901). May contribute to cell volume homeostasis in single cells (Probable). {ECO:0000269|PubMed:16048901, ECO:0000305|PubMed:16048901}. |
Q9UKN1 | MUC12 | T5424 | ochoa | Mucin-12 (MUC-12) (Mucin-11) (MUC-11) | Involved in epithelial cell protection, adhesion modulation, and signaling. May be involved in epithelial cell growth regulation. Stimulated by both cytokine TNF-alpha and TGF-beta in intestinal epithelium. {ECO:0000269|PubMed:17058067}. |
Q9UKN8 | GTF3C4 | T655 | ochoa | General transcription factor 3C polypeptide 4 (EC 2.3.1.48) (TF3C-delta) (Transcription factor IIIC 90 kDa subunit) (TFIIIC 90 kDa subunit) (TFIIIC90) (Transcription factor IIIC subunit delta) | Essential for RNA polymerase III to make a number of small nuclear and cytoplasmic RNAs, including 5S RNA, tRNA, and adenovirus-associated (VA) RNA of both cellular and viral origin (PubMed:10523658). Has histone acetyltransferase activity (HAT) with unique specificity for free and nucleosomal H3 (PubMed:10523658). May cooperate with GTF3C5 in facilitating the recruitment of TFIIIB and RNA polymerase through direct interactions with BRF1, POLR3C and POLR3F (PubMed:10523658). May be localized close to the A box (PubMed:10523658). {ECO:0000269|PubMed:10523658}. |
Q9UKX2 | MYH2 | T1025 | ochoa | Myosin-2 (Myosin heavy chain 2) (Myosin heavy chain 2a) (MyHC-2a) (Myosin heavy chain IIa) (MyHC-IIa) (Myosin heavy chain, skeletal muscle, adult 2) | Myosins are actin-based motor molecules with ATPase activity essential for muscle contraction. {ECO:0000250|UniProtKB:P12883}. |
Q9UKX2 | MYH2 | T1288 | ochoa | Myosin-2 (Myosin heavy chain 2) (Myosin heavy chain 2a) (MyHC-2a) (Myosin heavy chain IIa) (MyHC-IIa) (Myosin heavy chain, skeletal muscle, adult 2) | Myosins are actin-based motor molecules with ATPase activity essential for muscle contraction. {ECO:0000250|UniProtKB:P12883}. |
Q9UKX2 | MYH2 | T1485 | ochoa | Myosin-2 (Myosin heavy chain 2) (Myosin heavy chain 2a) (MyHC-2a) (Myosin heavy chain IIa) (MyHC-IIa) (Myosin heavy chain, skeletal muscle, adult 2) | Myosins are actin-based motor molecules with ATPase activity essential for muscle contraction. {ECO:0000250|UniProtKB:P12883}. |
Q9UKX2 | MYH2 | T1503 | ochoa | Myosin-2 (Myosin heavy chain 2) (Myosin heavy chain 2a) (MyHC-2a) (Myosin heavy chain IIa) (MyHC-IIa) (Myosin heavy chain, skeletal muscle, adult 2) | Myosins are actin-based motor molecules with ATPase activity essential for muscle contraction. {ECO:0000250|UniProtKB:P12883}. |
Q9UKX3 | MYH13 | T1483 | ochoa | Myosin-13 (Myosin heavy chain 13) (Myosin heavy chain, skeletal muscle, extraocular) (MyHC-EO) (Myosin heavy chain, skeletal muscle, laryngeal) (MyHC-IIL) (Superfast myosin) | Fast twitching myosin mediating the high-velocity and low-tension contractions of specific striated muscles. {ECO:0000269|PubMed:23908353}. |
Q9ULD2 | MTUS1 | T1204 | ochoa | Microtubule-associated tumor suppressor 1 (AT2 receptor-binding protein) (Angiotensin-II type 2 receptor-interacting protein) (Mitochondrial tumor suppressor 1) | Cooperates with AGTR2 to inhibit ERK2 activation and cell proliferation. May be required for AGTR2 cell surface expression. Together with PTPN6, induces UBE2V2 expression upon angiotensin-II stimulation. Isoform 1 inhibits breast cancer cell proliferation, delays the progression of mitosis by prolonging metaphase and reduces tumor growth. {ECO:0000269|PubMed:12692079, ECO:0000269|PubMed:19794912}. |
Q9UP95 | SLC12A4 | T926 | ochoa | Solute carrier family 12 member 4 (Electroneutral potassium-chloride cotransporter 1) (Erythroid K-Cl cotransporter 1) (hKCC1) | Mediates electroneutral potassium-chloride cotransport when activated by cell swelling (PubMed:35759661). May contribute to cell volume homeostasis in single cells (PubMed:10913127, PubMed:34031912). May be involved in the regulation of basolateral Cl(-) exit in NaCl absorbing epithelia (By similarity). {ECO:0000250|UniProtKB:Q9JIS8, ECO:0000269|PubMed:10913127, ECO:0000269|PubMed:34031912, ECO:0000269|PubMed:35759661}.; FUNCTION: [Isoform 4]: No transporter activity. {ECO:0000269|PubMed:11551954}. |
Q9UQC2 | GAB2 | T294 | ochoa | GRB2-associated-binding protein 2 (GRB2-associated binder 2) (Growth factor receptor bound protein 2-associated protein 2) (pp100) | Adapter protein which acts downstream of several membrane receptors including cytokine, antigen, hormone, cell matrix and growth factor receptors to regulate multiple signaling pathways. Regulates osteoclast differentiation mediating the TNFRSF11A/RANK signaling. In allergic response, it plays a role in mast cells activation and degranulation through PI-3-kinase regulation. Also involved in the regulation of cell proliferation and hematopoiesis. {ECO:0000269|PubMed:15750601, ECO:0000269|PubMed:19172738}. |
Q9Y247 | FAM50B | T150 | ochoa | Protein FAM50B (Protein XAP-5-like) | None |
Q9Y4B5 | MTCL1 | T553 | ochoa | Microtubule cross-linking factor 1 (Coiled-coil domain-containing protein 165) (PAR-1-interacting protein) (SOGA family member 2) | Microtubule-associated factor involved in the late phase of epithelial polarization and microtubule dynamics regulation (PubMed:23902687). Plays a role in the development and maintenance of non-centrosomal microtubule bundles at the lateral membrane in polarized epithelial cells (PubMed:23902687). Required for faithful chromosome segregation during mitosis (PubMed:33587225). {ECO:0000269|PubMed:23902687, ECO:0000269|PubMed:33587225}. |
Q9Y623 | MYH4 | T1483 | ochoa | Myosin-4 (Myosin heavy chain 2b) (MyHC-2b) (Myosin heavy chain 4) (Myosin heavy chain IIb) (MyHC-IIb) (Myosin heavy chain, skeletal muscle, fetal) | Muscle contraction. |
Q9Y666 | SLC12A7 | T926 | ochoa|psp | Solute carrier family 12 member 7 (Electroneutral potassium-chloride cotransporter 4) (K-Cl cotransporter 4) | Mediates electroneutral potassium-chloride cotransport when activated by cell swelling (PubMed:10913127). May mediate K(+) uptake into Deiters' cells in the cochlea and contribute to K(+) recycling in the inner ear. Important for the survival of cochlear outer and inner hair cells and the maintenance of the organ of Corti. May be required for basolateral Cl(-) extrusion in the kidney and contribute to renal acidification (By similarity). {ECO:0000250, ECO:0000269|PubMed:10913127}. |
Q9Y6C2 | EMILIN1 | T701 | ochoa | EMILIN-1 (Elastin microfibril interface-located protein 1) (Elastin microfibril interfacer 1) | Involved in elastic and collagen fibers formation. It is required for EFEMP2 deposition into the extracellular matrix, and collagen network assembly and cross-linking via protein-lysine 6-oxidase/LOX activity (PubMed:36351433). May be responsible for anchoring smooth muscle cells to elastic fibers, and may be involved in the processes that regulate vessel assembly. Has cell adhesive capacity. {ECO:0000269|PubMed:36351433}. |
Q58FF6 | HSP90AB4P | T165 | Sugiyama | Putative heat shock protein HSP 90-beta 4 | Putative molecular chaperone that may promote the maturation, structural maintenance and proper regulation of specific target proteins. {ECO:0000250}. |
Q96A49 | SYAP1 | T306 | Sugiyama | Synapse-associated protein 1 (BSD domain-containing signal transducer and Akt interactor protein) (BSTA) | Plays a role in adipocyte differentiation by promoting mTORC2-mediated phosphorylation of AKT1 at 'Ser-473' after growth factor stimulation (PubMed:23300339). {ECO:0000269|PubMed:23300339}. |
P33176 | KIF5B | T809 | Sugiyama | Kinesin-1 heavy chain (Conventional kinesin heavy chain) (Ubiquitous kinesin heavy chain) (UKHC) | Microtubule-dependent motor required for normal distribution of mitochondria and lysosomes. Can induce formation of neurite-like membrane protrusions in non-neuronal cells in a ZFYVE27-dependent manner (By similarity). Regulates centrosome and nuclear positioning during mitotic entry. During the G2 phase of the cell cycle in a BICD2-dependent manner, antagonizes dynein function and drives the separation of nuclei and centrosomes (PubMed:20386726). Required for anterograde axonal transportation of MAPK8IP3/JIP3 which is essential for MAPK8IP3/JIP3 function in axon elongation (By similarity). Through binding with PLEKHM2 and ARL8B, directs lysosome movement toward microtubule plus ends (Probable). Involved in NK cell-mediated cytotoxicity. Drives the polarization of cytolytic granules and microtubule-organizing centers (MTOCs) toward the immune synapse between effector NK lymphocytes and target cells (PubMed:24088571). {ECO:0000250|UniProtKB:Q2PQA9, ECO:0000250|UniProtKB:Q61768, ECO:0000269|PubMed:20386726, ECO:0000269|PubMed:24088571, ECO:0000305|PubMed:22172677, ECO:0000305|PubMed:24088571}. |
Q14157 | UBAP2L | T23 | Sugiyama | Ubiquitin-associated protein 2-like (Protein NICE-4) (RNA polymerase II degradation factor UBAP2L) | Recruits the ubiquitination machinery to RNA polymerase II for polyubiquitination, removal and degradation, when the transcription-coupled nucleotide excision repair (TC-NER) machinery fails to resolve DNA damage (PubMed:35633597). Plays an important role in the activity of long-term repopulating hematopoietic stem cells (LT-HSCs) (By similarity). Is a regulator of stress granule assembly, required for their efficient formation (PubMed:29395067, PubMed:35977029). Required for proper brain development and neocortex lamination (By similarity). {ECO:0000250|UniProtKB:Q80X50, ECO:0000269|PubMed:29395067, ECO:0000269|PubMed:35633597}. |
Q86VS8 | HOOK3 | T291 | Sugiyama | Protein Hook homolog 3 (h-hook3) (hHK3) | Acts as an adapter protein linking the dynein motor complex to various cargos and converts dynein from a non-processive to a highly processive motor in the presence of dynactin. Facilitates the interaction between dynein and dynactin and activates dynein processivity (the ability to move along a microtubule for a long distance without falling off the track). Predominantly recruits 2 dyneins, which increases both the force and speed of the microtubule motor (PubMed:25035494, PubMed:33734450). Component of the FTS/Hook/FHIP complex (FHF complex). The FHF complex may function to promote vesicle trafficking and/or fusion via the homotypic vesicular protein sorting complex (the HOPS complex). May regulate clearance of endocytosed receptors such as MSR1. Participates in defining the architecture and localization of the Golgi complex. FHF complex promotes the distribution of AP-4 complex to the perinuclear area of the cell (PubMed:32073997). {ECO:0000250|UniProtKB:Q8BUK6, ECO:0000269|PubMed:11238449, ECO:0000269|PubMed:17237231, ECO:0000269|PubMed:18799622, ECO:0000269|PubMed:25035494, ECO:0000269|PubMed:32073997, ECO:0000269|PubMed:33734450}.; FUNCTION: (Microbial infection) May serve as a target for the spiC protein from Salmonella typhimurium, which inactivates it, leading to a strong alteration in cellular trafficking. {ECO:0000305}. |
Q13619 | CUL4A | Y259 | Sugiyama | Cullin-4A (CUL-4A) | Core component of multiple cullin-RING-based E3 ubiquitin-protein ligase complexes which mediate the ubiquitination of target proteins (PubMed:14578910, PubMed:14739464, PubMed:15448697, PubMed:15548678, PubMed:15811626, PubMed:16678110, PubMed:17041588, PubMed:24209620, PubMed:30166453, PubMed:33854232, PubMed:33854239). As a scaffold protein may contribute to catalysis through positioning of the substrate and the ubiquitin-conjugating enzyme (PubMed:14578910, PubMed:14739464, PubMed:15448697, PubMed:15548678, PubMed:15811626, PubMed:16678110, PubMed:17041588, PubMed:24209620). The E3 ubiquitin-protein ligase activity of the complex is dependent on the neddylation of the cullin subunit and is inhibited by the association of the deneddylated cullin subunit with TIP120A/CAND1 (PubMed:14578910, PubMed:14739464, PubMed:15448697, PubMed:15548678, PubMed:15811626, PubMed:16678110, PubMed:17041588, PubMed:24209620). The functional specificity of the E3 ubiquitin-protein ligase complex depends on the variable substrate recognition component (PubMed:14578910, PubMed:14739464, PubMed:15448697, PubMed:15548678, PubMed:15811626, PubMed:16678110, PubMed:17041588, PubMed:24209620). DCX(DET1-COP1) directs ubiquitination of JUN (PubMed:14739464). DCX(DDB2) directs ubiquitination of XPC (PubMed:15811626). DCX(DDB2) ubiquitinates histones H3-H4 and is required for efficient histone deposition during replication-coupled (H3.1) and replication-independent (H3.3) nucleosome assembly, probably by facilitating the transfer of H3 from ASF1A/ASF1B to other chaperones involved in histone deposition (PubMed:16678110, PubMed:17041588, PubMed:24209620). DCX(DTL) plays a role in PCNA-dependent polyubiquitination of CDT1 and MDM2-dependent ubiquitination of p53/TP53 in response to radiation-induced DNA damage and during DNA replication (PubMed:14578910, PubMed:15448697, PubMed:15548678). DCX(DTL) directs autoubiquitination of DTL (PubMed:23478445). In association with DDB1 and SKP2 probably is involved in ubiquitination of CDKN1B/p27kip (PubMed:16537899). Is involved in ubiquitination of HOXA9 (PubMed:14609952). The DDB1-CUL4A-DTL E3 ligase complex regulates the circadian clock function by mediating the ubiquitination and degradation of CRY1 (PubMed:26431207). The DCX(ERCC8) complex (also named CSA complex) plays a role in transcription-coupled repair (TCR) (PubMed:12732143, PubMed:32355176, PubMed:38316879). A number of DCX complexes (containing either TRPC4AP or DCAF12 as substrate-recognition component) are part of the DesCEND (destruction via C-end degrons) pathway, which recognizes a C-degron located at the extreme C terminus of target proteins, leading to their ubiquitination and degradation (PubMed:29779948). The DCX(AMBRA1) complex is a master regulator of the transition from G1 to S cell phase by mediating ubiquitination of phosphorylated cyclin-D (CCND1, CCND2 and CCND3) (PubMed:33854232, PubMed:33854239). The DCX(AMBRA1) complex also acts as a regulator of Cul5-RING (CRL5) E3 ubiquitin-protein ligase complexes by mediating ubiquitination and degradation of Elongin-C (ELOC) component of CRL5 complexes (PubMed:30166453). With CUL4B, contributes to ribosome biogenesis (PubMed:26711351). {ECO:0000269|PubMed:12732143, ECO:0000269|PubMed:14578910, ECO:0000269|PubMed:14609952, ECO:0000269|PubMed:14739464, ECO:0000269|PubMed:15448697, ECO:0000269|PubMed:15548678, ECO:0000269|PubMed:15811626, ECO:0000269|PubMed:16537899, ECO:0000269|PubMed:16678110, ECO:0000269|PubMed:17041588, ECO:0000269|PubMed:23478445, ECO:0000269|PubMed:24209620, ECO:0000269|PubMed:26431207, ECO:0000269|PubMed:26711351, ECO:0000269|PubMed:29779948, ECO:0000269|PubMed:30166453, ECO:0000269|PubMed:32355176, ECO:0000269|PubMed:33854232, ECO:0000269|PubMed:33854239}. |
O43283 | MAP3K13 | T421 | Sugiyama | Mitogen-activated protein kinase kinase kinase 13 (EC 2.7.11.25) (Leucine zipper-bearing kinase) (Mixed lineage kinase) (MLK) | Activates the JUN N-terminal pathway through activation of the MAP kinase kinase MAP2K7. Acts synergistically with PRDX3 to regulate the activation of NF-kappa-B in the cytosol. This activation is kinase-dependent and involves activating the IKK complex, the IKBKB-containing complex that phosphorylates inhibitors of NF-kappa-B. {ECO:0000269|PubMed:11726277, ECO:0000269|PubMed:12492477, ECO:0000269|PubMed:9353328}. |
P13987 | CD59 | T85 | Sugiyama | CD59 glycoprotein (1F5 antigen) (20 kDa homologous restriction factor) (HRF-20) (HRF20) (MAC-inhibitory protein) (MAC-IP) (MEM43 antigen) (Membrane attack complex inhibition factor) (MACIF) (Membrane inhibitor of reactive lysis) (MIRL) (Protectin) (CD antigen CD59) | Potent inhibitor of the complement membrane attack complex (MAC) action, which protects human cells from damage during complement activation (PubMed:11882685, PubMed:1698710, PubMed:2475111, PubMed:2475570, PubMed:2606909, PubMed:9053451). Acts by binding to the beta-haipins of C8 (C8A and C8B) components of the assembling MAC, forming an intermolecular beta-sheet that prevents incorporation of the multiple copies of C9 required for complete formation of the osmolytic pore (PubMed:11882685, PubMed:1698710, PubMed:36797260). {ECO:0000269|PubMed:11882685, ECO:0000269|PubMed:1698710, ECO:0000269|PubMed:2475111, ECO:0000269|PubMed:2475570, ECO:0000269|PubMed:2606909, ECO:0000269|PubMed:36797260, ECO:0000269|PubMed:9053451}.; FUNCTION: The soluble form from urine retains its specific complement binding activity, but exhibits greatly reduced ability to inhibit complement membrane attack complex (MAC) assembly on cell membranes. {ECO:0000269|PubMed:8670172}. |
P49959 | MRE11 | T524 | Sugiyama | Double-strand break repair protein MRE11 (EC 3.1.-.-) (Meiotic recombination 11 homolog 1) (MRE11 homolog 1) (Meiotic recombination 11 homolog A) (MRE11 homolog A) | Core component of the MRN complex, which plays a central role in double-strand break (DSB) repair, DNA recombination, maintenance of telomere integrity and meiosis (PubMed:11741547, PubMed:14657032, PubMed:22078559, PubMed:23080121, PubMed:24316220, PubMed:26240375, PubMed:27889449, PubMed:28867292, PubMed:29670289, PubMed:30464262, PubMed:30612738, PubMed:31353207, PubMed:37696958, PubMed:38128537, PubMed:9590181, PubMed:9651580, PubMed:9705271). The MRN complex is involved in the repair of DNA double-strand breaks (DSBs) via homologous recombination (HR), an error-free mechanism which primarily occurs during S and G2 phases (PubMed:24316220, PubMed:28867292, PubMed:31353207, PubMed:38128537). The complex (1) mediates the end resection of damaged DNA, which generates proper single-stranded DNA, a key initial steps in HR, and is (2) required for the recruitment of other repair factors and efficient activation of ATM and ATR upon DNA damage (PubMed:24316220, PubMed:27889449, PubMed:28867292, PubMed:36050397, PubMed:38128537). Within the MRN complex, MRE11 possesses both single-strand endonuclease activity and double-strand-specific 3'-5' exonuclease activity (PubMed:11741547, PubMed:22078559, PubMed:24316220, PubMed:26240375, PubMed:27889449, PubMed:29670289, PubMed:31353207, PubMed:36563124, PubMed:9590181, PubMed:9651580, PubMed:9705271). After DSBs, MRE11 is loaded onto DSBs sites and cleaves DNA by cooperating with RBBP8/CtIP to initiate end resection (PubMed:27814491, PubMed:27889449, PubMed:30787182). MRE11 first endonucleolytically cleaves the 5' strand at DNA DSB ends to prevent non-homologous end joining (NHEJ) and licence HR (PubMed:24316220). It then generates a single-stranded DNA gap via 3' to 5' exonucleolytic degradation to create entry sites for EXO1- and DNA2-mediated 5' to 3' long-range resection, which is required for single-strand invasion and recombination (PubMed:24316220, PubMed:28867292). RBBP8/CtIP specifically promotes the endonuclease activity of MRE11 to clear protein-DNA adducts and generate clean double-strand break ends (PubMed:27814491, PubMed:27889449, PubMed:30787182). MRE11 endonuclease activity is also enhanced by AGER/RAGE (By similarity). The MRN complex is also required for DNA damage signaling via activation of the ATM and ATR kinases: the nuclease activity of MRE11 is not required to activate ATM and ATR (PubMed:14657032, PubMed:15064416, PubMed:15790808, PubMed:16622404). The MRN complex is also required for the processing of R-loops (PubMed:31537797). The MRN complex is involved in the activation of the cGAS-STING pathway induced by DNA damage during tumorigenesis: the MRN complex acts by displacing CGAS from nucleosome sequestration, thereby activating it (By similarity). In telomeres the MRN complex may modulate t-loop formation (PubMed:10888888). {ECO:0000250|UniProtKB:Q61216, ECO:0000269|PubMed:10888888, ECO:0000269|PubMed:11741547, ECO:0000269|PubMed:14657032, ECO:0000269|PubMed:15064416, ECO:0000269|PubMed:15790808, ECO:0000269|PubMed:16622404, ECO:0000269|PubMed:22078559, ECO:0000269|PubMed:23080121, ECO:0000269|PubMed:24316220, ECO:0000269|PubMed:26240375, ECO:0000269|PubMed:27814491, ECO:0000269|PubMed:27889449, ECO:0000269|PubMed:28867292, ECO:0000269|PubMed:29670289, ECO:0000269|PubMed:30464262, ECO:0000269|PubMed:30612738, ECO:0000269|PubMed:30787182, ECO:0000269|PubMed:31353207, ECO:0000269|PubMed:31537797, ECO:0000269|PubMed:36050397, ECO:0000269|PubMed:36563124, ECO:0000269|PubMed:37696958, ECO:0000269|PubMed:38128537, ECO:0000269|PubMed:9590181, ECO:0000269|PubMed:9651580, ECO:0000269|PubMed:9705271}.; FUNCTION: MRE11 contains two DNA-binding domains (DBDs), enabling it to bind both single-stranded DNA (ssDNA) and double-stranded DNA (dsDNA). {ECO:0000305}. |
Q13620 | CUL4B | Y413 | Sugiyama | Cullin-4B (CUL-4B) | Core component of multiple cullin-RING-based E3 ubiquitin-protein ligase complexes which mediate the ubiquitination and subsequent proteasomal degradation of target proteins (PubMed:14578910, PubMed:16322693, PubMed:16678110, PubMed:18593899, PubMed:22118460, PubMed:29779948, PubMed:30166453, PubMed:33854232, PubMed:33854239). The functional specificity of the E3 ubiquitin-protein ligase complex depends on the variable substrate recognition subunit (PubMed:14578910, PubMed:16678110, PubMed:18593899, PubMed:22118460, PubMed:29779948). CUL4B may act within the complex as a scaffold protein, contributing to catalysis through positioning of the substrate and the ubiquitin-conjugating enzyme (PubMed:14578910, PubMed:16678110, PubMed:18593899, PubMed:22118460). Plays a role as part of the E3 ubiquitin-protein ligase complex in polyubiquitination of CDT1, histone H2A, histone H3 and histone H4 in response to radiation-induced DNA damage (PubMed:14578910, PubMed:16678110, PubMed:18593899). Targeted to UV damaged chromatin by DDB2 and may be important for DNA repair and DNA replication (PubMed:16678110). A number of DCX complexes (containing either TRPC4AP or DCAF12 as substrate-recognition component) are part of the DesCEND (destruction via C-end degrons) pathway, which recognizes a C-degron located at the extreme C terminus of target proteins, leading to their ubiquitination and degradation (PubMed:29779948). The DCX(AMBRA1) complex is a master regulator of the transition from G1 to S cell phase by mediating ubiquitination of phosphorylated cyclin-D (CCND1, CCND2 and CCND3) (PubMed:33854232, PubMed:33854239). The DCX(AMBRA1) complex also acts as a regulator of Cul5-RING (CRL5) E3 ubiquitin-protein ligase complexes by mediating ubiquitination and degradation of Elongin-C (ELOC) component of CRL5 complexes (PubMed:30166453). Required for ubiquitination of cyclin E (CCNE1 or CCNE2), and consequently, normal G1 cell cycle progression (PubMed:16322693, PubMed:19801544). Regulates the mammalian target-of-rapamycin (mTOR) pathway involved in control of cell growth, size and metabolism (PubMed:18235224). Specific CUL4B regulation of the mTORC1-mediated pathway is dependent upon 26S proteasome function and requires interaction between CUL4B and MLST8 (PubMed:18235224). With CUL4A, contributes to ribosome biogenesis (PubMed:26711351). {ECO:0000269|PubMed:14578910, ECO:0000269|PubMed:16322693, ECO:0000269|PubMed:16678110, ECO:0000269|PubMed:18235224, ECO:0000269|PubMed:18593899, ECO:0000269|PubMed:19801544, ECO:0000269|PubMed:22118460, ECO:0000269|PubMed:26711351, ECO:0000269|PubMed:29779948, ECO:0000269|PubMed:30166453, ECO:0000269|PubMed:33854232, ECO:0000269|PubMed:33854239}. |
P00966 | ASS1 | T208 | Sugiyama | Argininosuccinate synthase (EC 6.3.4.5) (Citrulline--aspartate ligase) | One of the enzymes of the urea cycle, the metabolic pathway transforming neurotoxic amonia produced by protein catabolism into inocuous urea in the liver of ureotelic animals. Catalyzes the formation of arginosuccinate from aspartate, citrulline and ATP and together with ASL it is responsible for the biosynthesis of arginine in most body tissues. {ECO:0000305|PubMed:18473344, ECO:0000305|PubMed:27287393, ECO:0000305|PubMed:8792870}. |
O60841 | EIF5B | T78 | Sugiyama | Eukaryotic translation initiation factor 5B (eIF-5B) (EC 3.6.5.3) (Translation initiation factor IF-2) | Plays a role in translation initiation (PubMed:10659855, PubMed:35732735). Ribosome-dependent GTPase that promotes the joining of the 60S ribosomal subunit to the pre-initiation complex to form the 80S initiation complex with the initiator methionine-tRNA in the P-site base paired to the start codon (PubMed:10659855, PubMed:35732735). Together with eIF1A (EIF1AX), actively orients the initiator methionine-tRNA in a conformation that allows 60S ribosomal subunit joining to form the 80S initiation complex (PubMed:12569173, PubMed:35732735). Is released after formation of the 80S initiation complex (PubMed:35732735). Its GTPase activity is not essential for ribosomal subunits joining, but GTP hydrolysis is needed for eIF1A (EIF1AX) ejection quickly followed by EIF5B release to form elongation-competent ribosomes (PubMed:10659855, PubMed:35732735). In contrast to its procaryotic homolog, does not promote recruitment of Met-rRNA to the small ribosomal subunit (PubMed:10659855). {ECO:0000269|PubMed:10659855, ECO:0000269|PubMed:12569173, ECO:0000269|PubMed:35732735}. |
P17980 | PSMC3 | T166 | Sugiyama | 26S proteasome regulatory subunit 6A (26S proteasome AAA-ATPase subunit RPT5) (Proteasome 26S subunit ATPase 3) (Proteasome subunit P50) (Tat-binding protein 1) (TBP-1) | Component of the 26S proteasome, a multiprotein complex involved in the ATP-dependent degradation of ubiquitinated proteins. This complex plays a key role in the maintenance of protein homeostasis by removing misfolded or damaged proteins, which could impair cellular functions, and by removing proteins whose functions are no longer required. Therefore, the proteasome participates in numerous cellular processes, including cell cycle progression, apoptosis, or DNA damage repair. PSMC3 belongs to the heterohexameric ring of AAA (ATPases associated with diverse cellular activities) proteins that unfolds ubiquitinated target proteins that are concurrently translocated into a proteolytic chamber and degraded into peptides. {ECO:0000269|PubMed:1317798}. |
P27816 | MAP4 | T57 | Sugiyama | Microtubule-associated protein 4 (MAP-4) | Non-neuronal microtubule-associated protein. Promotes microtubule assembly. {ECO:0000269|PubMed:10791892, ECO:0000269|PubMed:34782749}. |
Q15293 | RCN1 | T211 | Sugiyama | Reticulocalbin-1 | May regulate calcium-dependent activities in the endoplasmic reticulum lumen or post-ER compartment. |
Q5JSH3 | WDR44 | T364 | Sugiyama | WD repeat-containing protein 44 (Rab11-binding protein) (Rab11BP) (Rabphilin-11) | Downstream effector for Rab11 which regulates Rab11 intracellular membrane trafficking functions such as endocytic recycling, intracellular ciliogenesis and protein export (PubMed:31204173, PubMed:32344433). ATK1-mediated phosphorylation of WDR44 induces binding to Rab11 which activates endocytic recycling of transferrin receptor back to the plasma membrane (PubMed:31204173). When bound to Rab11, prevents the formation of the ciliogenic Rab11-Rabin8/RAB3IP-RAB11FIP3 complex, therefore inhibiting preciliary trafficking and ciliogenesis (PubMed:31204173). Participates in neo-synthesized protein export by connecting the endoplasmic reticulum (ER) with the endosomal tubule via direct interactions with the integral ER proteins VAPA or VAPB and the endosomal protein GRAFs (GRAF1/ARHGAP26 or GRAF2/ARHGAP10), which facilitates the transfer of proteins such as E-cadherin, MPP14 and CFTR into a Rab8-Rab10-Rab11-dependent export route (PubMed:32344433). {ECO:0000269|PubMed:31204173, ECO:0000269|PubMed:32344433}. |
P61758 | VBP1 | T45 | Sugiyama | Prefoldin subunit 3 (HIBBJ46) (von Hippel-Lindau-binding protein 1) (VBP-1) (VHL-binding protein 1) | Binds specifically to cytosolic chaperonin (c-CPN) and transfers target proteins to it. Binds to nascent polypeptide chain and promotes folding in an environment in which there are many competing pathways for nonnative proteins. {ECO:0000269|PubMed:9630229}. |
Q9UBU7 | DBF4 | T390 | Sugiyama | Protein DBF4 homolog A (Activator of S phase kinase) (Chiffon homolog A) (DBF4-type zinc finger-containing protein 1) | Regulatory subunit for CDC7 which activates its kinase activity thereby playing a central role in DNA replication and cell proliferation. Required for progression of S phase. The complex CDC7-DBF4A selectively phosphorylates MCM2 subunit at 'Ser-40' and 'Ser-53' and then is involved in regulating the initiation of DNA replication during cell cycle. {ECO:0000269|PubMed:10373557, ECO:0000269|PubMed:10523313, ECO:0000269|PubMed:17062569}. |
P00505 | GOT2 | T192 | Sugiyama | Aspartate aminotransferase, mitochondrial (mAspAT) (EC 2.6.1.1) (EC 2.6.1.7) (Fatty acid-binding protein) (FABP-1) (Glutamate oxaloacetate transaminase 2) (Kynurenine aminotransferase 4) (Kynurenine aminotransferase IV) (Kynurenine--oxoglutarate transaminase 4) (Kynurenine--oxoglutarate transaminase IV) (Plasma membrane-associated fatty acid-binding protein) (FABPpm) (Transaminase A) | Catalyzes the irreversible transamination of the L-tryptophan metabolite L-kynurenine to form kynurenic acid (KA). As a member of the malate-aspartate shuttle, it has a key role in the intracellular NAD(H) redox balance. Is important for metabolite exchange between mitochondria and cytosol, and for amino acid metabolism. Facilitates cellular uptake of long-chain free fatty acids. {ECO:0000269|PubMed:31422819, ECO:0000269|PubMed:9537447}. |
P35579 | MYH9 | T1221 | Sugiyama | Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) | Cellular myosin that appears to play a role in cytokinesis, cell shape, and specialized functions such as secretion and capping. Required for cortical actin clearance prior to oocyte exocytosis (By similarity). Promotes cell motility in conjunction with S100A4 (PubMed:16707441). During cell spreading, plays an important role in cytoskeleton reorganization, focal contact formation (in the margins but not the central part of spreading cells), and lamellipodial retraction; this function is mechanically antagonized by MYH10 (PubMed:20052411). {ECO:0000250|UniProtKB:Q8VDD5, ECO:0000269|PubMed:16707441, ECO:0000269|PubMed:20052411}.; FUNCTION: (Microbial infection) Acts as a receptor for herpes simplex virus 1/HHV-1 envelope glycoprotein B. {ECO:0000269|PubMed:20944748, ECO:0000269|PubMed:39048823}. |
Q7KZF4 | SND1 | T134 | Sugiyama | Staphylococcal nuclease domain-containing protein 1 (EC 3.1.31.1) (100 kDa coactivator) (EBNA2 coactivator p100) (Tudor domain-containing protein 11) (p100 co-activator) | Endonuclease that mediates miRNA decay of both protein-free and AGO2-loaded miRNAs (PubMed:18453631, PubMed:28546213). As part of its function in miRNA decay, regulates mRNAs involved in G1-to-S phase transition (PubMed:28546213). Functions as a bridging factor between STAT6 and the basal transcription factor (PubMed:12234934). Plays a role in PIM1 regulation of MYB activity (PubMed:9809063). Functions as a transcriptional coactivator for STAT5 (By similarity). {ECO:0000250|UniProtKB:Q78PY7, ECO:0000269|PubMed:12234934, ECO:0000269|PubMed:18453631, ECO:0000269|PubMed:28546213, ECO:0000269|PubMed:9809063}.; FUNCTION: (Microbial infection) Functions as a transcriptional coactivator for the Epstein-Barr virus nuclear antigen 2 (EBNA2). {ECO:0000269|PubMed:7651391}.; FUNCTION: (Microbial infection) Promotes SARS-CoV-2 RNA synthesis by binding to negative-sense RNA and the viral protein nsp9. {ECO:0000269|PubMed:37794589}. |
P31947 | SFN | T228 | Sugiyama | 14-3-3 protein sigma (Epithelial cell marker protein 1) (Stratifin) | Adapter protein implicated in the regulation of a large spectrum of both general and specialized signaling pathways (PubMed:15731107, PubMed:22634725, PubMed:28202711, PubMed:37797010). Binds to a large number of partners, usually by recognition of a phosphoserine or phosphothreonine motif (PubMed:15731107, PubMed:22634725, PubMed:28202711, PubMed:37797010). Binding generally results in the modulation of the activity of the binding partner (PubMed:15731107, PubMed:22634725, PubMed:28202711, PubMed:37797010). Promotes cytosolic retention of GBP1 GTPase by binding to phosphorylated GBP1, thereby inhibiting the innate immune response (PubMed:37797010). Also acts as a TP53/p53-regulated inhibitor of G2/M progression (PubMed:9659898). When bound to KRT17, regulates protein synthesis and epithelial cell growth by stimulating Akt/mTOR pathway (By similarity). Acts to maintain desmosome cell junction adhesion in epithelial cells via interacting with and sequestering PKP3 to the cytoplasm, thereby restricting its translocation to existing desmosome structures and therefore maintaining desmosome protein homeostasis (PubMed:24124604). Also acts to facilitate PKP3 exchange at desmosome plaques, thereby maintaining keratinocyte intercellular adhesion (PubMed:29678907). May also regulate MDM2 autoubiquitination and degradation and thereby activate p53/TP53 (PubMed:18382127). {ECO:0000250|UniProtKB:O70456, ECO:0000269|PubMed:15731107, ECO:0000269|PubMed:18382127, ECO:0000269|PubMed:22634725, ECO:0000269|PubMed:24124604, ECO:0000269|PubMed:28202711, ECO:0000269|PubMed:29678907, ECO:0000269|PubMed:37797010, ECO:0000269|PubMed:9659898}. |
P63104 | YWHAZ | T226 | Sugiyama | 14-3-3 protein zeta/delta (Protein kinase C inhibitor protein 1) (KCIP-1) | Adapter protein implicated in the regulation of a large spectrum of both general and specialized signaling pathways (PubMed:14578935, PubMed:15071501, PubMed:15644438, PubMed:16376338, PubMed:16959763, PubMed:31024343, PubMed:9360956). Binds to a large number of partners, usually by recognition of a phosphoserine or phosphothreonine motif (PubMed:35662396). Binding generally results in the modulation of the activity of the binding partner (PubMed:35662396). Promotes cytosolic retention and inactivation of TFEB transcription factor by binding to phosphorylated TFEB (PubMed:35662396). Induces ARHGEF7 activity on RAC1 as well as lamellipodia and membrane ruffle formation (PubMed:16959763). In neurons, regulates spine maturation through the modulation of ARHGEF7 activity (By similarity). {ECO:0000250|UniProtKB:O55043, ECO:0000269|PubMed:14578935, ECO:0000269|PubMed:15071501, ECO:0000269|PubMed:15644438, ECO:0000269|PubMed:16376338, ECO:0000269|PubMed:16959763, ECO:0000269|PubMed:31024343, ECO:0000269|PubMed:35662396, ECO:0000269|PubMed:9360956}. |
Q9UHV9 | PFDN2 | T103 | Sugiyama | Prefoldin subunit 2 | Binds specifically to cytosolic chaperonin (c-CPN) and transfers target proteins to it. Binds to nascent polypeptide chain and promotes folding in an environment in which there are many competing pathways for nonnative proteins. {ECO:0000269|PubMed:9630229}. |
P11413 | G6PD | T406 | SIGNOR | Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49) | Catalyzes the rate-limiting step of the oxidative pentose-phosphate pathway, which represents a route for the dissimilation of carbohydrates besides glycolysis. The main function of this enzyme is to provide reducing power (NADPH) and pentose phosphates for fatty acid and nucleic acid synthesis. {ECO:0000269|PubMed:15858258, ECO:0000269|PubMed:24769394, ECO:0000269|PubMed:26479991, ECO:0000269|PubMed:35122041, ECO:0000269|PubMed:38066190, ECO:0000269|PubMed:743300}. |
P50395 | GDI2 | T412 | Sugiyama | Rab GDP dissociation inhibitor beta (Rab GDI beta) (Guanosine diphosphate dissociation inhibitor 2) (GDI-2) | GDP-dissociation inhibitor preventing the GDP to GTP exchange of most Rab proteins. By keeping these small GTPases in their inactive GDP-bound form regulates intracellular membrane trafficking (PubMed:25860027). Negatively regulates protein transport to the cilium and ciliogenesis through the inhibition of RAB8A (PubMed:25860027). {ECO:0000269|PubMed:25860027}. |
A0MZ66 | SHTN1 | T298 | Sugiyama | Shootin-1 (Shootin1) | Involved in the generation of internal asymmetric signals required for neuronal polarization and neurite outgrowth. Mediates netrin-1-induced F-actin-substrate coupling or 'clutch engagement' within the axon growth cone through activation of CDC42, RAC1 and PAK1-dependent signaling pathway, thereby converting the F-actin retrograde flow into traction forces, concomitantly with filopodium extension and axon outgrowth. Plays a role in cytoskeletal organization by regulating the subcellular localization of phosphoinositide 3-kinase (PI3K) activity at the axonal growth cone. Also plays a role in regenerative neurite outgrowth. In the developing cortex, cooperates with KIF20B to promote both the transition from the multipolar to the bipolar stage and the radial migration of cortical neurons from the ventricular zone toward the superficial layer of the neocortex. Involved in the accumulation of phosphatidylinositol 3,4,5-trisphosphate (PIP3) in the growth cone of primary hippocampal neurons. {ECO:0000250|UniProtKB:A0MZ67, ECO:0000250|UniProtKB:Q8K2Q9}. |
Q13164 | MAPK7 | T209 | Sugiyama | Mitogen-activated protein kinase 7 (MAP kinase 7) (MAPK 7) (EC 2.7.11.24) (Big MAP kinase 1) (BMK-1) (Extracellular signal-regulated kinase 5) (ERK-5) | Plays a role in various cellular processes such as proliferation, differentiation and cell survival. The upstream activator of MAPK7 is the MAPK kinase MAP2K5. Upon activation, it translocates to the nucleus and phosphorylates various downstream targets including MEF2C. EGF activates MAPK7 through a Ras-independent and MAP2K5-dependent pathway. As part of the MAPK/ERK signaling pathway, acts as a negative regulator of apoptosis in cardiomyocytes via interaction with STUB1/CHIP and promotion of STUB1-mediated ubiquitination and degradation of ICER-type isoforms of CREM (By similarity). May have a role in muscle cell differentiation. May be important for endothelial function and maintenance of blood vessel integrity. MAP2K5 and MAPK7 interact specifically with one another and not with MEK1/ERK1 or MEK2/ERK2 pathways. Phosphorylates SGK1 at Ser-78 and this is required for growth factor-induced cell cycle progression. Involved in the regulation of p53/TP53 by disrupting the PML-MDM2 interaction. {ECO:0000250|UniProtKB:P0C865, ECO:0000269|PubMed:11254654, ECO:0000269|PubMed:11278431, ECO:0000269|PubMed:22869143, ECO:0000269|PubMed:9384584, ECO:0000269|PubMed:9790194}. |
P51812 | RPS6KA3 | T157 | Sugiyama | Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2) | Serine/threonine-protein kinase that acts downstream of ERK (MAPK1/ERK2 and MAPK3/ERK1) signaling and mediates mitogenic and stress-induced activation of the transcription factors CREB1, ETV1/ER81 and NR4A1/NUR77, regulates translation through RPS6 and EIF4B phosphorylation, and mediates cellular proliferation, survival, and differentiation by modulating mTOR signaling and repressing pro-apoptotic function of BAD and DAPK1 (PubMed:16213824, PubMed:16223362, PubMed:17360704, PubMed:9770464). In fibroblast, is required for EGF-stimulated phosphorylation of CREB1 and histone H3 at 'Ser-10', which results in the subsequent transcriptional activation of several immediate-early genes (PubMed:10436156, PubMed:9770464). In response to mitogenic stimulation (EGF and PMA), phosphorylates and activates NR4A1/NUR77 and ETV1/ER81 transcription factors and the cofactor CREBBP (PubMed:16223362). Upon insulin-derived signal, acts indirectly on the transcription regulation of several genes by phosphorylating GSK3B at 'Ser-9' and inhibiting its activity (PubMed:8250835). Phosphorylates RPS6 in response to serum or EGF via an mTOR-independent mechanism and promotes translation initiation by facilitating assembly of the preinitiation complex (PubMed:17360704). In response to insulin, phosphorylates EIF4B, enhancing EIF4B affinity for the EIF3 complex and stimulating cap-dependent translation (PubMed:18508509, PubMed:18813292). Is involved in the mTOR nutrient-sensing pathway by directly phosphorylating TSC2 at 'Ser-1798', which potently inhibits TSC2 ability to suppress mTOR signaling, and mediates phosphorylation of RPTOR, which regulates mTORC1 activity and may promote rapamycin-sensitive signaling independently of the PI3K/AKT pathway (PubMed:18722121). Mediates cell survival by phosphorylating the pro-apoptotic proteins BAD and DAPK1 and suppressing their pro-apoptotic function (PubMed:16213824). Promotes the survival of hepatic stellate cells by phosphorylating CEBPB in response to the hepatotoxin carbon tetrachloride (CCl4) (PubMed:18508509, PubMed:18813292). Is involved in cell cycle regulation by phosphorylating the CDK inhibitor CDKN1B, which promotes CDKN1B association with 14-3-3 proteins and prevents its translocation to the nucleus and inhibition of G1 progression (By similarity). In LPS-stimulated dendritic cells, is involved in TLR4-induced macropinocytosis, and in myeloma cells, acts as effector of FGFR3-mediated transformation signaling, after direct phosphorylation at Tyr-529 by FGFR3 (By similarity). Negatively regulates EGF-induced MAPK1/3 phosphorylation via phosphorylation of SOS1 (By similarity). Phosphorylates SOS1 at 'Ser-1134' and 'Ser-1161' that create YWHAB and YWHAE binding sites and which contribute to the negative regulation of MAPK1/3 phosphorylation (By similarity). Phosphorylates EPHA2 at 'Ser-897', the RPS6KA-EPHA2 signaling pathway controls cell migration (PubMed:26158630). Acts as a regulator of osteoblast differentiation by mediating phosphorylation of ATF4, thereby promoting ATF4 transactivation activity (By similarity). {ECO:0000250|UniProtKB:P18654, ECO:0000269|PubMed:10436156, ECO:0000269|PubMed:16213824, ECO:0000269|PubMed:16223362, ECO:0000269|PubMed:17360704, ECO:0000269|PubMed:18722121, ECO:0000269|PubMed:26158630, ECO:0000269|PubMed:8250835, ECO:0000269|PubMed:9770464, ECO:0000303|PubMed:18508509, ECO:0000303|PubMed:18813292}. |
Q15349 | RPS6KA2 | T148 | Sugiyama | Ribosomal protein S6 kinase alpha-2 (S6K-alpha-2) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 2) (p90-RSK 2) (p90RSK2) (MAP kinase-activated protein kinase 1c) (MAPK-activated protein kinase 1c) (MAPKAP kinase 1c) (MAPKAPK-1c) (Ribosomal S6 kinase 3) (RSK-3) (pp90RSK3) | Serine/threonine-protein kinase that acts downstream of ERK (MAPK1/ERK2 and MAPK3/ERK1) signaling and mediates mitogenic and stress-induced activation of transcription factors, regulates translation, and mediates cellular proliferation, survival, and differentiation. May function as tumor suppressor in epithelial ovarian cancer cells. {ECO:0000269|PubMed:16878154, ECO:0000269|PubMed:7623830}. |
Q15418 | RPS6KA1 | T151 | Sugiyama | Ribosomal protein S6 kinase alpha-1 (S6K-alpha-1) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 1) (p90-RSK 1) (p90RSK1) (p90S6K) (MAP kinase-activated protein kinase 1a) (MAPK-activated protein kinase 1a) (MAPKAP kinase 1a) (MAPKAPK-1a) (Ribosomal S6 kinase 1) (RSK-1) | Serine/threonine-protein kinase that acts downstream of ERK (MAPK1/ERK2 and MAPK3/ERK1) signaling and mediates mitogenic and stress-induced activation of the transcription factors CREB1, ETV1/ER81 and NR4A1/NUR77, regulates translation through RPS6 and EIF4B phosphorylation, and mediates cellular proliferation, survival, and differentiation by modulating mTOR signaling and repressing pro-apoptotic function of BAD and DAPK1 (PubMed:10679322, PubMed:12213813, PubMed:15117958, PubMed:16223362, PubMed:17360704, PubMed:18722121, PubMed:26158630, PubMed:35772404, PubMed:9430688). In fibroblast, is required for EGF-stimulated phosphorylation of CREB1, which results in the subsequent transcriptional activation of several immediate-early genes (PubMed:18508509, PubMed:18813292). In response to mitogenic stimulation (EGF and PMA), phosphorylates and activates NR4A1/NUR77 and ETV1/ER81 transcription factors and the cofactor CREBBP (PubMed:12213813, PubMed:16223362). Upon insulin-derived signal, acts indirectly on the transcription regulation of several genes by phosphorylating GSK3B at 'Ser-9' and inhibiting its activity (PubMed:18508509, PubMed:18813292). Phosphorylates RPS6 in response to serum or EGF via an mTOR-independent mechanism and promotes translation initiation by facilitating assembly of the pre-initiation complex (PubMed:17360704). In response to insulin, phosphorylates EIF4B, enhancing EIF4B affinity for the EIF3 complex and stimulating cap-dependent translation (PubMed:16763566). Is involved in the mTOR nutrient-sensing pathway by directly phosphorylating TSC2 at 'Ser-1798', which potently inhibits TSC2 ability to suppress mTOR signaling, and mediates phosphorylation of RPTOR, which regulates mTORC1 activity and may promote rapamycin-sensitive signaling independently of the PI3K/AKT pathway (PubMed:15342917). Also involved in feedback regulation of mTORC1 and mTORC2 by phosphorylating DEPTOR (PubMed:22017876). Mediates cell survival by phosphorylating the pro-apoptotic proteins BAD and DAPK1 and suppressing their pro-apoptotic function (PubMed:10679322, PubMed:16213824). Promotes the survival of hepatic stellate cells by phosphorylating CEBPB in response to the hepatotoxin carbon tetrachloride (CCl4) (PubMed:11684016). Mediates induction of hepatocyte prolifration by TGFA through phosphorylation of CEBPB (PubMed:18508509, PubMed:18813292). Is involved in cell cycle regulation by phosphorylating the CDK inhibitor CDKN1B, which promotes CDKN1B association with 14-3-3 proteins and prevents its translocation to the nucleus and inhibition of G1 progression (PubMed:18508509, PubMed:18813292). Phosphorylates EPHA2 at 'Ser-897', the RPS6KA-EPHA2 signaling pathway controls cell migration (PubMed:26158630). In response to mTORC1 activation, phosphorylates EIF4B at 'Ser-406' and 'Ser-422' which stimulates bicarbonate cotransporter SLC4A7 mRNA translation, increasing SLC4A7 protein abundance and function (PubMed:35772404). {ECO:0000269|PubMed:10679322, ECO:0000269|PubMed:11684016, ECO:0000269|PubMed:12213813, ECO:0000269|PubMed:15117958, ECO:0000269|PubMed:15342917, ECO:0000269|PubMed:16213824, ECO:0000269|PubMed:16223362, ECO:0000269|PubMed:16763566, ECO:0000269|PubMed:17360704, ECO:0000269|PubMed:18722121, ECO:0000269|PubMed:22017876, ECO:0000269|PubMed:26158630, ECO:0000269|PubMed:35772404, ECO:0000269|PubMed:9430688, ECO:0000303|PubMed:18508509, ECO:0000303|PubMed:18813292}.; FUNCTION: (Microbial infection) Promotes the late transcription and translation of viral lytic genes during Kaposi's sarcoma-associated herpesvirus/HHV-8 infection, when constitutively activated. {ECO:0000269|PubMed:30842327}. |
P35606 | COPB2 | T792 | Sugiyama | Coatomer subunit beta' (Beta'-coat protein) (Beta'-COP) (p102) | The coatomer is a cytosolic protein complex that binds to dilysine motifs and reversibly associates with Golgi non-clathrin-coated vesicles, which further mediate biosynthetic protein transport from the ER, via the Golgi up to the trans Golgi network. Coatomer complex is required for budding from Golgi membranes, and is essential for the retrograde Golgi-to-ER transport of dilysine-tagged proteins. In mammals, the coatomer can only be recruited by membranes associated to ADP-ribosylation factors (ARFs), which are small GTP-binding proteins; the complex also influences the Golgi structural integrity, as well as the processing, activity, and endocytic recycling of LDL receptors. {ECO:0000269|PubMed:34450031}.; FUNCTION: This coatomer complex protein, essential for Golgi budding and vesicular trafficking, is a selective binding protein (RACK) for protein kinase C, epsilon type. It binds to Golgi membranes in a GTP-dependent manner (By similarity). {ECO:0000250}. |
O75116 | ROCK2 | T878 | Sugiyama | Rho-associated protein kinase 2 (EC 2.7.11.1) (Rho kinase 2) (Rho-associated, coiled-coil-containing protein kinase 2) (Rho-associated, coiled-coil-containing protein kinase II) (ROCK-II) (p164 ROCK-2) | Protein kinase which is a key regulator of actin cytoskeleton and cell polarity. Involved in regulation of smooth muscle contraction, actin cytoskeleton organization, stress fiber and focal adhesion formation, neurite retraction, cell adhesion and motility via phosphorylation of ADD1, BRCA2, CNN1, EZR, DPYSL2, EP300, MSN, MYL9/MLC2, NPM1, RDX, PPP1R12A and VIM. Phosphorylates SORL1 and IRF4. Acts as a negative regulator of VEGF-induced angiogenic endothelial cell activation. Positively regulates the activation of p42/MAPK1-p44/MAPK3 and of p90RSK/RPS6KA1 during myogenic differentiation. Plays an important role in the timely initiation of centrosome duplication. Inhibits keratinocyte terminal differentiation. May regulate closure of the eyelids and ventral body wall through organization of actomyosin bundles. Plays a critical role in the regulation of spine and synaptic properties in the hippocampus. Plays an important role in generating the circadian rhythm of the aortic myofilament Ca(2+) sensitivity and vascular contractility by modulating the myosin light chain phosphorylation. {ECO:0000269|PubMed:10579722, ECO:0000269|PubMed:15699075, ECO:0000269|PubMed:16574662, ECO:0000269|PubMed:17015463, ECO:0000269|PubMed:19131646, ECO:0000269|PubMed:19997641, ECO:0000269|PubMed:21084279, ECO:0000269|PubMed:21147781}. |
P27797 | CALR | T181 | Sugiyama | Calreticulin (CRP55) (Calregulin) (Endoplasmic reticulum resident protein 60) (ERp60) (HACBP) (grp60) | Calcium-binding chaperone that promotes folding, oligomeric assembly and quality control in the endoplasmic reticulum (ER) via the calreticulin/calnexin cycle. This lectin interacts transiently with almost all of the monoglucosylated glycoproteins that are synthesized in the ER (PubMed:7876246). Interacts with the DNA-binding domain of NR3C1 and mediates its nuclear export (PubMed:11149926). Involved in maternal gene expression regulation. May participate in oocyte maturation via the regulation of calcium homeostasis (By similarity). Present in the cortical granules of non-activated oocytes, is exocytosed during the cortical reaction in response to oocyte activation and might participate in the block to polyspermy (By similarity). {ECO:0000250|UniProtKB:P28491, ECO:0000250|UniProtKB:Q8K3H7, ECO:0000269|PubMed:11149926, ECO:0000269|PubMed:7876246}. |
P31946 | YWHAB | T228 | Sugiyama | 14-3-3 protein beta/alpha (Protein 1054) (Protein kinase C inhibitor protein 1) (KCIP-1) [Cleaved into: 14-3-3 protein beta/alpha, N-terminally processed] | Adapter protein implicated in the regulation of a large spectrum of both general and specialized signaling pathways. Binds to a large number of partners, usually by recognition of a phosphoserine or phosphothreonine motif. Binding generally results in the modulation of the activity of the binding partner. Negative regulator of osteogenesis. Blocks the nuclear translocation of the phosphorylated form (by AKT1) of SRPK2 and antagonizes its stimulatory effect on cyclin D1 expression resulting in blockage of neuronal apoptosis elicited by SRPK2. Negative regulator of signaling cascades that mediate activation of MAP kinases via AKAP13. {ECO:0000269|PubMed:17717073, ECO:0000269|PubMed:19592491, ECO:0000269|PubMed:21224381}. |
Q9P2E9 | RRBP1 | T1306 | Sugiyama | Ribosome-binding protein 1 (180 kDa ribosome receptor homolog) (RRp) (ES/130-related protein) (Ribosome receptor protein) | Acts as a ribosome receptor and mediates interaction between the ribosome and the endoplasmic reticulum membrane. {ECO:0000250}. |
Download
reactome_id | name | p | -log10_p |
---|---|---|---|
R-HSA-199991 | Membrane Trafficking | 4.721963e-07 | 6.326 |
R-HSA-373760 | L1CAM interactions | 1.244818e-06 | 5.905 |
R-HSA-5653656 | Vesicle-mediated transport | 1.543324e-06 | 5.812 |
R-HSA-437239 | Recycling pathway of L1 | 2.046285e-06 | 5.689 |
R-HSA-1445148 | Translocation of SLC2A4 (GLUT4) to the plasma membrane | 2.440623e-06 | 5.612 |
R-HSA-9913351 | Formation of the dystrophin-glycoprotein complex (DGC) | 2.850172e-06 | 5.545 |
R-HSA-426117 | Cation-coupled Chloride cotransporters | 4.186800e-06 | 5.378 |
R-HSA-9764561 | Regulation of CDH1 Function | 6.046446e-06 | 5.218 |
R-HSA-422475 | Axon guidance | 7.118269e-06 | 5.148 |
R-HSA-9675108 | Nervous system development | 1.710213e-05 | 4.767 |
R-HSA-1640170 | Cell Cycle | 2.258904e-05 | 4.646 |
R-HSA-3000171 | Non-integrin membrane-ECM interactions | 2.867940e-05 | 4.542 |
R-HSA-75035 | Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | 3.306024e-05 | 4.481 |
R-HSA-111447 | Activation of BAD and translocation to mitochondria | 5.076573e-05 | 4.294 |
R-HSA-9755779 | SARS-CoV-2 targets host intracellular signalling and regulatory pathways | 5.076573e-05 | 4.294 |
R-HSA-9735871 | SARS-CoV-1 targets host intracellular signalling and regulatory pathways | 5.076573e-05 | 4.294 |
R-HSA-390522 | Striated Muscle Contraction | 6.707155e-05 | 4.173 |
R-HSA-6802952 | Signaling by BRAF and RAF1 fusions | 1.239983e-04 | 3.907 |
R-HSA-416572 | Sema4D induced cell migration and growth-cone collapse | 1.450370e-04 | 3.839 |
R-HSA-198753 | ERK/MAPK targets | 1.683228e-04 | 3.774 |
R-HSA-69481 | G2/M Checkpoints | 1.283882e-04 | 3.891 |
R-HSA-9662360 | Sensory processing of sound by inner hair cells of the cochlea | 1.539488e-04 | 3.813 |
R-HSA-199920 | CREB phosphorylation | 1.220899e-04 | 3.913 |
R-HSA-881907 | Gastrin-CREB signalling pathway via PKC and MAPK | 1.241750e-04 | 3.906 |
R-HSA-69620 | Cell Cycle Checkpoints | 1.652699e-04 | 3.782 |
R-HSA-373755 | Semaphorin interactions | 1.067466e-04 | 3.972 |
R-HSA-9958790 | SLC-mediated transport of inorganic anions | 1.159734e-04 | 3.936 |
R-HSA-109581 | Apoptosis | 1.194684e-04 | 3.923 |
R-HSA-5357801 | Programmed Cell Death | 1.305869e-04 | 3.884 |
R-HSA-444257 | RSK activation | 2.195667e-04 | 3.658 |
R-HSA-69473 | G2/M DNA damage checkpoint | 2.309006e-04 | 3.637 |
R-HSA-8863678 | Neurodegenerative Diseases | 2.889802e-04 | 3.539 |
R-HSA-8862803 | Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's dis... | 2.889802e-04 | 3.539 |
R-HSA-68886 | M Phase | 3.101063e-04 | 3.508 |
R-HSA-9659379 | Sensory processing of sound | 3.157758e-04 | 3.501 |
R-HSA-400685 | Sema4D in semaphorin signaling | 3.268631e-04 | 3.486 |
R-HSA-69278 | Cell Cycle, Mitotic | 4.130707e-04 | 3.384 |
R-HSA-445095 | Interaction between L1 and Ankyrins | 4.130952e-04 | 3.384 |
R-HSA-3928663 | EPHA-mediated growth cone collapse | 4.130952e-04 | 3.384 |
R-HSA-9734009 | Defective Intrinsic Pathway for Apoptosis | 4.130952e-04 | 3.384 |
R-HSA-6802957 | Oncogenic MAPK signaling | 4.479665e-04 | 3.349 |
R-HSA-9614399 | Regulation of localization of FOXO transcription factors | 4.425257e-04 | 3.354 |
R-HSA-352238 | Breakdown of the nuclear lamina | 4.657529e-04 | 3.332 |
R-HSA-450282 | MAPK targets/ Nuclear events mediated by MAP kinases | 5.144535e-04 | 3.289 |
R-HSA-9662361 | Sensory processing of sound by outer hair cells of the cochlea | 5.770142e-04 | 3.239 |
R-HSA-114452 | Activation of BH3-only proteins | 5.712489e-04 | 3.243 |
R-HSA-111465 | Apoptotic cleavage of cellular proteins | 6.979684e-04 | 3.156 |
R-HSA-2682334 | EPH-Ephrin signaling | 7.229604e-04 | 3.141 |
R-HSA-5696394 | DNA Damage Recognition in GG-NER | 8.433962e-04 | 3.074 |
R-HSA-380284 | Loss of proteins required for interphase microtubule organization from the centr... | 9.153615e-04 | 3.038 |
R-HSA-380259 | Loss of Nlp from mitotic centrosomes | 9.153615e-04 | 3.038 |
R-HSA-8854518 | AURKA Activation by TPX2 | 1.098407e-03 | 2.959 |
R-HSA-6802948 | Signaling by high-kinase activity BRAF mutants | 1.196179e-03 | 2.922 |
R-HSA-380270 | Recruitment of mitotic centrosome proteins and complexes | 1.629670e-03 | 2.788 |
R-HSA-9656223 | Signaling by RAF1 mutants | 1.768221e-03 | 2.752 |
R-HSA-5674135 | MAP2K and MAPK activation | 1.768221e-03 | 2.752 |
R-HSA-380287 | Centrosome maturation | 1.811130e-03 | 2.742 |
R-HSA-9613829 | Chaperone Mediated Autophagy | 1.833665e-03 | 2.737 |
R-HSA-4419969 | Depolymerization of the Nuclear Lamina | 1.833665e-03 | 2.737 |
R-HSA-4420097 | VEGFA-VEGFR2 Pathway | 2.359607e-03 | 2.627 |
R-HSA-3928662 | EPHB-mediated forward signaling | 2.189974e-03 | 2.660 |
R-HSA-9649948 | Signaling downstream of RAS mutants | 2.506812e-03 | 2.601 |
R-HSA-6802955 | Paradoxical activation of RAF signaling by kinase inactive BRAF | 2.506812e-03 | 2.601 |
R-HSA-6802946 | Signaling by moderate kinase activity BRAF mutants | 2.506812e-03 | 2.601 |
R-HSA-6802949 | Signaling by RAS mutants | 2.506812e-03 | 2.601 |
R-HSA-75153 | Apoptotic execution phase | 2.506812e-03 | 2.601 |
R-HSA-2559582 | Senescence-Associated Secretory Phenotype (SASP) | 2.563852e-03 | 2.591 |
R-HSA-5696399 | Global Genome Nucleotide Excision Repair (GG-NER) | 2.815261e-03 | 2.550 |
R-HSA-2565942 | Regulation of PLK1 Activity at G2/M Transition | 2.815261e-03 | 2.550 |
R-HSA-2995383 | Initiation of Nuclear Envelope (NE) Reformation | 2.878685e-03 | 2.541 |
R-HSA-389957 | Prefoldin mediated transfer of substrate to CCT/TriC | 3.513901e-03 | 2.454 |
R-HSA-8935964 | RUNX1 regulates expression of components of tight junctions | 3.201952e-03 | 2.495 |
R-HSA-194138 | Signaling by VEGF | 3.517120e-03 | 2.454 |
R-HSA-380320 | Recruitment of NuMA to mitotic centrosomes | 3.521283e-03 | 2.453 |
R-HSA-5620912 | Anchoring of the basal body to the plasma membrane | 3.836447e-03 | 2.416 |
R-HSA-110314 | Recognition of DNA damage by PCNA-containing replication complex | 3.861073e-03 | 2.413 |
R-HSA-9764265 | Regulation of CDH1 Expression and Function | 4.016203e-03 | 2.396 |
R-HSA-9764274 | Regulation of Expression and Function of Type I Classical Cadherins | 4.016203e-03 | 2.396 |
R-HSA-109606 | Intrinsic Pathway for Apoptosis | 4.570251e-03 | 2.340 |
R-HSA-2559583 | Cellular Senescence | 4.863723e-03 | 2.313 |
R-HSA-5336415 | Uptake and function of diphtheria toxin | 4.936060e-03 | 2.307 |
R-HSA-196025 | Formation of annular gap junctions | 5.932560e-03 | 2.227 |
R-HSA-9615710 | Late endosomal microautophagy | 5.906310e-03 | 2.229 |
R-HSA-917729 | Endosomal Sorting Complex Required For Transport (ESCRT) | 5.906310e-03 | 2.229 |
R-HSA-6807878 | COPI-mediated anterograde transport | 5.300904e-03 | 2.276 |
R-HSA-69275 | G2/M Transition | 5.691906e-03 | 2.245 |
R-HSA-450294 | MAP kinase activation | 5.936029e-03 | 2.227 |
R-HSA-453274 | Mitotic G2-G2/M phases | 5.990160e-03 | 2.223 |
R-HSA-382556 | ABC-family proteins mediated transport | 6.164608e-03 | 2.210 |
R-HSA-2029482 | Regulation of actin dynamics for phagocytic cup formation | 6.255596e-03 | 2.204 |
R-HSA-190873 | Gap junction degradation | 7.012906e-03 | 2.154 |
R-HSA-5696398 | Nucleotide Excision Repair | 7.638979e-03 | 2.117 |
R-HSA-442742 | CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | 7.931389e-03 | 2.101 |
R-HSA-389958 | Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | 6.874414e-03 | 2.163 |
R-HSA-162588 | Budding and maturation of HIV virion | 6.874414e-03 | 2.163 |
R-HSA-8856828 | Clathrin-mediated endocytosis | 6.830518e-03 | 2.166 |
R-HSA-68877 | Mitotic Prometaphase | 6.786872e-03 | 2.168 |
R-HSA-9834752 | Respiratory syncytial virus genome replication | 7.012906e-03 | 2.154 |
R-HSA-9759476 | Regulation of Homotypic Cell-Cell Adhesion | 7.301260e-03 | 2.137 |
R-HSA-9820962 | Assembly and release of respiratory syncytial virus (RSV) virions | 8.175294e-03 | 2.087 |
R-HSA-448424 | Interleukin-17 signaling | 9.030969e-03 | 2.044 |
R-HSA-8953897 | Cellular responses to stimuli | 9.065903e-03 | 2.043 |
R-HSA-5696400 | Dual Incision in GG-NER | 9.079009e-03 | 2.042 |
R-HSA-9856649 | Transcriptional and post-translational regulation of MITF-M expression and activ... | 9.428752e-03 | 2.026 |
R-HSA-198725 | Nuclear Events (kinase and transcription factor activation) | 9.837774e-03 | 2.007 |
R-HSA-5663202 | Diseases of signal transduction by growth factor receptors and second messengers | 1.004425e-02 | 1.998 |
R-HSA-3371511 | HSF1 activation | 1.031883e-02 | 1.986 |
R-HSA-9013694 | Signaling by NOTCH4 | 1.069001e-02 | 1.971 |
R-HSA-9818028 | NFE2L2 regulates pentose phosphate pathway genes | 1.073912e-02 | 1.969 |
R-HSA-381183 | ATF6 (ATF6-alpha) activates chaperone genes | 1.073912e-02 | 1.969 |
R-HSA-397014 | Muscle contraction | 1.077856e-02 | 1.967 |
R-HSA-5628897 | TP53 Regulates Metabolic Genes | 1.094965e-02 | 1.961 |
R-HSA-68882 | Mitotic Anaphase | 1.174684e-02 | 1.930 |
R-HSA-2555396 | Mitotic Metaphase and Anaphase | 1.199844e-02 | 1.921 |
R-HSA-3000484 | Scavenging by Class F Receptors | 1.213709e-02 | 1.916 |
R-HSA-418990 | Adherens junctions interactions | 1.225392e-02 | 1.912 |
R-HSA-5696395 | Formation of Incision Complex in GG-NER | 1.308020e-02 | 1.883 |
R-HSA-5685939 | HDR through MMEJ (alt-NHEJ) | 1.361017e-02 | 1.866 |
R-HSA-174490 | Membrane binding and targetting of GAG proteins | 1.361017e-02 | 1.866 |
R-HSA-174495 | Synthesis And Processing Of GAG, GAGPOL Polyproteins | 1.515667e-02 | 1.819 |
R-HSA-399954 | Sema3A PAK dependent Axon repulsion | 1.677497e-02 | 1.775 |
R-HSA-2029480 | Fcgamma receptor (FCGR) dependent phagocytosis | 1.555013e-02 | 1.808 |
R-HSA-1500620 | Meiosis | 1.622787e-02 | 1.790 |
R-HSA-187037 | Signaling by NTRK1 (TRKA) | 1.687946e-02 | 1.773 |
R-HSA-381033 | ATF6 (ATF6-alpha) activates chaperones | 1.361017e-02 | 1.866 |
R-HSA-446353 | Cell-extracellular matrix interactions | 1.677497e-02 | 1.775 |
R-HSA-9006934 | Signaling by Receptor Tyrosine Kinases | 1.471700e-02 | 1.832 |
R-HSA-9705683 | SARS-CoV-2-host interactions | 1.502898e-02 | 1.823 |
R-HSA-449147 | Signaling by Interleukins | 1.690760e-02 | 1.772 |
R-HSA-9645723 | Diseases of programmed cell death | 1.861469e-02 | 1.730 |
R-HSA-6804114 | TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | 2.022050e-02 | 1.694 |
R-HSA-73893 | DNA Damage Bypass | 2.166711e-02 | 1.664 |
R-HSA-2262752 | Cellular responses to stress | 2.179189e-02 | 1.662 |
R-HSA-5083632 | Defective C1GALT1C1 causes TNPS | 2.204458e-02 | 1.657 |
R-HSA-2028269 | Signaling by Hippo | 2.204458e-02 | 1.657 |
R-HSA-421270 | Cell-cell junction organization | 2.306210e-02 | 1.637 |
R-HSA-381119 | Unfolded Protein Response (UPR) | 2.348669e-02 | 1.629 |
R-HSA-5339562 | Uptake and actions of bacterial toxins | 2.471837e-02 | 1.607 |
R-HSA-9709603 | Impaired BRCA2 binding to PALB2 | 2.588763e-02 | 1.587 |
R-HSA-392517 | Rap1 signalling | 2.588763e-02 | 1.587 |
R-HSA-449836 | Other interleukin signaling | 2.588763e-02 | 1.587 |
R-HSA-6811442 | Intra-Golgi and retrograde Golgi-to-ER traffic | 2.679645e-02 | 1.572 |
R-HSA-975871 | MyD88 cascade initiated on plasma membrane | 2.703401e-02 | 1.568 |
R-HSA-168142 | Toll Like Receptor 10 (TLR10) Cascade | 2.703401e-02 | 1.568 |
R-HSA-168176 | Toll Like Receptor 5 (TLR5) Cascade | 2.703401e-02 | 1.568 |
R-HSA-5619050 | Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tu... | 3.045539e-02 | 1.516 |
R-HSA-5619039 | Defective SLC12A6 causes agenesis of the corpus callosum, with peripheral neurop... | 3.045539e-02 | 1.516 |
R-HSA-9701193 | Defective homologous recombination repair (HRR) due to PALB2 loss of function | 2.790361e-02 | 1.554 |
R-HSA-9701192 | Defective homologous recombination repair (HRR) due to BRCA1 loss of function | 2.790361e-02 | 1.554 |
R-HSA-9704331 | Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of... | 2.790361e-02 | 1.554 |
R-HSA-9704646 | Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of... | 2.790361e-02 | 1.554 |
R-HSA-6782210 | Gap-filling DNA repair synthesis and ligation in TC-NER | 2.912835e-02 | 1.536 |
R-HSA-6782135 | Dual incision in TC-NER | 3.147915e-02 | 1.502 |
R-HSA-199977 | ER to Golgi Anterograde Transport | 2.892195e-02 | 1.539 |
R-HSA-2980766 | Nuclear Envelope Breakdown | 3.029164e-02 | 1.519 |
R-HSA-9612973 | Autophagy | 3.509477e-02 | 1.455 |
R-HSA-8856825 | Cargo recognition for clathrin-mediated endocytosis | 3.197285e-02 | 1.495 |
R-HSA-175474 | Assembly Of The HIV Virion | 3.211708e-02 | 1.493 |
R-HSA-9013695 | NOTCH4 Intracellular Domain Regulates Transcription | 2.998057e-02 | 1.523 |
R-HSA-166520 | Signaling by NTRKs | 2.957095e-02 | 1.529 |
R-HSA-1474244 | Extracellular matrix organization | 2.997752e-02 | 1.523 |
R-HSA-975138 | TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | 3.646739e-02 | 1.438 |
R-HSA-1266738 | Developmental Biology | 3.024180e-02 | 1.519 |
R-HSA-168164 | Toll Like Receptor 3 (TLR3) Cascade | 3.372916e-02 | 1.472 |
R-HSA-446728 | Cell junction organization | 3.579666e-02 | 1.446 |
R-HSA-9692914 | SARS-CoV-1-host interactions | 3.462805e-02 | 1.461 |
R-HSA-8852276 | The role of GTSE1 in G2/M progression after G2 checkpoint | 3.647005e-02 | 1.438 |
R-HSA-975155 | MyD88 dependent cascade initiated on endosome | 3.740787e-02 | 1.427 |
R-HSA-937061 | TRIF (TICAM1)-mediated TLR4 signaling | 3.836224e-02 | 1.416 |
R-HSA-166166 | MyD88-independent TLR4 cascade | 3.836224e-02 | 1.416 |
R-HSA-9665230 | Drug resistance in ERBB2 KD mutants | 4.040089e-02 | 1.394 |
R-HSA-9652282 | Drug-mediated inhibition of ERBB2 signaling | 4.040089e-02 | 1.394 |
R-HSA-198765 | Signalling to ERK5 | 4.040089e-02 | 1.394 |
R-HSA-9665245 | Resistance of ERBB2 KD mutants to tesevatinib | 4.040089e-02 | 1.394 |
R-HSA-9665233 | Resistance of ERBB2 KD mutants to trastuzumab | 4.040089e-02 | 1.394 |
R-HSA-9665251 | Resistance of ERBB2 KD mutants to lapatinib | 4.040089e-02 | 1.394 |
R-HSA-9665246 | Resistance of ERBB2 KD mutants to neratinib | 4.040089e-02 | 1.394 |
R-HSA-9665244 | Resistance of ERBB2 KD mutants to sapitinib | 4.040089e-02 | 1.394 |
R-HSA-9665247 | Resistance of ERBB2 KD mutants to osimertinib | 4.040089e-02 | 1.394 |
R-HSA-9918454 | Defective visual phototransduction due to ABCA4 loss of function | 4.040089e-02 | 1.394 |
R-HSA-9665737 | Drug resistance in ERBB2 TMD/JMD mutants | 4.040089e-02 | 1.394 |
R-HSA-9665250 | Resistance of ERBB2 KD mutants to AEE788 | 4.040089e-02 | 1.394 |
R-HSA-9665249 | Resistance of ERBB2 KD mutants to afatinib | 4.040089e-02 | 1.394 |
R-HSA-5693554 | Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SD... | 4.123044e-02 | 1.385 |
R-HSA-1482801 | Acyl chain remodelling of PS | 4.123044e-02 | 1.385 |
R-HSA-168181 | Toll Like Receptor 7/8 (TLR7/8) Cascade | 4.130872e-02 | 1.384 |
R-HSA-5685942 | HDR through Homologous Recombination (HRR) | 4.324430e-02 | 1.364 |
R-HSA-70635 | Urea cycle | 4.364377e-02 | 1.360 |
R-HSA-9022699 | MECP2 regulates neuronal receptors and channels | 4.364377e-02 | 1.360 |
R-HSA-168138 | Toll Like Receptor 9 (TLR9) Cascade | 4.438031e-02 | 1.353 |
R-HSA-264876 | Insulin processing | 4.610844e-02 | 1.336 |
R-HSA-166058 | MyD88:MAL(TIRAP) cascade initiated on plasma membrane | 4.977728e-02 | 1.303 |
R-HSA-168188 | Toll Like Receptor TLR6:TLR2 Cascade | 4.977728e-02 | 1.303 |
R-HSA-450531 | Regulation of mRNA stability by proteins that bind AU-rich elements | 5.060130e-02 | 1.296 |
R-HSA-68875 | Mitotic Prophase | 5.089822e-02 | 1.293 |
R-HSA-9927432 | Developmental Lineage of Mammary Gland Myoepithelial Cells | 5.118663e-02 | 1.291 |
R-HSA-9709570 | Impaired BRCA2 binding to RAD51 | 5.118663e-02 | 1.291 |
R-HSA-168179 | Toll Like Receptor TLR1:TLR2 Cascade | 5.318150e-02 | 1.274 |
R-HSA-181438 | Toll Like Receptor 2 (TLR2) Cascade | 5.318150e-02 | 1.274 |
R-HSA-8876198 | RAB GEFs exchange GTP for GDP on RABs | 7.415178e-02 | 1.130 |
R-HSA-354192 | Integrin signaling | 6.190353e-02 | 1.208 |
R-HSA-6781827 | Transcription-Coupled Nucleotide Excision Repair (TC-NER) | 5.528853e-02 | 1.257 |
R-HSA-8849472 | PTK6 Down-Regulation | 6.963301e-02 | 1.157 |
R-HSA-5685938 | HDR through Single Strand Annealing (SSA) | 6.190353e-02 | 1.208 |
R-HSA-5693537 | Resolution of D-Loop Structures | 6.469250e-02 | 1.189 |
R-HSA-8937144 | Aryl hydrocarbon receptor signalling | 7.917898e-02 | 1.101 |
R-HSA-5693568 | Resolution of D-loop Structures through Holliday Junction Intermediates | 6.190353e-02 | 1.208 |
R-HSA-9675136 | Diseases of DNA Double-Strand Break Repair | 6.752303e-02 | 1.171 |
R-HSA-9701190 | Defective homologous recombination repair (HRR) due to BRCA2 loss of function | 6.752303e-02 | 1.171 |
R-HSA-8856688 | Golgi-to-ER retrograde transport | 6.802893e-02 | 1.167 |
R-HSA-2129379 | Molecules associated with elastic fibres | 5.645492e-02 | 1.248 |
R-HSA-5693579 | Homologous DNA Pairing and Strand Exchange | 7.923834e-02 | 1.101 |
R-HSA-205025 | NADE modulates death signalling | 5.998867e-02 | 1.222 |
R-HSA-948021 | Transport to the Golgi and subsequent modification | 7.985262e-02 | 1.098 |
R-HSA-1566948 | Elastic fibre formation | 7.923834e-02 | 1.101 |
R-HSA-5693616 | Presynaptic phase of homologous DNA pairing and strand exchange | 7.039398e-02 | 1.152 |
R-HSA-447038 | NrCAM interactions | 6.963301e-02 | 1.157 |
R-HSA-9664407 | Parasite infection | 8.042763e-02 | 1.095 |
R-HSA-9664422 | FCGR3A-mediated phagocytosis | 8.042763e-02 | 1.095 |
R-HSA-9664417 | Leishmania phagocytosis | 8.042763e-02 | 1.095 |
R-HSA-390466 | Chaperonin-mediated protein folding | 7.785254e-02 | 1.109 |
R-HSA-8853659 | RET signaling | 7.330425e-02 | 1.135 |
R-HSA-5250982 | Toxicity of tetanus toxin (tetX) | 5.998867e-02 | 1.222 |
R-HSA-5250989 | Toxicity of botulinum toxin type G (botG) | 6.963301e-02 | 1.157 |
R-HSA-9758919 | Epithelial-Mesenchymal Transition (EMT) during gastrulation | 7.917898e-02 | 1.101 |
R-HSA-416482 | G alpha (12/13) signalling events | 6.017570e-02 | 1.221 |
R-HSA-5617833 | Cilium Assembly | 6.641133e-02 | 1.178 |
R-HSA-438064 | Post NMDA receptor activation events | 7.785254e-02 | 1.109 |
R-HSA-1643685 | Disease | 7.799278e-02 | 1.108 |
R-HSA-9860927 | Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZ... | 7.039398e-02 | 1.152 |
R-HSA-1474165 | Reproduction | 6.541908e-02 | 1.184 |
R-HSA-168316 | Assembly of Viral Components at the Budding Site | 6.963301e-02 | 1.157 |
R-HSA-2995410 | Nuclear Envelope (NE) Reassembly | 6.354277e-02 | 1.197 |
R-HSA-1500931 | Cell-Cell communication | 6.051949e-02 | 1.218 |
R-HSA-1236974 | ER-Phagosome pathway | 8.163298e-02 | 1.088 |
R-HSA-8953750 | Transcriptional Regulation by E2F6 | 8.226004e-02 | 1.085 |
R-HSA-9820965 | Respiratory syncytial virus (RSV) genome replication, transcription and translat... | 8.226004e-02 | 1.085 |
R-HSA-9646399 | Aggrephagy | 8.531676e-02 | 1.069 |
R-HSA-9604323 | Negative regulation of NOTCH4 signaling | 8.531676e-02 | 1.069 |
R-HSA-3371568 | Attenuation phase | 8.531676e-02 | 1.069 |
R-HSA-168256 | Immune System | 8.722749e-02 | 1.059 |
R-HSA-3214841 | PKMTs methylate histone lysines | 8.840749e-02 | 1.054 |
R-HSA-9645135 | STAT5 Activation | 8.862760e-02 | 1.052 |
R-HSA-447043 | Neurofascin interactions | 8.862760e-02 | 1.052 |
R-HSA-5250981 | Toxicity of botulinum toxin type F (botF) | 8.862760e-02 | 1.052 |
R-HSA-5250955 | Toxicity of botulinum toxin type D (botD) | 8.862760e-02 | 1.052 |
R-HSA-8964011 | HDL clearance | 8.862760e-02 | 1.052 |
R-HSA-9694516 | SARS-CoV-2 Infection | 8.886441e-02 | 1.051 |
R-HSA-391251 | Protein folding | 8.942657e-02 | 1.049 |
R-HSA-166016 | Toll Like Receptor 4 (TLR4) Cascade | 9.386663e-02 | 1.027 |
R-HSA-9730414 | MITF-M-regulated melanocyte development | 9.464172e-02 | 1.024 |
R-HSA-512988 | Interleukin-3, Interleukin-5 and GM-CSF signaling | 9.468695e-02 | 1.024 |
R-HSA-72731 | Recycling of eIF2:GDP | 9.797983e-02 | 1.009 |
R-HSA-9726840 | SHOC2 M1731 mutant abolishes MRAS complex function | 9.797983e-02 | 1.009 |
R-HSA-9660537 | Signaling by MRAS-complex mutants | 1.072367e-01 | 0.970 |
R-HSA-9726842 | Gain-of-function MRAS complexes activate RAF signaling | 1.072367e-01 | 0.970 |
R-HSA-390450 | Folding of actin by CCT/TriC | 1.254680e-01 | 0.901 |
R-HSA-202670 | ERKs are inactivated | 1.433293e-01 | 0.844 |
R-HSA-69166 | Removal of the Flap Intermediate | 1.694435e-01 | 0.771 |
R-HSA-354194 | GRB2:SOS provides linkage to MAPK signaling for Integrins | 1.864118e-01 | 0.730 |
R-HSA-176412 | Phosphorylation of the APC/C | 1.864118e-01 | 0.730 |
R-HSA-5083625 | Defective GALNT3 causes HFTC | 1.864118e-01 | 0.730 |
R-HSA-5083636 | Defective GALNT12 causes CRCS1 | 1.864118e-01 | 0.730 |
R-HSA-9687136 | Aberrant regulation of mitotic exit in cancer due to RB1 defects | 1.864118e-01 | 0.730 |
R-HSA-5678895 | Defective CFTR causes cystic fibrosis | 1.043365e-01 | 0.982 |
R-HSA-174084 | Autodegradation of Cdh1 by Cdh1:APC/C | 1.076107e-01 | 0.968 |
R-HSA-174154 | APC/C:Cdc20 mediated degradation of Securin | 1.109121e-01 | 0.955 |
R-HSA-174184 | Cdc20:Phospho-APC/C mediated degradation of Cyclin A | 1.277979e-01 | 0.893 |
R-HSA-179419 | APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of th... | 1.312449e-01 | 0.882 |
R-HSA-174178 | APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins ... | 1.312449e-01 | 0.882 |
R-HSA-176409 | APC/C:Cdc20 mediated degradation of mitotic proteins | 1.382019e-01 | 0.859 |
R-HSA-176814 | Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | 1.417105e-01 | 0.849 |
R-HSA-72702 | Ribosomal scanning and start codon recognition | 1.417105e-01 | 0.849 |
R-HSA-913709 | O-linked glycosylation of mucins | 1.850894e-01 | 0.733 |
R-HSA-72706 | GTP hydrolysis and joining of the 60S ribosomal subunit | 1.280058e-01 | 0.893 |
R-HSA-3371497 | HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of lig... | 1.850894e-01 | 0.733 |
R-HSA-69183 | Processive synthesis on the lagging strand | 1.779711e-01 | 0.750 |
R-HSA-162658 | Golgi Cisternae Pericentriolar Stack Reorganization | 1.608279e-01 | 0.794 |
R-HSA-5693538 | Homology Directed Repair | 1.564687e-01 | 0.806 |
R-HSA-76009 | Platelet Aggregation (Plug Formation) | 1.043365e-01 | 0.982 |
R-HSA-432722 | Golgi Associated Vesicle Biogenesis | 1.312449e-01 | 0.882 |
R-HSA-69618 | Mitotic Spindle Checkpoint | 1.080362e-01 | 0.966 |
R-HSA-5693567 | HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | 1.419950e-01 | 0.848 |
R-HSA-6798695 | Neutrophil degranulation | 1.227301e-01 | 0.911 |
R-HSA-5693548 | Sensing of DNA Double Strand Breaks | 1.433293e-01 | 0.844 |
R-HSA-72737 | Cap-dependent Translation Initiation | 1.515933e-01 | 0.819 |
R-HSA-204005 | COPII-mediated vesicle transport | 1.925007e-01 | 0.716 |
R-HSA-2467813 | Separation of Sister Chromatids | 1.201706e-01 | 0.920 |
R-HSA-72613 | Eukaryotic Translation Initiation | 1.515933e-01 | 0.819 |
R-HSA-6781823 | Formation of TC-NER Pre-Incision Complex | 1.076107e-01 | 0.968 |
R-HSA-6811434 | COPI-dependent Golgi-to-ER retrograde traffic | 9.958798e-02 | 1.002 |
R-HSA-9007101 | Rab regulation of trafficking | 1.540248e-01 | 0.812 |
R-HSA-192905 | vRNP Assembly | 1.344444e-01 | 0.871 |
R-HSA-9634285 | Constitutive Signaling by Overexpressed ERBB2 | 1.521234e-01 | 0.818 |
R-HSA-2559584 | Formation of Senescence-Associated Heterochromatin Foci (SAHF) | 1.608279e-01 | 0.794 |
R-HSA-9933947 | Formation of the non-canonical BAF (ncBAF) complex | 1.608279e-01 | 0.794 |
R-HSA-69017 | CDK-mediated phosphorylation and removal of Cdc6 | 1.347131e-01 | 0.871 |
R-HSA-2559586 | DNA Damage/Telomere Stress Induced Senescence | 1.631350e-01 | 0.787 |
R-HSA-9925563 | Developmental Lineage of Pancreatic Ductal Cells | 1.887900e-01 | 0.724 |
R-HSA-170968 | Frs2-mediated activation | 1.608279e-01 | 0.794 |
R-HSA-430116 | GP1b-IX-V activation signalling | 1.163991e-01 | 0.934 |
R-HSA-169893 | Prolonged ERK activation events | 1.864118e-01 | 0.730 |
R-HSA-69239 | Synthesis of DNA | 1.257248e-01 | 0.901 |
R-HSA-73894 | DNA Repair | 9.974346e-02 | 1.001 |
R-HSA-176408 | Regulation of APC/C activators between G1/S and early anaphase | 1.631350e-01 | 0.787 |
R-HSA-170984 | ARMS-mediated activation | 1.163991e-01 | 0.934 |
R-HSA-428359 | Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RN... | 1.254680e-01 | 0.901 |
R-HSA-450385 | Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | 1.779711e-01 | 0.750 |
R-HSA-6811440 | Retrograde transport at the Trans-Golgi-Network | 1.109121e-01 | 0.955 |
R-HSA-983189 | Kinesins | 1.559273e-01 | 0.807 |
R-HSA-425381 | Bicarbonate transporters | 1.344444e-01 | 0.871 |
R-HSA-877312 | Regulation of IFNG signaling | 1.521234e-01 | 0.818 |
R-HSA-69091 | Polymerase switching | 1.521234e-01 | 0.818 |
R-HSA-69109 | Leading Strand Synthesis | 1.521234e-01 | 0.818 |
R-HSA-450513 | Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | 1.779711e-01 | 0.750 |
R-HSA-3371571 | HSF1-dependent transactivation | 1.243732e-01 | 0.905 |
R-HSA-445355 | Smooth Muscle Contraction | 1.312449e-01 | 0.882 |
R-HSA-69002 | DNA Replication Pre-Initiation | 1.303017e-01 | 0.885 |
R-HSA-69306 | DNA Replication | 1.017647e-01 | 0.992 |
R-HSA-3371556 | Cellular response to heat stress | 1.638721e-01 | 0.785 |
R-HSA-1236975 | Antigen processing-Cross presentation | 1.280058e-01 | 0.893 |
R-HSA-447041 | CHL1 interactions | 9.797983e-02 | 1.009 |
R-HSA-5250958 | Toxicity of botulinum toxin type B (botB) | 1.072367e-01 | 0.970 |
R-HSA-9013700 | NOTCH4 Activation and Transmission of Signal to the Nucleus | 1.163991e-01 | 0.934 |
R-HSA-9933937 | Formation of the canonical BAF (cBAF) complex | 1.694435e-01 | 0.771 |
R-HSA-3270619 | IRF3-mediated induction of type I IFN | 1.779711e-01 | 0.750 |
R-HSA-9933946 | Formation of the embryonic stem cell BAF (esBAF) complex | 1.779711e-01 | 0.750 |
R-HSA-450604 | KSRP (KHSRP) binds and destabilizes mRNA | 1.864118e-01 | 0.730 |
R-HSA-190828 | Gap junction trafficking | 1.010905e-01 | 0.995 |
R-HSA-912446 | Meiotic recombination | 1.243732e-01 | 0.905 |
R-HSA-9734767 | Developmental Cell Lineages | 1.694672e-01 | 0.771 |
R-HSA-9840373 | Cellular response to mitochondrial stress | 1.163991e-01 | 0.934 |
R-HSA-1247673 | Erythrocytes take up oxygen and release carbon dioxide | 1.521234e-01 | 0.818 |
R-HSA-9933939 | Formation of the polybromo-BAF (pBAF) complex | 1.694435e-01 | 0.771 |
R-HSA-157858 | Gap junction trafficking and regulation | 1.175933e-01 | 0.930 |
R-HSA-1221632 | Meiotic synapsis | 1.312449e-01 | 0.882 |
R-HSA-9675135 | Diseases of DNA repair | 1.076107e-01 | 0.968 |
R-HSA-210990 | PECAM1 interactions | 1.344444e-01 | 0.871 |
R-HSA-9856872 | Malate-aspartate shuttle | 1.694435e-01 | 0.771 |
R-HSA-9725370 | Signaling by ALK fusions and activated point mutants | 1.257248e-01 | 0.901 |
R-HSA-9700206 | Signaling by ALK in cancer | 1.257248e-01 | 0.901 |
R-HSA-6791312 | TP53 Regulates Transcription of Cell Cycle Genes | 1.452381e-01 | 0.838 |
R-HSA-8983432 | Interleukin-15 signaling | 1.521234e-01 | 0.818 |
R-HSA-9662834 | CD163 mediating an anti-inflammatory response | 1.344444e-01 | 0.871 |
R-HSA-3928665 | EPH-ephrin mediated repulsion of cells | 1.109121e-01 | 0.955 |
R-HSA-351906 | Apoptotic cleavage of cell adhesion proteins | 1.072367e-01 | 0.970 |
R-HSA-9855142 | Cellular responses to mechanical stimuli | 1.419950e-01 | 0.848 |
R-HSA-9860931 | Response of endothelial cells to shear stress | 1.167532e-01 | 0.933 |
R-HSA-442755 | Activation of NMDA receptors and postsynaptic events | 1.123620e-01 | 0.949 |
R-HSA-9679191 | Potential therapeutics for SARS | 9.698962e-02 | 1.013 |
R-HSA-1280215 | Cytokine Signaling in Immune system | 1.601412e-01 | 0.795 |
R-HSA-168268 | Virus Assembly and Release | 1.864118e-01 | 0.730 |
R-HSA-168249 | Innate Immune System | 1.031027e-01 | 0.987 |
R-HSA-9614085 | FOXO-mediated transcription | 1.058984e-01 | 0.975 |
R-HSA-9759194 | Nuclear events mediated by NFE2L2 | 1.638721e-01 | 0.785 |
R-HSA-3700989 | Transcriptional Regulation by TP53 | 1.312009e-01 | 0.882 |
R-HSA-8950505 | Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulati... | 1.740550e-01 | 0.759 |
R-HSA-168898 | Toll-like Receptor Cascades | 1.727031e-01 | 0.763 |
R-HSA-9679506 | SARS-CoV Infections | 1.425789e-01 | 0.846 |
R-HSA-9678108 | SARS-CoV-1 Infection | 1.417550e-01 | 0.848 |
R-HSA-141430 | Inactivation of APC/C via direct inhibition of the APC/C complex | 1.947663e-01 | 0.710 |
R-HSA-141405 | Inhibition of the proteolytic activity of APC/C required for the onset of anapha... | 1.947663e-01 | 0.710 |
R-HSA-9702518 | STAT5 activation downstream of FLT3 ITD mutants | 1.947663e-01 | 0.710 |
R-HSA-453276 | Regulation of mitotic cell cycle | 1.962211e-01 | 0.707 |
R-HSA-174143 | APC/C-mediated degradation of cell cycle proteins | 1.962211e-01 | 0.707 |
R-HSA-3906995 | Diseases associated with O-glycosylation of proteins | 1.962211e-01 | 0.707 |
R-HSA-199992 | trans-Golgi Network Vesicle Budding | 1.999505e-01 | 0.699 |
R-HSA-9924644 | Developmental Lineages of the Mammary Gland | 1.999505e-01 | 0.699 |
R-HSA-9824443 | Parasitic Infection Pathways | 2.008326e-01 | 0.697 |
R-HSA-9658195 | Leishmania infection | 2.008326e-01 | 0.697 |
R-HSA-5637810 | Constitutive Signaling by EGFRvIII | 2.030355e-01 | 0.692 |
R-HSA-5637812 | Signaling by EGFRvIII in Cancer | 2.030355e-01 | 0.692 |
R-HSA-174437 | Removal of the Flap Intermediate from the C-strand | 2.030355e-01 | 0.692 |
R-HSA-372708 | p130Cas linkage to MAPK signaling for integrins | 2.030355e-01 | 0.692 |
R-HSA-176407 | Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | 2.030355e-01 | 0.692 |
R-HSA-5358606 | Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | 2.030355e-01 | 0.692 |
R-HSA-5358565 | Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | 2.030355e-01 | 0.692 |
R-HSA-69052 | Switching of origins to a post-replicative state | 2.036884e-01 | 0.691 |
R-HSA-204998 | Cell death signalling via NRAGE, NRIF and NADE | 2.036884e-01 | 0.691 |
R-HSA-5651801 | PCNA-Dependent Long Patch Base Excision Repair | 2.112203e-01 | 0.675 |
R-HSA-181429 | Serotonin Neurotransmitter Release Cycle | 2.112203e-01 | 0.675 |
R-HSA-1839117 | Signaling by cytosolic FGFR1 fusion mutants | 2.112203e-01 | 0.675 |
R-HSA-9665348 | Signaling by ERBB2 ECD mutants | 2.112203e-01 | 0.675 |
R-HSA-5358508 | Mismatch Repair | 2.112203e-01 | 0.675 |
R-HSA-5689603 | UCH proteinases | 2.149471e-01 | 0.668 |
R-HSA-9020591 | Interleukin-12 signaling | 2.149471e-01 | 0.668 |
R-HSA-5673001 | RAF/MAP kinase cascade | 2.153734e-01 | 0.667 |
R-HSA-112314 | Neurotransmitter receptors and postsynaptic signal transmission | 2.185956e-01 | 0.660 |
R-HSA-174048 | APC/C:Cdc20 mediated degradation of Cyclin B | 2.193215e-01 | 0.659 |
R-HSA-844456 | The NLRP3 inflammasome | 2.193215e-01 | 0.659 |
R-HSA-1480926 | O2/CO2 exchange in erythrocytes | 2.193215e-01 | 0.659 |
R-HSA-1237044 | Erythrocytes take up carbon dioxide and release oxygen | 2.193215e-01 | 0.659 |
R-HSA-9856532 | Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | 2.193215e-01 | 0.659 |
R-HSA-1834941 | STING mediated induction of host immune responses | 2.193215e-01 | 0.659 |
R-HSA-5619084 | ABC transporter disorders | 2.224853e-01 | 0.653 |
R-HSA-9609523 | Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | 2.273400e-01 | 0.643 |
R-HSA-9934037 | Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | 2.273400e-01 | 0.643 |
R-HSA-445144 | Signal transduction by L1 | 2.273400e-01 | 0.643 |
R-HSA-6807004 | Negative regulation of MET activity | 2.273400e-01 | 0.643 |
R-HSA-5684996 | MAPK1/MAPK3 signaling | 2.283632e-01 | 0.641 |
R-HSA-162599 | Late Phase of HIV Life Cycle | 2.290169e-01 | 0.640 |
R-HSA-5693607 | Processing of DNA double-strand break ends | 2.338305e-01 | 0.631 |
R-HSA-5637815 | Signaling by Ligand-Responsive EGFR Variants in Cancer | 2.352767e-01 | 0.628 |
R-HSA-1236382 | Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | 2.352767e-01 | 0.628 |
R-HSA-179409 | APC-Cdc20 mediated degradation of Nek2A | 2.352767e-01 | 0.628 |
R-HSA-69186 | Lagging Strand Synthesis | 2.352767e-01 | 0.628 |
R-HSA-264642 | Acetylcholine Neurotransmitter Release Cycle | 2.352767e-01 | 0.628 |
R-HSA-5357786 | TNFR1-induced proapoptotic signaling | 2.352767e-01 | 0.628 |
R-HSA-8951664 | Neddylation | 2.382543e-01 | 0.623 |
R-HSA-983169 | Class I MHC mediated antigen processing & presentation | 2.393686e-01 | 0.621 |
R-HSA-76066 | RNA Polymerase III Transcription Initiation From Type 2 Promoter | 2.431323e-01 | 0.614 |
R-HSA-5696397 | Gap-filling DNA repair synthesis and ligation in GG-NER | 2.431323e-01 | 0.614 |
R-HSA-211979 | Eicosanoids | 2.431323e-01 | 0.614 |
R-HSA-211958 | Miscellaneous substrates | 2.431323e-01 | 0.614 |
R-HSA-69242 | S Phase | 2.453457e-01 | 0.610 |
R-HSA-8878171 | Transcriptional regulation by RUNX1 | 2.493534e-01 | 0.603 |
R-HSA-76061 | RNA Polymerase III Transcription Initiation From Type 1 Promoter | 2.509077e-01 | 0.600 |
R-HSA-212676 | Dopamine Neurotransmitter Release Cycle | 2.509077e-01 | 0.600 |
R-HSA-166208 | mTORC1-mediated signalling | 2.509077e-01 | 0.600 |
R-HSA-912694 | Regulation of IFNA/IFNB signaling | 2.509077e-01 | 0.600 |
R-HSA-168799 | Neurotoxicity of clostridium toxins | 2.509077e-01 | 0.600 |
R-HSA-162906 | HIV Infection | 2.515869e-01 | 0.599 |
R-HSA-141444 | Amplification of signal from unattached kinetochores via a MAD2 inhibitory si... | 2.528086e-01 | 0.597 |
R-HSA-141424 | Amplification of signal from the kinetochores | 2.528086e-01 | 0.597 |
R-HSA-9755511 | KEAP1-NFE2L2 pathway | 2.535800e-01 | 0.596 |
R-HSA-9820448 | Developmental Cell Lineages of the Exocrine Pancreas | 2.563338e-01 | 0.591 |
R-HSA-6804756 | Regulation of TP53 Activity through Phosphorylation | 2.566105e-01 | 0.591 |
R-HSA-381038 | XBP1(S) activates chaperone genes | 2.566105e-01 | 0.591 |
R-HSA-977068 | Termination of O-glycan biosynthesis | 2.586037e-01 | 0.587 |
R-HSA-912526 | Interleukin receptor SHC signaling | 2.586037e-01 | 0.587 |
R-HSA-211935 | Fatty acids | 2.586037e-01 | 0.587 |
R-HSA-9648895 | Response of EIF2AK1 (HRI) to heme deficiency | 2.586037e-01 | 0.587 |
R-HSA-1369062 | ABC transporters in lipid homeostasis | 2.586037e-01 | 0.587 |
R-HSA-3000170 | Syndecan interactions | 2.586037e-01 | 0.587 |
R-HSA-982772 | Growth hormone receptor signaling | 2.586037e-01 | 0.587 |
R-HSA-5693532 | DNA Double-Strand Break Repair | 2.590919e-01 | 0.587 |
R-HSA-447115 | Interleukin-12 family signaling | 2.604135e-01 | 0.584 |
R-HSA-73887 | Death Receptor Signaling | 2.618540e-01 | 0.582 |
R-HSA-9663891 | Selective autophagy | 2.642171e-01 | 0.578 |
R-HSA-9703648 | Signaling by FLT3 ITD and TKD mutants | 2.662211e-01 | 0.575 |
R-HSA-181430 | Norepinephrine Neurotransmitter Release Cycle | 2.662211e-01 | 0.575 |
R-HSA-9665686 | Signaling by ERBB2 TMD/JMD mutants | 2.662211e-01 | 0.575 |
R-HSA-9836573 | Mitochondrial RNA degradation | 2.662211e-01 | 0.575 |
R-HSA-162582 | Signal Transduction | 2.673696e-01 | 0.573 |
R-HSA-162587 | HIV Life Cycle | 2.701628e-01 | 0.568 |
R-HSA-9932451 | SWI/SNF chromatin remodelers | 2.737608e-01 | 0.563 |
R-HSA-9932444 | ATP-dependent chromatin remodelers | 2.737608e-01 | 0.563 |
R-HSA-174411 | Polymerase switching on the C-strand of the telomere | 2.737608e-01 | 0.563 |
R-HSA-2453864 | Retinoid cycle disease events | 2.737608e-01 | 0.563 |
R-HSA-9675143 | Diseases of the neuronal system | 2.737608e-01 | 0.563 |
R-HSA-2474795 | Diseases associated with visual transduction | 2.737608e-01 | 0.563 |
R-HSA-5601884 | PIWI-interacting RNA (piRNA) biogenesis | 2.737608e-01 | 0.563 |
R-HSA-1852241 | Organelle biogenesis and maintenance | 2.744760e-01 | 0.561 |
R-HSA-8986944 | Transcriptional Regulation by MECP2 | 2.756278e-01 | 0.560 |
R-HSA-381070 | IRE1alpha activates chaperones | 2.794299e-01 | 0.554 |
R-HSA-112315 | Transmission across Chemical Synapses | 2.803819e-01 | 0.552 |
R-HSA-157118 | Signaling by NOTCH | 2.809773e-01 | 0.551 |
R-HSA-1643713 | Signaling by EGFR in Cancer | 2.812234e-01 | 0.551 |
R-HSA-210500 | Glutamate Neurotransmitter Release Cycle | 2.812234e-01 | 0.551 |
R-HSA-110373 | Resolution of AP sites via the multiple-nucleotide patch replacement pathway | 2.812234e-01 | 0.551 |
R-HSA-9703465 | Signaling by FLT3 fusion proteins | 2.812234e-01 | 0.551 |
R-HSA-74752 | Signaling by Insulin receptor | 2.832308e-01 | 0.548 |
R-HSA-68867 | Assembly of the pre-replicative complex | 2.870300e-01 | 0.542 |
R-HSA-174414 | Processive synthesis on the C-strand of the telomere | 2.886097e-01 | 0.540 |
R-HSA-5357956 | TNFR1-induced NF-kappa-B signaling pathway | 2.886097e-01 | 0.540 |
R-HSA-168928 | DDX58/IFIH1-mediated induction of interferon-alpha/beta | 2.946218e-01 | 0.531 |
R-HSA-77387 | Insulin receptor recycling | 2.959207e-01 | 0.529 |
R-HSA-622312 | Inflammasomes | 2.959207e-01 | 0.529 |
R-HSA-9824446 | Viral Infection Pathways | 2.964888e-01 | 0.528 |
R-HSA-5619115 | Disorders of transmembrane transporters | 2.970270e-01 | 0.527 |
R-HSA-9664565 | Signaling by ERBB2 KD Mutants | 3.031569e-01 | 0.518 |
R-HSA-5656169 | Termination of translesion DNA synthesis | 3.031569e-01 | 0.518 |
R-HSA-9674555 | Signaling by CSF3 (G-CSF) | 3.031569e-01 | 0.518 |
R-HSA-446203 | Asparagine N-linked glycosylation | 3.074496e-01 | 0.512 |
R-HSA-68962 | Activation of the pre-replicative complex | 3.103192e-01 | 0.508 |
R-HSA-76046 | RNA Polymerase III Transcription Initiation | 3.103192e-01 | 0.508 |
R-HSA-1227990 | Signaling by ERBB2 in Cancer | 3.103192e-01 | 0.508 |
R-HSA-9687139 | Aberrant regulation of mitotic cell cycle due to RB1 defects | 3.103192e-01 | 0.508 |
R-HSA-888590 | GABA synthesis, release, reuptake and degradation | 3.103192e-01 | 0.508 |
R-HSA-8863795 | Downregulation of ERBB2 signaling | 3.103192e-01 | 0.508 |
R-HSA-1474151 | Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | 3.103192e-01 | 0.508 |
R-HSA-193704 | p75 NTR receptor-mediated signalling | 3.135473e-01 | 0.504 |
R-HSA-5688426 | Deubiquitination | 3.155065e-01 | 0.501 |
R-HSA-211733 | Regulation of activated PAK-2p34 by proteasome mediated degradation | 3.174084e-01 | 0.498 |
R-HSA-399719 | Trafficking of AMPA receptors | 3.174084e-01 | 0.498 |
R-HSA-5694530 | Cargo concentration in the ER | 3.174084e-01 | 0.498 |
R-HSA-8963693 | Aspartate and asparagine metabolism | 3.174084e-01 | 0.498 |
R-HSA-5689880 | Ub-specific processing proteases | 3.176726e-01 | 0.498 |
R-HSA-983231 | Factors involved in megakaryocyte development and platelet production | 3.232864e-01 | 0.490 |
R-HSA-69190 | DNA strand elongation | 3.244251e-01 | 0.489 |
R-HSA-350562 | Regulation of ornithine decarboxylase (ODC) | 3.244251e-01 | 0.489 |
R-HSA-9675126 | Diseases of mitotic cell cycle | 3.244251e-01 | 0.489 |
R-HSA-5683057 | MAPK family signaling cascades | 3.284092e-01 | 0.484 |
R-HSA-176187 | Activation of ATR in response to replication stress | 3.313701e-01 | 0.480 |
R-HSA-1839124 | FGFR1 mutant receptor activation | 3.313701e-01 | 0.480 |
R-HSA-399721 | Glutamate binding, activation of AMPA receptors and synaptic plasticity | 3.313701e-01 | 0.480 |
R-HSA-5675482 | Regulation of necroptotic cell death | 3.313701e-01 | 0.480 |
R-HSA-416476 | G alpha (q) signalling events | 3.364134e-01 | 0.473 |
R-HSA-1482788 | Acyl chain remodelling of PC | 3.382441e-01 | 0.471 |
R-HSA-180534 | Vpu mediated degradation of CD4 | 3.382441e-01 | 0.471 |
R-HSA-8964539 | Glutamate and glutamine metabolism | 3.382441e-01 | 0.471 |
R-HSA-5223345 | Miscellaneous transport and binding events | 3.382441e-01 | 0.471 |
R-HSA-382551 | Transport of small molecules | 3.386199e-01 | 0.470 |
R-HSA-5673000 | RAF activation | 3.450479e-01 | 0.462 |
R-HSA-203615 | eNOS activation | 3.450479e-01 | 0.462 |
R-HSA-901042 | Calnexin/calreticulin cycle | 3.450479e-01 | 0.462 |
R-HSA-9680350 | Signaling by CSF1 (M-CSF) in myeloid cells | 3.450479e-01 | 0.462 |
R-HSA-75815 | Ubiquitin-dependent degradation of Cyclin D | 3.450479e-01 | 0.462 |
R-HSA-349425 | Autodegradation of the E3 ubiquitin ligase COP1 | 3.450479e-01 | 0.462 |
R-HSA-983170 | Antigen Presentation: Folding, assembly and peptide loading of class I MHC | 3.450479e-01 | 0.462 |
R-HSA-9734779 | Developmental Cell Lineages of the Integumentary System | 3.510331e-01 | 0.455 |
R-HSA-8854050 | FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | 3.517821e-01 | 0.454 |
R-HSA-174113 | SCF-beta-TrCP mediated degradation of Emi1 | 3.517821e-01 | 0.454 |
R-HSA-187687 | Signalling to ERKs | 3.517821e-01 | 0.454 |
R-HSA-1482839 | Acyl chain remodelling of PE | 3.517821e-01 | 0.454 |
R-HSA-169911 | Regulation of Apoptosis | 3.517821e-01 | 0.454 |
R-HSA-381042 | PERK regulates gene expression | 3.517821e-01 | 0.454 |
R-HSA-9772755 | Formation of WDR5-containing histone-modifying complexes | 3.517821e-01 | 0.454 |
R-HSA-9648025 | EML4 and NUDC in mitotic spindle formation | 3.547466e-01 | 0.450 |
R-HSA-432720 | Lysosome Vesicle Biogenesis | 3.584475e-01 | 0.446 |
R-HSA-74158 | RNA Polymerase III Transcription | 3.584475e-01 | 0.446 |
R-HSA-749476 | RNA Polymerase III Abortive And Retractive Initiation | 3.584475e-01 | 0.446 |
R-HSA-9682385 | FLT3 signaling in disease | 3.584475e-01 | 0.446 |
R-HSA-450408 | AUF1 (hnRNP D0) binds and destabilizes mRNA | 3.584475e-01 | 0.446 |
R-HSA-180585 | Vif-mediated degradation of APOBEC3G | 3.584475e-01 | 0.446 |
R-HSA-76002 | Platelet activation, signaling and aggregation | 3.597122e-01 | 0.444 |
R-HSA-4641258 | Degradation of DVL | 3.650448e-01 | 0.438 |
R-HSA-4641257 | Degradation of AXIN | 3.650448e-01 | 0.438 |
R-HSA-9762114 | GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | 3.650448e-01 | 0.438 |
R-HSA-3769402 | Deactivation of the beta-catenin transactivating complex | 3.650448e-01 | 0.438 |
R-HSA-392499 | Metabolism of proteins | 3.680659e-01 | 0.434 |
R-HSA-597592 | Post-translational protein modification | 3.705871e-01 | 0.431 |
R-HSA-202131 | Metabolism of nitric oxide: NOS3 activation and regulation | 3.715747e-01 | 0.430 |
R-HSA-5213460 | RIPK1-mediated regulated necrosis | 3.715747e-01 | 0.430 |
R-HSA-9929356 | GSK3B-mediated proteasomal degradation of PD-L1(CD274) | 3.780378e-01 | 0.422 |
R-HSA-1236978 | Cross-presentation of soluble exogenous antigens (endosomes) | 3.780378e-01 | 0.422 |
R-HSA-69541 | Stabilization of p53 | 3.780378e-01 | 0.422 |
R-HSA-71336 | Pentose phosphate pathway | 3.780378e-01 | 0.422 |
R-HSA-8964043 | Plasma lipoprotein clearance | 3.780378e-01 | 0.422 |
R-HSA-983168 | Antigen processing: Ubiquitination & Proteasome degradation | 3.783482e-01 | 0.422 |
R-HSA-8941858 | Regulation of RUNX3 expression and activity | 3.844348e-01 | 0.415 |
R-HSA-451927 | Interleukin-2 family signaling | 3.844348e-01 | 0.415 |
R-HSA-8953854 | Metabolism of RNA | 3.887681e-01 | 0.410 |
R-HSA-5218920 | VEGFR2 mediated vascular permeability | 3.907664e-01 | 0.408 |
R-HSA-9607240 | FLT3 Signaling | 3.907664e-01 | 0.408 |
R-HSA-9929491 | SPOP-mediated proteasomal degradation of PD-L1(CD274) | 3.907664e-01 | 0.408 |
R-HSA-5362768 | Hh mutants are degraded by ERAD | 3.907664e-01 | 0.408 |
R-HSA-73933 | Resolution of Abasic Sites (AP sites) | 3.907664e-01 | 0.408 |
R-HSA-5676590 | NIK-->noncanonical NF-kB signaling | 3.907664e-01 | 0.408 |
R-HSA-8853884 | Transcriptional Regulation by VENTX | 3.907664e-01 | 0.408 |
R-HSA-110313 | Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA templa... | 3.907664e-01 | 0.408 |
R-HSA-2980736 | Peptide hormone metabolism | 3.914367e-01 | 0.407 |
R-HSA-174417 | Telomere C-strand (Lagging Strand) Synthesis | 3.970333e-01 | 0.401 |
R-HSA-9932298 | Degradation of CRY and PER proteins | 3.970333e-01 | 0.401 |
R-HSA-5610780 | Degradation of GLI1 by the proteasome | 3.970333e-01 | 0.401 |
R-HSA-3000480 | Scavenging by Class A Receptors | 3.970333e-01 | 0.401 |
R-HSA-5610785 | GLI3 is processed to GLI3R by the proteasome | 3.970333e-01 | 0.401 |
R-HSA-5610783 | Degradation of GLI2 by the proteasome | 3.970333e-01 | 0.401 |
R-HSA-5675221 | Negative regulation of MAPK pathway | 3.970333e-01 | 0.401 |
R-HSA-5655302 | Signaling by FGFR1 in disease | 3.970333e-01 | 0.401 |
R-HSA-5663205 | Infectious disease | 4.028869e-01 | 0.395 |
R-HSA-165159 | MTOR signalling | 4.032361e-01 | 0.394 |
R-HSA-73886 | Chromosome Maintenance | 4.058568e-01 | 0.392 |
R-HSA-2500257 | Resolution of Sister Chromatid Cohesion | 4.058568e-01 | 0.392 |
R-HSA-5387390 | Hh mutants abrogate ligand secretion | 4.093755e-01 | 0.388 |
R-HSA-1433557 | Signaling by SCF-KIT | 4.093755e-01 | 0.388 |
R-HSA-2173789 | TGF-beta receptor signaling activates SMADs | 4.093755e-01 | 0.388 |
R-HSA-2132295 | MHC class II antigen presentation | 4.130059e-01 | 0.384 |
R-HSA-9907900 | Proteasome assembly | 4.154521e-01 | 0.381 |
R-HSA-2142691 | Synthesis of Leukotrienes (LT) and Eoxins (EX) | 4.154521e-01 | 0.381 |
R-HSA-187577 | SCF(Skp2)-mediated degradation of p27/p21 | 4.154521e-01 | 0.381 |
R-HSA-373752 | Netrin-1 signaling | 4.154521e-01 | 0.381 |
R-HSA-5683826 | Surfactant metabolism | 4.154521e-01 | 0.381 |
R-HSA-774815 | Nucleosome assembly | 4.214666e-01 | 0.375 |
R-HSA-606279 | Deposition of new CENPA-containing nucleosomes at the centromere | 4.214666e-01 | 0.375 |
R-HSA-9824585 | Regulation of MITF-M-dependent genes involved in pigmentation | 4.214666e-01 | 0.375 |
R-HSA-4608870 | Asymmetric localization of PCP proteins | 4.214666e-01 | 0.375 |
R-HSA-5607761 | Dectin-1 mediated noncanonical NF-kB signaling | 4.214666e-01 | 0.375 |
R-HSA-2453902 | The canonical retinoid cycle in rods (twilight vision) | 4.214666e-01 | 0.375 |
R-HSA-69601 | Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | 4.214666e-01 | 0.375 |
R-HSA-69613 | p53-Independent G1/S DNA Damage Checkpoint | 4.214666e-01 | 0.375 |
R-HSA-9824272 | Somitogenesis | 4.214666e-01 | 0.375 |
R-HSA-1614558 | Degradation of cysteine and homocysteine | 4.214666e-01 | 0.375 |
R-HSA-69206 | G1/S Transition | 4.236498e-01 | 0.373 |
R-HSA-72695 | Formation of the ternary complex, and subsequently, the 43S complex | 4.274195e-01 | 0.369 |
R-HSA-5357905 | Regulation of TNFR1 signaling | 4.274195e-01 | 0.369 |
R-HSA-9664424 | Cell recruitment (pro-inflammatory response) | 4.274195e-01 | 0.369 |
R-HSA-9660826 | Purinergic signaling in leishmaniasis infection | 4.274195e-01 | 0.369 |
R-HSA-114608 | Platelet degranulation | 4.306907e-01 | 0.366 |
R-HSA-425407 | SLC-mediated transmembrane transport | 4.320825e-01 | 0.364 |
R-HSA-5693571 | Nonhomologous End-Joining (NHEJ) | 4.391433e-01 | 0.357 |
R-HSA-532668 | N-glycan trimming in the ER and Calnexin/Calreticulin cycle | 4.449154e-01 | 0.352 |
R-HSA-9766229 | Degradation of CDH1 | 4.449154e-01 | 0.352 |
R-HSA-389661 | Glyoxylate metabolism and glycine degradation | 4.449154e-01 | 0.352 |
R-HSA-69580 | p53-Dependent G1/S DNA damage checkpoint | 4.449154e-01 | 0.352 |
R-HSA-69563 | p53-Dependent G1 DNA Damage Response | 4.449154e-01 | 0.352 |
R-HSA-5658442 | Regulation of RAS by GAPs | 4.506285e-01 | 0.346 |
R-HSA-109704 | PI3K Cascade | 4.506285e-01 | 0.346 |
R-HSA-76005 | Response to elevated platelet cytosolic Ca2+ | 4.549696e-01 | 0.342 |
R-HSA-1169091 | Activation of NF-kappaB in B cells | 4.562831e-01 | 0.341 |
R-HSA-1234176 | Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | 4.562831e-01 | 0.341 |
R-HSA-5358346 | Hedgehog ligand biogenesis | 4.562831e-01 | 0.341 |
R-HSA-212436 | Generic Transcription Pathway | 4.564472e-01 | 0.341 |
R-HSA-72187 | mRNA 3'-end processing | 4.618799e-01 | 0.335 |
R-HSA-68949 | Orc1 removal from chromatin | 4.618799e-01 | 0.335 |
R-HSA-9931269 | AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | 4.618799e-01 | 0.335 |
R-HSA-6794361 | Neurexins and neuroligins | 4.618799e-01 | 0.335 |
R-HSA-5250924 | B-WICH complex positively regulates rRNA expression | 4.674194e-01 | 0.330 |
R-HSA-8948751 | Regulation of PTEN stability and activity | 4.674194e-01 | 0.330 |
R-HSA-9018519 | Estrogen-dependent gene expression | 4.685771e-01 | 0.329 |
R-HSA-5173105 | O-linked glycosylation | 4.719475e-01 | 0.326 |
R-HSA-9820952 | Respiratory Syncytial Virus Infection Pathway | 4.719475e-01 | 0.326 |
R-HSA-72649 | Translation initiation complex formation | 4.729022e-01 | 0.325 |
R-HSA-9754678 | SARS-CoV-2 modulates host translation machinery | 4.729022e-01 | 0.325 |
R-HSA-6811436 | COPI-independent Golgi-to-ER retrograde traffic | 4.783289e-01 | 0.320 |
R-HSA-75893 | TNF signaling | 4.837001e-01 | 0.315 |
R-HSA-193648 | NRAGE signals death through JNK | 4.837001e-01 | 0.315 |
R-HSA-1632852 | Macroautophagy | 4.853011e-01 | 0.314 |
R-HSA-3247509 | Chromatin modifying enzymes | 4.874069e-01 | 0.312 |
R-HSA-112399 | IRS-mediated signalling | 4.890162e-01 | 0.311 |
R-HSA-5621480 | Dectin-2 family | 4.890162e-01 | 0.311 |
R-HSA-74160 | Gene expression (Transcription) | 4.894537e-01 | 0.310 |
R-HSA-9705671 | SARS-CoV-2 activates/modulates innate and adaptive immune responses | 4.918996e-01 | 0.308 |
R-HSA-72662 | Activation of the mRNA upon binding of the cap-binding complex and eIFs, and sub... | 4.942780e-01 | 0.306 |
R-HSA-194441 | Metabolism of non-coding RNA | 4.994860e-01 | 0.301 |
R-HSA-191859 | snRNP Assembly | 4.994860e-01 | 0.301 |
R-HSA-5693565 | Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at... | 4.994860e-01 | 0.301 |
R-HSA-180786 | Extension of Telomeres | 4.994860e-01 | 0.301 |
R-HSA-9845323 | Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | 5.046406e-01 | 0.297 |
R-HSA-1227986 | Signaling by ERBB2 | 5.046406e-01 | 0.297 |
R-HSA-351202 | Metabolism of polyamines | 5.046406e-01 | 0.297 |
R-HSA-73857 | RNA Polymerase II Transcription | 5.047338e-01 | 0.297 |
R-HSA-453279 | Mitotic G1 phase and G1/S transition | 5.049368e-01 | 0.297 |
R-HSA-73856 | RNA Polymerase II Transcription Termination | 5.097424e-01 | 0.293 |
R-HSA-8939902 | Regulation of RUNX2 expression and activity | 5.097424e-01 | 0.293 |
R-HSA-2428928 | IRS-related events triggered by IGF1R | 5.097424e-01 | 0.293 |
R-HSA-9793380 | Formation of paraxial mesoderm | 5.097424e-01 | 0.293 |
R-HSA-9758941 | Gastrulation | 5.145727e-01 | 0.289 |
R-HSA-2173782 | Binding and Uptake of Ligands by Scavenger Receptors | 5.177573e-01 | 0.286 |
R-HSA-6790901 | rRNA modification in the nucleus and cytosol | 5.197899e-01 | 0.284 |
R-HSA-69615 | G1/S DNA Damage Checkpoints | 5.197899e-01 | 0.284 |
R-HSA-9006927 | Signaling by Non-Receptor Tyrosine Kinases | 5.197899e-01 | 0.284 |
R-HSA-8848021 | Signaling by PTK6 | 5.197899e-01 | 0.284 |
R-HSA-168643 | Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signali... | 5.247367e-01 | 0.280 |
R-HSA-2428924 | IGF1R signaling cascade | 5.247367e-01 | 0.280 |
R-HSA-74751 | Insulin receptor signalling cascade | 5.247367e-01 | 0.280 |
R-HSA-4839726 | Chromatin organization | 5.256556e-01 | 0.279 |
R-HSA-2404192 | Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | 5.296327e-01 | 0.276 |
R-HSA-1234174 | Cellular response to hypoxia | 5.296327e-01 | 0.276 |
R-HSA-9909649 | Regulation of PD-L1(CD274) transcription | 5.344787e-01 | 0.272 |
R-HSA-5693606 | DNA Double Strand Break Response | 5.392750e-01 | 0.268 |
R-HSA-9610379 | HCMV Late Events | 5.396605e-01 | 0.268 |
R-HSA-8936459 | RUNX1 regulates genes involved in megakaryocyte differentiation and platelet fun... | 5.440222e-01 | 0.264 |
R-HSA-5218859 | Regulated Necrosis | 5.440222e-01 | 0.264 |
R-HSA-1280218 | Adaptive Immune System | 5.441391e-01 | 0.264 |
R-HSA-5633007 | Regulation of TP53 Activity | 5.488367e-01 | 0.261 |
R-HSA-1168372 | Downstream signaling events of B Cell Receptor (BCR) | 5.533712e-01 | 0.257 |
R-HSA-69202 | Cyclin E associated events during G1/S transition | 5.533712e-01 | 0.257 |
R-HSA-195253 | Degradation of beta-catenin by the destruction complex | 5.533712e-01 | 0.257 |
R-HSA-1834949 | Cytosolic sensors of pathogen-associated DNA | 5.533712e-01 | 0.257 |
R-HSA-5250913 | Positive epigenetic regulation of rRNA expression | 5.579740e-01 | 0.253 |
R-HSA-3000178 | ECM proteoglycans | 5.579740e-01 | 0.253 |
R-HSA-8978934 | Metabolism of cofactors | 5.579740e-01 | 0.253 |
R-HSA-5632684 | Hedgehog 'on' state | 5.579740e-01 | 0.253 |
R-HSA-69656 | Cyclin A:Cdk2-associated events at S phase entry | 5.625297e-01 | 0.250 |
R-HSA-159236 | Transport of Mature mRNA derived from an Intron-Containing Transcript | 5.670387e-01 | 0.246 |
R-HSA-112316 | Neuronal System | 5.694554e-01 | 0.245 |
R-HSA-5619102 | SLC transporter disorders | 5.697492e-01 | 0.244 |
R-HSA-1226099 | Signaling by FGFR in disease | 5.715014e-01 | 0.243 |
R-HSA-9711123 | Cellular response to chemical stress | 5.717834e-01 | 0.243 |
R-HSA-5621481 | C-type lectin receptors (CLRs) | 5.842556e-01 | 0.233 |
R-HSA-9909648 | Regulation of PD-L1(CD274) expression | 5.871136e-01 | 0.231 |
R-HSA-216083 | Integrin cell surface interactions | 5.889000e-01 | 0.230 |
R-HSA-4086400 | PCP/CE pathway | 5.889000e-01 | 0.230 |
R-HSA-9925561 | Developmental Lineage of Pancreatic Acinar Cells | 5.931387e-01 | 0.227 |
R-HSA-72203 | Processing of Capped Intron-Containing Pre-mRNA | 5.972000e-01 | 0.224 |
R-HSA-9856530 | High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR... | 5.973340e-01 | 0.224 |
R-HSA-9833482 | PKR-mediated signaling | 5.973340e-01 | 0.224 |
R-HSA-6806834 | Signaling by MET | 5.973340e-01 | 0.224 |
R-HSA-72202 | Transport of Mature Transcript to Cytoplasm | 6.055961e-01 | 0.218 |
R-HSA-168255 | Influenza Infection | 6.067145e-01 | 0.217 |
R-HSA-5668541 | TNFR2 non-canonical NF-kB pathway | 6.096637e-01 | 0.215 |
R-HSA-8939236 | RUNX1 regulates transcription of genes involved in differentiation of HSCs | 6.136897e-01 | 0.212 |
R-HSA-201681 | TCF dependent signaling in response to WNT | 6.175968e-01 | 0.209 |
R-HSA-6794362 | Protein-protein interactions at synapses | 6.176743e-01 | 0.209 |
R-HSA-5687128 | MAPK6/MAPK4 signaling | 6.176743e-01 | 0.209 |
R-HSA-3781865 | Diseases of glycosylation | 6.202812e-01 | 0.207 |
R-HSA-9909615 | Regulation of PD-L1(CD274) Post-translational modification | 6.216181e-01 | 0.206 |
R-HSA-1614635 | Sulfur amino acid metabolism | 6.255215e-01 | 0.204 |
R-HSA-70268 | Pyruvate metabolism | 6.293848e-01 | 0.201 |
R-HSA-112310 | Neurotransmitter release cycle | 6.407387e-01 | 0.193 |
R-HSA-73884 | Base Excision Repair | 6.407387e-01 | 0.193 |
R-HSA-202424 | Downstream TCR signaling | 6.407387e-01 | 0.193 |
R-HSA-6785807 | Interleukin-4 and Interleukin-13 signaling | 6.412388e-01 | 0.193 |
R-HSA-72163 | mRNA Splicing - Major Pathway | 6.463348e-01 | 0.190 |
R-HSA-174824 | Plasma lipoprotein assembly, remodeling, and clearance | 6.517468e-01 | 0.186 |
R-HSA-2219530 | Constitutive Signaling by Aberrant PI3K in Cancer | 6.588986e-01 | 0.181 |
R-HSA-389948 | Co-inhibition by PD-1 | 6.612816e-01 | 0.180 |
R-HSA-9954709 | Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | 6.659044e-01 | 0.177 |
R-HSA-2454202 | Fc epsilon receptor (FCERI) signaling | 6.685642e-01 | 0.175 |
R-HSA-1483206 | Glycerophospholipid biosynthesis | 6.685642e-01 | 0.175 |
R-HSA-2730905 | Role of LAT2/NTAL/LAB on calcium mobilization | 6.693534e-01 | 0.174 |
R-HSA-5607764 | CLEC7A (Dectin-1) signaling | 6.693534e-01 | 0.174 |
R-HSA-157579 | Telomere Maintenance | 6.727671e-01 | 0.172 |
R-HSA-8878159 | Transcriptional regulation by RUNX3 | 6.727671e-01 | 0.172 |
R-HSA-170834 | Signaling by TGF-beta Receptor Complex | 6.727671e-01 | 0.172 |
R-HSA-72172 | mRNA Splicing | 6.733492e-01 | 0.172 |
R-HSA-8957275 | Post-translational protein phosphorylation | 6.761458e-01 | 0.170 |
R-HSA-422356 | Regulation of insulin secretion | 6.761458e-01 | 0.170 |
R-HSA-3214847 | HATs acetylate histones | 6.794897e-01 | 0.168 |
R-HSA-5610787 | Hedgehog 'off' state | 6.827994e-01 | 0.166 |
R-HSA-72766 | Translation | 6.843291e-01 | 0.165 |
R-HSA-9009391 | Extra-nuclear estrogen signaling | 6.860750e-01 | 0.164 |
R-HSA-9020702 | Interleukin-1 signaling | 6.860750e-01 | 0.164 |
R-HSA-9842860 | Regulation of endogenous retroelements | 6.893171e-01 | 0.162 |
R-HSA-3371453 | Regulation of HSF1-mediated heat shock response | 6.893171e-01 | 0.162 |
R-HSA-9633012 | Response of EIF2AK4 (GCN2) to amino acid deficiency | 6.957017e-01 | 0.158 |
R-HSA-5617472 | Activation of anterior HOX genes in hindbrain development during early embryogen... | 6.988449e-01 | 0.156 |
R-HSA-5619507 | Activation of HOX genes during differentiation | 6.988449e-01 | 0.156 |
R-HSA-211000 | Gene Silencing by RNA | 7.080822e-01 | 0.150 |
R-HSA-156827 | L13a-mediated translational silencing of Ceruloplasmin expression | 7.110983e-01 | 0.148 |
R-HSA-388396 | GPCR downstream signalling | 7.163614e-01 | 0.145 |
R-HSA-202403 | TCR signaling | 7.170379e-01 | 0.144 |
R-HSA-109582 | Hemostasis | 7.283629e-01 | 0.138 |
R-HSA-381426 | Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-l... | 7.313610e-01 | 0.136 |
R-HSA-909733 | Interferon alpha/beta signaling | 7.368864e-01 | 0.133 |
R-HSA-8939211 | ESR-mediated signaling | 7.444769e-01 | 0.128 |
R-HSA-2219528 | PI3K/AKT Signaling in Cancer | 7.449634e-01 | 0.128 |
R-HSA-8878166 | Transcriptional regulation by RUNX2 | 7.476005e-01 | 0.126 |
R-HSA-6811558 | PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | 7.578809e-01 | 0.120 |
R-HSA-162909 | Host Interactions of HIV factors | 7.603852e-01 | 0.119 |
R-HSA-977606 | Regulation of Complement cascade | 7.628639e-01 | 0.118 |
R-HSA-9851695 | Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | 7.653170e-01 | 0.116 |
R-HSA-9841922 | MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesi... | 7.653170e-01 | 0.116 |
R-HSA-9818564 | Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | 7.653170e-01 | 0.116 |
R-HSA-9609646 | HCMV Infection | 7.686579e-01 | 0.114 |
R-HSA-199418 | Negative regulation of the PI3K/AKT network | 7.772094e-01 | 0.109 |
R-HSA-388841 | Regulation of T cell activation by CD28 family | 7.791357e-01 | 0.108 |
R-HSA-9909396 | Circadian clock | 7.840553e-01 | 0.106 |
R-HSA-3858494 | Beta-catenin independent WNT signaling | 7.950035e-01 | 0.100 |
R-HSA-163685 | Integration of energy metabolism | 7.950035e-01 | 0.100 |
R-HSA-9824439 | Bacterial Infection Pathways | 7.983279e-01 | 0.098 |
R-HSA-9948299 | Ribosome-associated quality control | 7.992267e-01 | 0.097 |
R-HSA-5358351 | Signaling by Hedgehog | 7.992267e-01 | 0.097 |
R-HSA-6807070 | PTEN Regulation | 8.013057e-01 | 0.096 |
R-HSA-372790 | Signaling by GPCR | 8.054508e-01 | 0.094 |
R-HSA-2871837 | FCERI mediated NF-kB activation | 8.133381e-01 | 0.090 |
R-HSA-211945 | Phase I - Functionalization of compounds | 8.140918e-01 | 0.089 |
R-HSA-166658 | Complement cascade | 8.152719e-01 | 0.089 |
R-HSA-2187338 | Visual phototransduction | 8.190799e-01 | 0.087 |
R-HSA-9856651 | MITF-M-dependent gene expression | 8.246460e-01 | 0.084 |
R-HSA-9010553 | Regulation of expression of SLITs and ROBOs | 8.282619e-01 | 0.082 |
R-HSA-2142753 | Arachidonate metabolism | 8.282619e-01 | 0.082 |
R-HSA-446652 | Interleukin-1 family signaling | 8.282619e-01 | 0.082 |
R-HSA-9609507 | Protein localization | 8.300419e-01 | 0.081 |
R-HSA-9917777 | Epigenetic regulation by WDR5-containing histone modifying complexes | 8.318036e-01 | 0.080 |
R-HSA-1169410 | Antiviral mechanism by IFN-stimulated genes | 8.318036e-01 | 0.080 |
R-HSA-168273 | Influenza Viral RNA Transcription and Replication | 8.335472e-01 | 0.079 |
R-HSA-1483257 | Phospholipid metabolism | 8.376495e-01 | 0.077 |
R-HSA-1257604 | PIP3 activates AKT signaling | 8.376495e-01 | 0.077 |
R-HSA-9711097 | Cellular response to starvation | 8.386708e-01 | 0.076 |
R-HSA-983705 | Signaling by the B Cell Receptor (BCR) | 8.386708e-01 | 0.076 |
R-HSA-877300 | Interferon gamma signaling | 8.403436e-01 | 0.076 |
R-HSA-195721 | Signaling by WNT | 8.415172e-01 | 0.075 |
R-HSA-9006936 | Signaling by TGFB family members | 8.419991e-01 | 0.075 |
R-HSA-211897 | Cytochrome P450 - arranged by substrate type | 8.531197e-01 | 0.069 |
R-HSA-9662851 | Anti-inflammatory response favouring Leishmania parasite infection | 8.634621e-01 | 0.064 |
R-HSA-9664433 | Leishmania parasite growth and survival | 8.634621e-01 | 0.064 |
R-HSA-611105 | Respiratory electron transport | 8.704031e-01 | 0.060 |
R-HSA-212165 | Epigenetic regulation of gene expression | 8.706489e-01 | 0.060 |
R-HSA-8868773 | rRNA processing in the nucleus and cytosol | 8.832502e-01 | 0.054 |
R-HSA-1428517 | Aerobic respiration and respiratory electron transport | 8.885014e-01 | 0.051 |
R-HSA-9006925 | Intracellular signaling by second messengers | 8.894234e-01 | 0.051 |
R-HSA-71291 | Metabolism of amino acids and derivatives | 8.987209e-01 | 0.046 |
R-HSA-376176 | Signaling by ROBO receptors | 9.001852e-01 | 0.046 |
R-HSA-9006931 | Signaling by Nuclear Receptors | 9.072308e-01 | 0.042 |
R-HSA-913531 | Interferon Signaling | 9.223419e-01 | 0.035 |
R-HSA-72312 | rRNA processing | 9.270746e-01 | 0.033 |
R-HSA-202733 | Cell surface interactions at the vascular wall | 9.307955e-01 | 0.031 |
R-HSA-5668914 | Diseases of metabolism | 9.468403e-01 | 0.024 |
R-HSA-211859 | Biological oxidations | 9.773434e-01 | 0.010 |
R-HSA-9709957 | Sensory Perception | 9.777377e-01 | 0.010 |
R-HSA-196854 | Metabolism of vitamins and cofactors | 9.818027e-01 | 0.008 |
R-HSA-8978868 | Fatty acid metabolism | 9.885732e-01 | 0.005 |
R-HSA-71387 | Metabolism of carbohydrates and carbohydrate derivatives | 9.931321e-01 | 0.003 |
R-HSA-556833 | Metabolism of lipids | 9.999867e-01 | 0.000 |
R-HSA-1430728 | Metabolism | 1.000000e+00 | 0.000 |
Download
kinase | JSD_mean | pearson_surrounding | kinase_max_IC_position | max_position_JSD |
---|---|---|---|---|
GAK |
0.820 | -0.041 | 1 | 0.716 |
TTK |
0.819 | 0.062 | -2 | 0.775 |
PKR |
0.817 | 0.029 | 1 | 0.727 |
ALK4 |
0.817 | 0.156 | -2 | 0.791 |
MST1 |
0.817 | 0.031 | 1 | 0.711 |
BRAF |
0.816 | 0.041 | -4 | 0.742 |
ALK2 |
0.815 | 0.221 | -2 | 0.781 |
TAK1 |
0.815 | -0.021 | 1 | 0.728 |
MST2 |
0.814 | 0.017 | 1 | 0.722 |
TNIK |
0.814 | 0.034 | 3 | 0.872 |
ALPHAK3 |
0.814 | 0.068 | -1 | 0.713 |
EEF2K |
0.814 | 0.033 | 3 | 0.851 |
GCK |
0.813 | 0.024 | 1 | 0.733 |
MINK |
0.812 | 0.003 | 1 | 0.714 |
VRK2 |
0.809 | -0.254 | 1 | 0.745 |
LRRK2 |
0.809 | -0.121 | 2 | 0.866 |
BMPR1B |
0.809 | 0.219 | 1 | 0.767 |
TGFBR1 |
0.809 | 0.180 | -2 | 0.772 |
CAMKK1 |
0.809 | 0.054 | -2 | 0.758 |
BMPR2 |
0.809 | 0.001 | -2 | 0.806 |
NIK |
0.809 | -0.012 | -3 | 0.847 |
MEK1 |
0.808 | -0.084 | 2 | 0.854 |
NEK1 |
0.808 | -0.055 | 1 | 0.695 |
OSR1 |
0.807 | -0.019 | 2 | 0.805 |
KHS1 |
0.806 | 0.024 | 1 | 0.725 |
CAMKK2 |
0.805 | 0.004 | -2 | 0.746 |
TAO2 |
0.805 | -0.066 | 2 | 0.861 |
KHS2 |
0.805 | 0.043 | 1 | 0.739 |
ASK1 |
0.805 | -0.107 | 1 | 0.670 |
HGK |
0.805 | -0.028 | 3 | 0.873 |
MEKK2 |
0.805 | -0.061 | 2 | 0.822 |
VRK1 |
0.804 | -0.196 | 2 | 0.847 |
NEK5 |
0.804 | -0.072 | 1 | 0.708 |
MYO3A |
0.804 | -0.029 | 1 | 0.699 |
BIKE |
0.804 | -0.026 | 1 | 0.596 |
ACVR2B |
0.803 | 0.150 | -2 | 0.792 |
LATS1 |
0.803 | 0.066 | -3 | 0.829 |
NEK8 |
0.803 | -0.042 | 2 | 0.840 |
HPK1 |
0.803 | 0.005 | 1 | 0.741 |
BMPR1A |
0.803 | 0.220 | 1 | 0.750 |
ACVR2A |
0.803 | 0.143 | -2 | 0.781 |
DLK |
0.803 | -0.034 | 1 | 0.733 |
MEK5 |
0.802 | -0.181 | 2 | 0.844 |
LKB1 |
0.802 | -0.041 | -3 | 0.785 |
PLK1 |
0.802 | 0.130 | -2 | 0.792 |
MOS |
0.802 | 0.054 | 1 | 0.790 |
CAMK1B |
0.801 | 0.034 | -3 | 0.815 |
TAO3 |
0.801 | -0.051 | 1 | 0.705 |
ZAK |
0.800 | -0.034 | 1 | 0.680 |
PRPK |
0.800 | -0.016 | -1 | 0.756 |
DAPK2 |
0.800 | -0.075 | -3 | 0.818 |
MYO3B |
0.800 | -0.052 | 2 | 0.823 |
ANKRD3 |
0.800 | -0.075 | 1 | 0.747 |
CAMLCK |
0.800 | -0.037 | -2 | 0.736 |
YSK4 |
0.799 | -0.008 | 1 | 0.700 |
STLK3 |
0.799 | -0.112 | 1 | 0.644 |
PDK1 |
0.799 | -0.098 | 1 | 0.743 |
MST3 |
0.798 | -0.027 | 2 | 0.825 |
MAP3K15 |
0.798 | -0.131 | 1 | 0.671 |
PASK |
0.798 | -0.000 | -3 | 0.806 |
MEKK3 |
0.798 | -0.040 | 1 | 0.704 |
NEK4 |
0.797 | -0.061 | 1 | 0.693 |
GRK6 |
0.797 | 0.161 | 1 | 0.788 |
MEKK1 |
0.795 | -0.113 | 1 | 0.681 |
NEK11 |
0.795 | -0.114 | 1 | 0.723 |
PLK3 |
0.794 | 0.170 | 2 | 0.870 |
YSK1 |
0.794 | -0.085 | 2 | 0.805 |
MEK2 |
0.794 | -0.166 | 2 | 0.818 |
COT |
0.794 | 0.214 | 2 | 0.895 |
PERK |
0.793 | -0.027 | -2 | 0.803 |
JNK2 |
0.793 | 0.048 | 1 | 0.539 |
LOK |
0.793 | -0.037 | -2 | 0.687 |
PBK |
0.792 | -0.068 | 1 | 0.619 |
CAMK2G |
0.792 | 0.117 | 2 | 0.879 |
NLK |
0.792 | -0.002 | 1 | 0.723 |
RAF1 |
0.791 | 0.044 | 1 | 0.775 |
DAPK3 |
0.791 | -0.033 | -3 | 0.758 |
JNK3 |
0.791 | 0.030 | 1 | 0.575 |
MEKK6 |
0.791 | -0.170 | 1 | 0.668 |
AAK1 |
0.791 | -0.012 | 1 | 0.499 |
DMPK1 |
0.791 | -0.004 | -3 | 0.711 |
SMMLCK |
0.790 | -0.056 | -3 | 0.758 |
HRI |
0.790 | -0.052 | -2 | 0.799 |
GRK7 |
0.789 | 0.076 | 1 | 0.747 |
MLK2 |
0.789 | -0.106 | 2 | 0.828 |
CDKL1 |
0.788 | -0.032 | -3 | 0.743 |
ROCK2 |
0.788 | -0.007 | -3 | 0.740 |
TSSK2 |
0.788 | 0.042 | -5 | 0.886 |
SKMLCK |
0.787 | -0.004 | -2 | 0.702 |
PLK2 |
0.786 | 0.185 | -3 | 0.843 |
TLK1 |
0.786 | 0.010 | -2 | 0.762 |
CHK1 |
0.786 | 0.048 | -3 | 0.806 |
PIM1 |
0.786 | 0.061 | -3 | 0.742 |
DSTYK |
0.786 | 0.150 | 2 | 0.891 |
ATR |
0.786 | -0.088 | 1 | 0.710 |
CHAK2 |
0.786 | 0.007 | -1 | 0.782 |
SLK |
0.785 | -0.041 | -2 | 0.634 |
MLK1 |
0.785 | -0.024 | 2 | 0.828 |
ERK5 |
0.785 | 0.045 | 1 | 0.698 |
PKN3 |
0.785 | 0.038 | -3 | 0.764 |
PRP4 |
0.784 | -0.027 | -3 | 0.720 |
MLK4 |
0.783 | 0.016 | 2 | 0.776 |
GRK5 |
0.783 | -0.038 | -3 | 0.858 |
ICK |
0.783 | -0.064 | -3 | 0.774 |
DCAMKL2 |
0.783 | 0.040 | -3 | 0.761 |
P38A |
0.782 | -0.015 | 1 | 0.604 |
CLK3 |
0.782 | 0.127 | 1 | 0.739 |
TLK2 |
0.781 | -0.053 | 1 | 0.674 |
P38B |
0.781 | 0.000 | 1 | 0.559 |
MPSK1 |
0.781 | -0.128 | 1 | 0.638 |
MLK3 |
0.781 | 0.027 | 2 | 0.781 |
DCAMKL1 |
0.780 | -0.012 | -3 | 0.743 |
NEK9 |
0.780 | -0.089 | 2 | 0.837 |
DAPK1 |
0.780 | -0.037 | -3 | 0.733 |
TAO1 |
0.779 | -0.100 | 1 | 0.639 |
PDHK4 |
0.779 | -0.120 | 1 | 0.770 |
PIM3 |
0.779 | 0.036 | -3 | 0.797 |
DRAK1 |
0.779 | -0.001 | 1 | 0.740 |
ERK2 |
0.778 | -0.005 | 1 | 0.590 |
CDC7 |
0.778 | 0.077 | 1 | 0.792 |
BUB1 |
0.778 | 0.036 | -5 | 0.859 |
PKCD |
0.778 | 0.006 | 2 | 0.824 |
GRK2 |
0.777 | 0.007 | -2 | 0.632 |
MRCKA |
0.777 | 0.009 | -3 | 0.716 |
MASTL |
0.777 | -0.198 | -2 | 0.726 |
ROCK1 |
0.776 | -0.017 | -3 | 0.709 |
IRAK4 |
0.776 | -0.094 | 1 | 0.681 |
PIM2 |
0.776 | 0.013 | -3 | 0.689 |
PDHK1 |
0.775 | -0.104 | 1 | 0.755 |
AMPKA1 |
0.775 | -0.045 | -3 | 0.804 |
PKN2 |
0.775 | 0.010 | -3 | 0.791 |
TGFBR2 |
0.775 | 0.043 | -2 | 0.777 |
WNK4 |
0.775 | -0.118 | -2 | 0.716 |
CAMK2B |
0.774 | 0.128 | 2 | 0.844 |
P70S6KB |
0.774 | 0.004 | -3 | 0.752 |
PINK1 |
0.774 | -0.111 | 1 | 0.691 |
RIPK3 |
0.773 | -0.057 | 3 | 0.784 |
DNAPK |
0.772 | 0.026 | 1 | 0.650 |
ATM |
0.772 | 0.020 | 1 | 0.670 |
WNK1 |
0.772 | -0.045 | -2 | 0.717 |
P38G |
0.772 | 0.002 | 1 | 0.477 |
HUNK |
0.772 | -0.066 | 2 | 0.855 |
HASPIN |
0.771 | -0.043 | -1 | 0.627 |
NEK2 |
0.771 | -0.102 | 2 | 0.814 |
RIPK1 |
0.771 | -0.169 | 1 | 0.719 |
TBK1 |
0.771 | 0.043 | 1 | 0.690 |
CDK5 |
0.770 | 0.007 | 1 | 0.586 |
IRE2 |
0.770 | -0.011 | 2 | 0.787 |
MRCKB |
0.770 | -0.012 | -3 | 0.688 |
CHAK1 |
0.770 | -0.080 | 2 | 0.790 |
NUAK2 |
0.770 | -0.041 | -3 | 0.783 |
CRIK |
0.770 | -0.016 | -3 | 0.642 |
TSSK1 |
0.769 | -0.029 | -3 | 0.812 |
P38D |
0.769 | 0.023 | 1 | 0.468 |
CAMK2D |
0.769 | 0.010 | -3 | 0.793 |
NEK7 |
0.769 | -0.050 | -3 | 0.798 |
PAK1 |
0.768 | 0.013 | -2 | 0.660 |
CAMK1D |
0.768 | 0.015 | -3 | 0.633 |
MST4 |
0.768 | -0.009 | 2 | 0.826 |
TTBK2 |
0.768 | -0.012 | 2 | 0.825 |
NEK6 |
0.768 | 0.020 | -2 | 0.784 |
GRK1 |
0.768 | 0.083 | -2 | 0.681 |
JNK1 |
0.768 | 0.010 | 1 | 0.544 |
CDK1 |
0.768 | 0.018 | 1 | 0.561 |
MYLK4 |
0.767 | -0.027 | -2 | 0.653 |
ULK2 |
0.767 | -0.096 | 2 | 0.834 |
NEK3 |
0.767 | -0.176 | 1 | 0.638 |
PAK2 |
0.766 | -0.042 | -2 | 0.656 |
CAMK4 |
0.766 | -0.029 | -3 | 0.784 |
CDKL5 |
0.765 | -0.037 | -3 | 0.725 |
MTOR |
0.765 | -0.098 | 1 | 0.729 |
CDK2 |
0.765 | 0.009 | 1 | 0.641 |
HIPK1 |
0.764 | -0.030 | 1 | 0.618 |
GSK3B |
0.764 | -0.056 | 4 | 0.315 |
SGK3 |
0.764 | -0.018 | -3 | 0.706 |
RSK2 |
0.764 | 0.030 | -3 | 0.716 |
AMPKA2 |
0.764 | -0.044 | -3 | 0.772 |
CAMK2A |
0.764 | 0.054 | 2 | 0.837 |
ERK7 |
0.764 | -0.002 | 2 | 0.561 |
IKKE |
0.763 | 0.038 | 1 | 0.690 |
IRE1 |
0.763 | -0.081 | 1 | 0.676 |
WNK3 |
0.762 | -0.147 | 1 | 0.713 |
MELK |
0.762 | -0.043 | -3 | 0.752 |
STK33 |
0.762 | -0.019 | 2 | 0.775 |
PKCH |
0.762 | -0.032 | 2 | 0.759 |
AKT2 |
0.762 | -0.009 | -3 | 0.627 |
GSK3A |
0.762 | -0.037 | 4 | 0.332 |
IKKB |
0.761 | 0.043 | -2 | 0.709 |
ERK1 |
0.761 | -0.021 | 1 | 0.543 |
GRK4 |
0.761 | -0.016 | -2 | 0.722 |
CDK14 |
0.761 | -0.022 | 1 | 0.564 |
MARK4 |
0.761 | -0.100 | 4 | 0.565 |
MOK |
0.761 | -0.014 | 1 | 0.634 |
P90RSK |
0.760 | -0.004 | -3 | 0.712 |
CAMK1G |
0.760 | -0.012 | -3 | 0.706 |
IRAK1 |
0.759 | -0.178 | -1 | 0.668 |
CHK2 |
0.759 | -0.028 | -3 | 0.578 |
CLK4 |
0.759 | -0.008 | -3 | 0.715 |
PLK4 |
0.759 | -0.044 | 2 | 0.735 |
CDK16 |
0.758 | 0.015 | 1 | 0.501 |
PAK3 |
0.758 | -0.045 | -2 | 0.672 |
MAPKAPK3 |
0.758 | -0.009 | -3 | 0.730 |
PKCZ |
0.758 | -0.074 | 2 | 0.804 |
SGK1 |
0.758 | -0.010 | -3 | 0.554 |
DYRK2 |
0.758 | -0.034 | 1 | 0.608 |
PKCA |
0.757 | -0.035 | 2 | 0.761 |
SMG1 |
0.757 | -0.091 | 1 | 0.659 |
MAK |
0.757 | -0.029 | -2 | 0.599 |
CDK6 |
0.757 | -0.023 | 1 | 0.534 |
RSK4 |
0.756 | 0.039 | -3 | 0.682 |
PKCB |
0.756 | -0.016 | 2 | 0.763 |
AKT1 |
0.756 | -0.003 | -3 | 0.648 |
CDK4 |
0.756 | -0.026 | 1 | 0.527 |
IKKA |
0.756 | 0.054 | -2 | 0.695 |
RIPK2 |
0.755 | -0.162 | 1 | 0.648 |
PKCG |
0.755 | -0.017 | 2 | 0.788 |
ULK1 |
0.755 | -0.074 | -3 | 0.775 |
PRKD3 |
0.755 | -0.005 | -3 | 0.680 |
DYRK1A |
0.754 | -0.051 | 1 | 0.631 |
SSTK |
0.754 | -0.058 | 4 | 0.534 |
NDR1 |
0.754 | -0.038 | -3 | 0.797 |
SRPK3 |
0.754 | -0.011 | -3 | 0.669 |
AURB |
0.753 | -0.019 | -2 | 0.549 |
SRPK1 |
0.753 | 0.010 | -3 | 0.686 |
AURA |
0.753 | 0.008 | -2 | 0.521 |
CAMK1A |
0.753 | -0.008 | -3 | 0.606 |
MNK1 |
0.752 | -0.005 | -2 | 0.674 |
CDK3 |
0.752 | 0.027 | 1 | 0.500 |
MSK1 |
0.752 | -0.010 | -3 | 0.704 |
GCN2 |
0.752 | -0.069 | 2 | 0.821 |
PKCE |
0.752 | -0.010 | 2 | 0.761 |
MAPKAPK2 |
0.751 | 0.054 | -3 | 0.698 |
QIK |
0.751 | -0.121 | -3 | 0.792 |
DYRK1B |
0.751 | -0.030 | 1 | 0.567 |
CDK17 |
0.751 | -0.030 | 1 | 0.486 |
GRK3 |
0.751 | 0.002 | -2 | 0.587 |
PKACG |
0.750 | -0.028 | -2 | 0.630 |
HIPK3 |
0.749 | -0.076 | 1 | 0.609 |
PKCI |
0.749 | -0.049 | 2 | 0.771 |
RSK3 |
0.749 | -0.018 | -3 | 0.711 |
TTBK1 |
0.749 | 0.006 | 2 | 0.781 |
PDHK3_TYR |
0.749 | 0.151 | 4 | 0.685 |
MARK2 |
0.748 | -0.106 | 4 | 0.470 |
CK2A2 |
0.748 | 0.107 | 1 | 0.666 |
PKCT |
0.748 | -0.053 | 2 | 0.768 |
NIM1 |
0.748 | -0.107 | 3 | 0.811 |
PRKD2 |
0.748 | 0.028 | -3 | 0.711 |
PRKD1 |
0.747 | -0.008 | -3 | 0.757 |
LATS2 |
0.747 | -0.012 | -5 | 0.773 |
MARK1 |
0.747 | -0.092 | 4 | 0.523 |
DYRK3 |
0.747 | -0.044 | 1 | 0.617 |
CDK18 |
0.746 | -0.029 | 1 | 0.520 |
MNK2 |
0.746 | -0.025 | -2 | 0.661 |
MSK2 |
0.746 | -0.046 | -3 | 0.697 |
CLK1 |
0.746 | -0.006 | -3 | 0.685 |
CDK8 |
0.746 | -0.040 | 1 | 0.547 |
SBK |
0.746 | -0.016 | -3 | 0.512 |
YANK3 |
0.746 | 0.052 | 2 | 0.597 |
FAM20C |
0.746 | 0.179 | 2 | 0.736 |
HIPK4 |
0.746 | -0.075 | 1 | 0.679 |
P70S6K |
0.745 | -0.030 | -3 | 0.656 |
CDK13 |
0.745 | -0.050 | 1 | 0.559 |
BCKDK |
0.743 | -0.092 | -1 | 0.719 |
PKG2 |
0.743 | -0.041 | -2 | 0.571 |
PHKG1 |
0.743 | -0.047 | -3 | 0.794 |
NUAK1 |
0.742 | -0.069 | -3 | 0.743 |
MARK3 |
0.742 | -0.088 | 4 | 0.500 |
QSK |
0.742 | -0.096 | 4 | 0.540 |
CDK10 |
0.742 | -0.011 | 1 | 0.550 |
EPHA6 |
0.742 | 0.125 | -1 | 0.773 |
CLK2 |
0.742 | 0.057 | -3 | 0.696 |
MAP2K6_TYR |
0.741 | 0.047 | -1 | 0.801 |
PKACB |
0.741 | -0.002 | -2 | 0.569 |
DYRK4 |
0.741 | -0.016 | 1 | 0.540 |
AURC |
0.740 | -0.008 | -2 | 0.541 |
TESK1_TYR |
0.740 | -0.035 | 3 | 0.892 |
PDHK4_TYR |
0.740 | 0.036 | 2 | 0.890 |
CDK7 |
0.740 | -0.065 | 1 | 0.570 |
CK2A1 |
0.739 | 0.072 | 1 | 0.649 |
CDK12 |
0.739 | -0.059 | 1 | 0.537 |
YANK2 |
0.739 | 0.031 | 2 | 0.610 |
BMPR2_TYR |
0.738 | 0.031 | -1 | 0.768 |
NDR2 |
0.738 | -0.046 | -3 | 0.805 |
PKN1 |
0.738 | -0.021 | -3 | 0.664 |
CK1D |
0.737 | -0.007 | -3 | 0.529 |
SIK |
0.737 | -0.082 | -3 | 0.740 |
CDK9 |
0.737 | -0.072 | 1 | 0.568 |
SRPK2 |
0.737 | 0.009 | -3 | 0.619 |
HIPK2 |
0.737 | -0.032 | 1 | 0.528 |
PDHK1_TYR |
0.736 | 0.025 | -1 | 0.813 |
AKT3 |
0.736 | -0.008 | -3 | 0.564 |
PINK1_TYR |
0.736 | -0.056 | 1 | 0.745 |
MAP2K4_TYR |
0.736 | -0.070 | -1 | 0.781 |
SNRK |
0.735 | -0.139 | 2 | 0.763 |
EPHA4 |
0.735 | 0.150 | 2 | 0.873 |
INSRR |
0.735 | 0.094 | 3 | 0.772 |
EPHB4 |
0.734 | 0.072 | -1 | 0.757 |
MAP2K7_TYR |
0.734 | -0.163 | 2 | 0.889 |
RET |
0.734 | -0.007 | 1 | 0.710 |
CDK19 |
0.732 | -0.038 | 1 | 0.514 |
PKACA |
0.732 | -0.014 | -2 | 0.524 |
LIMK2_TYR |
0.732 | -0.068 | -3 | 0.847 |
BRSK1 |
0.731 | -0.063 | -3 | 0.746 |
FER |
0.731 | 0.060 | 1 | 0.769 |
TYK2 |
0.730 | -0.026 | 1 | 0.708 |
CSF1R |
0.730 | 0.003 | 3 | 0.812 |
PHKG2 |
0.730 | -0.031 | -3 | 0.750 |
CK1A2 |
0.730 | -0.018 | -3 | 0.525 |
FGFR2 |
0.730 | 0.039 | 3 | 0.808 |
ABL2 |
0.730 | 0.029 | -1 | 0.741 |
FLT3 |
0.729 | 0.018 | 3 | 0.806 |
TYRO3 |
0.729 | -0.058 | 3 | 0.818 |
ROS1 |
0.729 | -0.025 | 3 | 0.799 |
BRSK2 |
0.729 | -0.108 | -3 | 0.772 |
CK1E |
0.728 | -0.013 | -3 | 0.577 |
PKMYT1_TYR |
0.728 | -0.199 | 3 | 0.861 |
PAK6 |
0.728 | -0.023 | -2 | 0.621 |
DDR1 |
0.728 | -0.076 | 4 | 0.595 |
JAK3 |
0.727 | -0.011 | 1 | 0.692 |
TXK |
0.727 | 0.053 | 1 | 0.725 |
EPHB1 |
0.727 | 0.053 | 1 | 0.750 |
MAPKAPK5 |
0.727 | -0.100 | -3 | 0.665 |
MST1R |
0.726 | -0.088 | 3 | 0.819 |
EPHB2 |
0.726 | 0.090 | -1 | 0.739 |
PDGFRB |
0.726 | -0.027 | 3 | 0.825 |
EPHB3 |
0.726 | 0.063 | -1 | 0.745 |
JAK2 |
0.725 | -0.046 | 1 | 0.699 |
KIT |
0.725 | -0.003 | 3 | 0.813 |
SRMS |
0.725 | 0.058 | 1 | 0.766 |
FGR |
0.725 | -0.020 | 1 | 0.721 |
LIMK1_TYR |
0.725 | -0.192 | 2 | 0.879 |
KIS |
0.725 | 0.032 | 1 | 0.586 |
PRKX |
0.724 | 0.022 | -3 | 0.635 |
YES1 |
0.724 | -0.022 | -1 | 0.704 |
TEK |
0.724 | -0.014 | 3 | 0.756 |
FGFR3 |
0.723 | 0.045 | 3 | 0.782 |
KDR |
0.723 | -0.020 | 3 | 0.779 |
ABL1 |
0.723 | -0.020 | -1 | 0.722 |
ITK |
0.722 | 0.006 | -1 | 0.685 |
MERTK |
0.722 | 0.016 | 3 | 0.783 |
FGFR1 |
0.721 | -0.034 | 3 | 0.781 |
EPHA7 |
0.721 | 0.070 | 2 | 0.888 |
FLT1 |
0.721 | 0.022 | -1 | 0.795 |
EPHA5 |
0.720 | 0.108 | 2 | 0.870 |
ERBB2 |
0.720 | 0.004 | 1 | 0.710 |
FLT4 |
0.720 | 0.008 | 3 | 0.770 |
NTRK1 |
0.719 | 0.001 | -1 | 0.752 |
HCK |
0.719 | -0.034 | -1 | 0.694 |
EGFR |
0.719 | 0.074 | 1 | 0.632 |
FRK |
0.719 | 0.041 | -1 | 0.748 |
EPHA3 |
0.719 | 0.032 | 2 | 0.866 |
AXL |
0.718 | -0.048 | 3 | 0.792 |
LCK |
0.718 | -0.013 | -1 | 0.695 |
LTK |
0.718 | -0.013 | 3 | 0.760 |
PDGFRA |
0.718 | -0.086 | 3 | 0.820 |
BTK |
0.718 | -0.052 | -1 | 0.659 |
TNK2 |
0.716 | -0.086 | 3 | 0.762 |
ALK |
0.716 | -0.046 | 3 | 0.740 |
INSR |
0.715 | -0.025 | 3 | 0.747 |
BMX |
0.715 | -0.013 | -1 | 0.616 |
EPHA8 |
0.715 | 0.068 | -1 | 0.724 |
BLK |
0.715 | 0.011 | -1 | 0.708 |
NEK10_TYR |
0.715 | -0.064 | 1 | 0.625 |
MET |
0.714 | -0.068 | 3 | 0.792 |
SYK |
0.714 | 0.094 | -1 | 0.713 |
TEC |
0.714 | -0.041 | -1 | 0.614 |
PAK5 |
0.713 | -0.071 | -2 | 0.552 |
MATK |
0.713 | -0.010 | -1 | 0.701 |
PTK2 |
0.713 | 0.081 | -1 | 0.680 |
TNK1 |
0.712 | -0.123 | 3 | 0.796 |
WEE1_TYR |
0.711 | -0.078 | -1 | 0.660 |
FYN |
0.711 | 0.013 | -1 | 0.647 |
NTRK2 |
0.711 | -0.079 | 3 | 0.762 |
FGFR4 |
0.710 | 0.044 | -1 | 0.714 |
EPHA1 |
0.710 | -0.057 | 3 | 0.771 |
JAK1 |
0.710 | -0.056 | 1 | 0.668 |
TNNI3K_TYR |
0.710 | -0.102 | 1 | 0.653 |
NTRK3 |
0.710 | -0.043 | -1 | 0.718 |
PTK2B |
0.708 | -0.006 | -1 | 0.644 |
PTK6 |
0.708 | -0.130 | -1 | 0.636 |
CSK |
0.708 | 0.010 | 2 | 0.885 |
EPHA2 |
0.708 | 0.069 | -1 | 0.710 |
DDR2 |
0.707 | -0.042 | 3 | 0.760 |
IGF1R |
0.707 | 0.014 | 3 | 0.685 |
LYN |
0.705 | -0.046 | 3 | 0.733 |
ERBB4 |
0.704 | 0.041 | 1 | 0.663 |
MUSK |
0.702 | -0.042 | 1 | 0.623 |
PAK4 |
0.702 | -0.072 | -2 | 0.548 |
SRC |
0.699 | -0.056 | -1 | 0.646 |
PKG1 |
0.696 | -0.092 | -2 | 0.505 |
CK1G1 |
0.696 | -0.036 | -3 | 0.595 |
CK1G3 |
0.694 | -0.019 | -3 | 0.406 |
FES |
0.682 | -0.077 | -1 | 0.583 |
ZAP70 |
0.682 | -0.031 | -1 | 0.624 |
CK1G2 |
0.677 | -0.027 | -3 | 0.506 |
CK1A |
0.668 | -0.025 | -3 | 0.452 |